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“Difficulties are just things to overcome, after all.” 
Ernest H. Shackleton (antarctic explorer)
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A Introduction – Synthesis and applications of cyclopropanated furan and 
pyrrole derivatives 
1 Introduction 
 
Cyclopropanated furan and pyrrole derivatives represent a class of highly valuable 
compounds with unique structural features that have been utilized in a number of elegant 
synthetic approaches so far. Their versatile reactivity makes them powerful intermediates and 
allows for various orthogonal functionalizations and transformations. This account will focus 
on compounds with the general substructures of 1 and 2 (figure 1).  
 
 
Figure 1. General structure of cyclopropanated furan (X = O) and pyrrole (X = NR) derivatives and possible 
transformations of them. 
 
Figure 1 illustrates the core structure of the title compounds and the general scope for their 
further transformation. A brief history of the first literature precedents will be given, followed 
by recent methods for the preparation of compounds like 1 and 2, with a special focus on 
enantioselective reactions. In addition, applications in the synthesis of natural products and 
other synthetically useful compounds will be presented. Cyclopropanated benzofurans and 
indoles as well as doubly cyclopropanated furans have also been described, but will not be 
covered in here.  
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2 Methods for the preparation of cyclopropanated furan and pyrrole derivatives 
 
The first examples of cyclopropanated furans date back to the 1960s, when Müller and 
co-workers used diazomethane and copper(I)-bromide for the cyclopropanation of furan to 
synthesize homofuran 1 (X = O, R1 = R2 = R3 = H).[1] While cyclopropanation of furan by 
photo-induced decomposition of diazo compounds was already reported in 1958 by Schenck 
and Steinmetz,[2, 3] the decomposition of diazoesters catalyzed by dirhodium tetraacetate for 
cylopropanation reactions of furan itself and derivatives thereof was carried out by Wenkert et 
al. in the 1990s.[4-6] Furthermore, they recognized the intrinsic instability of the 
unsubstituted furanocyclopropane moiety bearing an ester group at the three-membered ring, 
which was put to an advantage with the synthesis of highly unsaturated open-chain aldehydes 
via ring opening / isomerization. More importantly, the authors could already prove that 
electron-withdrawing groups on the furan ring increase the stability of the cyclopropanated 
adducts dramatically, thus allowing a multifaceted follow-up chemistry. On the other hand, 
first efforts for the cylcopropanation of pyrrole derivatives and their application in 
cycloaddition reactions were conducted by Fowler in the early 1970s.[7-9] Copper complexes 
with homoscorpionate based ligands were shown to be able to catalyze cyclopropanation 
reactions of furans, although only in racemic form.[10, 11] Current methods for the 
enantioselective synthesis of cyclopropanated furans (1) and pyrrols (2) are based on the 
decomposition of diazo compounds with chiral metal complexes.[12] Copper(I)-complexes 
with chiral bis(oxazoline) (box, 5-7) or aza-bis(oxazoline) (azabox, 8-9) ligands have been 
shown to be superior catalysts for intermolecular cyclopropanation reactions of furans 
(scheme 1).[13-15] However, only very few derivatives are accessible in enantiomerically 
pure form so far (scheme 1, lower part).  
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Scheme 1. Top: Enantioselective cyclopropanation of 2-methyl furoate 3 reported by Reiser et al. Depending on 
the absolute configuration of the applied ligand, both enantiomers of cyclopropane 4 can be obtained in 
enantiomerically pure form and multi-gram quantity.[15] Bottom: Overview of the most successful results in 
literature for enantioselectively cyclopropanated of furan and pyrrole derivatives with the applied ligand (or 
catalyst) and the corresponding reference (red values in brackets were obtained after recrystallization).  
Chiral rhodium(II)-catalysts like 10 have also emerged for such kind of transformations, 
however, with limited success (16, 17).[16] For the preparation of cyclopropanated pyrroles 2 
(see 17 and 18) no direct asymmetric cyclopropanation reaction is known so far. Nevertheless, 
other methods for accessing enantiomerically pure 18 have been achieved (see main part 
chapter B 1.3.1).[17, 18] New accomplishments and optimizations of asymmetric 
cyclopropanation reactions of furan and pyrrole derivatives will be presented in the main part 
of the present thesis. In the following chapter, possible transformations of the compounds 
presented above will be discussed.  
 
3 Transformations of cyclopropanated furans and pyrroles  
 
The simplest representatives of the title compounds are homofuran 1 (X = O) and 
homopyrrole 2 (X = NR). These molecules have been employed in a manifold of 
cycloaddition reactions, as they exhibit unique properties as masked 1,5-dipoles.[19-22] 
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Under thermal activation, 1 or 2 can rearrange to form compounds of type 19, being a highly 
reactive intermediate that can undergo [5+2] cycloaddition reactions with suitable dienophiles 
to form seven-membered ring systems 20 with ease (scheme 2). By density functional theory 
(DFT) calculations it was shown that homofuran 1 and homopyrrole 2 display relatively low 
distortion energies for the reaction to 19, which was claimed to be the main reason for their 
ability to undergo metal-free [5+2] cycloaddition reactions.[23] 
 
Scheme 2. Reactivity of homofuran 1 (X = O) and homopyrrole 2 (X = NR). Under thermal conditions 1 or 2 
can serve as masked 1,5-dipoles for [5+2] cycloaddition reactions, yielding products like 21-23.[7, 8, 23, 24] 
Tanny and Fowler could show that also cylopropanated pyrrole derivatives bearing an ethyl 
ester moiety at the 6-position are able to undergo analogous reactions with suitable 
nucleophiles.[25] On the other hand, racemic cyclopropanated furan 24 was shown to undergo 
a [4+2] cycloaddition reaction with diethyl azodicarboxylate (DEAD).[26] Nevertheless, 
applications of homofuran and homopyrrole derivatives are limited, and cyclopropanated 
furan and pyrrole esters (4, 15, 18, 24) proved to be superior building blocks for synthesis, 
since access to enantiomerically pure material is feasible and possible transformations are 
more diverse. Figure 2 gives an overview of accessible target compounds (25-34) and details 
on their syntheses and properties will be discussed in the following sections.   
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Figure 2. Overview of accessible compounds from cyclopropanated furan and pyrrole esters (mGlu = 
metabotropic glutamate; ACC = aminocyclopropanecarboxylic acid).  
 
3.1 Transformations of cyclopropanated furan derivatives 
 
A rhodium catalyzed cyclopropanation of furan 35 with diazo compound 36 was used for the 
total synthesis of racemic 12-hydroxyeicosatetraenoic acid 38 by Fitzsimmons and co-workers 
via an intermediary cyclopropane and open-chain aldehyde 37 (scheme 3).[27] Hereby, the 
authors made use of the cyclopropane ring unraveling process introduced earlier by Wenkert 
et al.[28] 
 
Scheme 3. Synthesis of 12-hydroxyeicosatetraenoic acid 38 by Fitzsimmons et al. through cyclopropanation of 
furan 35 with diazoester 36 and subsequent cyclopropane unraveling.[27] 
In 1999, Monn and colleagues synthesized bicyclic amino acid LY379268 (32) in ten steps 
from furan ester 24 and found it to be a remarkably potent agonist for group II metabotropic 
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glutamate (mGlu) receptors.[29, 30] A powerful methodology for the construction of 
trans-4,5-disubstituted γ-butyrolactones 43 from cyclopropanated furan 4 was presented by 
Reiser and co-workers,[13, 15, 31, 32] which enables the access to a manifold of natural 
products, including Paraconic acids, Eudesmanolides, Elemanolides, Guaianolides and 
Xanthanolides (scheme 4).[33-37] After ozonolytic cleavage of the double bond in 4 with 
reductive work-up, a diastereoselective addition of various nucleophiles (Nu) to the aldehyde 
function of 39 can be performed, which yields either the Felkin-Ahn or Cram-Chelate 
products (depending on the nucleophile) in high selectivity.[36] Base-induced saponification 
of the oxalic ester moiety in 40 leads to donor-acceptor (DA) substituted cyclopropane 41, 
which undergoes a retroaldol/lactonization sequence (via 42) to yield diversely substituted 
lactones of type 43.  
 
Scheme 4. Synthetic sequence for the stereoselective preparation of trans-4,5-disubstituted γ-butyrolactones 43 
as precursors for the synthesis of sesquiterpenelactone based natural products (FA = Felkin-Ahn).[38] 
This method has been applied successfully for the construction of several natural products, 
amongst them various Paraconic acids (e.g. Roccellaric acid 25),[31, 39] ArglabinTM 26[40] 
and Arteludovicinolide A 30 (see also figure 2).[41] Another promising method for the 
application of cyclopropanated furans is the acid-catalyzed cyclopropane ring opening 
reaction followed by lactonization that is depicted in scheme 5. It has to be noted that related 
transformations were reported earlier.[42, 43] As an application of this methodology cis-fused 
5-oxofuro[2,3-b]furans of type 44 and 45 can be generated, with an carboxylic acid function 
either in 2- or 3-position (44 and 45) depending on the furan starting material being used. 
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Scheme 5. Facile access to cis-fused 5-oxofuro[2,3-b]furans of type 44 and 45 based on acid-catalyzed 
cyclopropane opening and subsequent lactonization starting from 2- or 3-substituted furans.[44, 45] 
While bicyclic lactone 45 can serve as starting point into several spongiane diterpenoid 
natural products (e.g. Norrisolide, Macfarlandin C, Cheloviolene A and B),[46] 44 has been 
successfully used for the enantioselective synthesis of (-)-Paeonilide 27 in ten steps from 
cyclopropane 15 (in 83% ee, see main part chapter B 1.2 for details). Recently, 
tetrahydrofuran derivative 31 and various related compounds were prepared from 
cyclopropane 4 as potent histamine hH3 receptor antagonists (figure 2).[47] 
 
3.2 Transformations of cyclopropanated pyrrole derivatives 
 
In contrast to the furan derivatives presented above, cyclopropanated pyrroles have been 
applied for the construction of a variety of biologically relevant nitrogen containing 
compounds (figure 2). For instance, so-called β-aminocyclopropanecarboxylic acids (β-ACCs 
33)[17, 48-52] – conformationally constrained β-amino acids – have been successfully 
employed in a variety of artificial peptide sequences as rigidifying compounds. The 
combination of 33 with α-amino acids allowed in peptides the construction of new secondary 
structural motifs,[53] biologically active ligands toward Neuropeptide Y, Orexin and CPRG 
receptors [54-57] as well as organocatalysts (see main part chapter B 4 for details).[58, 59] 
Comparable to the procedure in scheme 4, an ozonolytic cleavage of the remaining double 
bond in 18 was again the key step for the preparation of these valuable unnatural amino acids. 
Besides opening the pyrrol ring that led to the synthesis of conformationally constrained 
amino acids 33, pyrrole derivative 18 could also be employed in transformations that 
selectively open the cyclopropane ring. For example, 18 can be converted into 
4-functionalized pyrrolidin-2-one 28 within four steps. From there, multiple functionalizations 
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of 28, as well as the synthesis of (S)-Vigabatrin 29 have been accomplished.[18] 
Cyclopropane 18 was also subjected to a Povarov reaction for the construction of complex 
heterocyclic compounds like 34 and 51 (scheme 6).[60] In this case aromatic imines, which 
are in situ formed from aldehydes 46 or 48 and aniline derivatives 47 or 49, undergo a [4+2] 
cycloaddition reaction with cyclopropanated pyrrole 18 in order to establish a six-membered 
ring system.  
 
Scheme 6. Lewis acid catalyzed multicomponent reactions for the construction of complex heterocyclic 
compounds 34 and 51 (mw = microwaves, single fragments are color coded for clarity).[60] 
Depending on the reaction conditions, these intermediates can react further in different 
pathways to form either cis-4,5-disubstituted pyrrolidinones 34 or compounds like 51, where 
pyrrole 50 was added as an external nucleophile for trapping the intermediary iminium ion 
resulting from cyclopropane opening. Landais and Renaud et al. were able to add phenylthiol 
to a cyclopropanated pyrrole (X = NCO2Me, R1 = R2 = H, R3 = Et) under UV irradiation via a 
free-radical mechanism, however, only in 32% yield and a 1:1 mixture of diastereomers for 
this single example.[61] All in all, the literature examples presented above demonstrate the 
synthetic utility of cyclopropanated furans and pyrrols. Moreover, it seems obvious that from 
such a class of important molecules new and creative ideas for their transformations will arise 
in the future. In the present thesis, attempts for the optimization of heterocycle 
cyclopropanation, as well as subsequent transformations of the latter were carried out. The 
results are presented in the following. 
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B Main part 
1 Asymmetric cyclopropanations of furan and pyrrole derivatives 
1.1 Synthesis of the ligands for asymmetric cyclopropanation reactions 
 
A central part of the present thesis deals with the asymmetric cyclopropanation of 
heterocyclic substrates using chiral copper(I)-complexes. Thus, we have focused on the 
application of the well-established aza-bis(oxazoline) (azabox) ligands 56 that were 
developed in the Reiser group[62, 63] and have already found various successful applications 
in asymmetric catalysis.[64-66] Structurally related to the parent semicorrines 52,[67-69] the 
aza-semicorrines 53,[70] and the bis(oxazolines) (box, 54),[71-75] azabox ligands combine 
several positive aspects like accessibility from the chiral pool (starting from amino alcohols), 
a high degree of diversity, and the potential of functionalization and/or immobilization on the 
central nitrogen atom (figure 3).[76-80] One step further from box and azabox ligands was 
made by Tang et al. and Gade et al. with the invention of tripodal tris(oxazoline) (tox) ligands 
with an additional binding site (figure 3).[81, 82] However, the basis of box, azabox and tox 
ligands was made by Brunner et al., who introduced oxazolines to catalysis already in 
1989.[83, 84] 
 
Figure 3. General chemical structures of different N-containing bi- and tridentate ligands for catalysis. 
 
The original synthesis of azabox ligands published in 2000 was based on the direct coupling 
of two molecules of aminoxazoline 57 promoted by benzaldehyde 48 (method A, table 1).[62] 
Using this method it was possible to prepare ligands with tert-butyl and iso-propyl 
substituents, however, yields were not always satisfying and there was no access to 
asymmetrically substituted ligands with a higher degree of diversity. In 2003, Reiser and 
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co-workers presented a new solution to such problems (method B, table 1). Thus, by making 
use of alkylated oxazolidinones 59 as coupling partners with the established aminooxazolines 
57 new types of ligands were accessible, partially in better yields.[63] Table 1 gives an 
overview of all so far synthesized azabox ligands (with free NH), the method of preparation, 
as well as the corresponding yields of the final coupling step, while figure 4 shows the 
chemical structures of the corresponding ligands. 
 
Table 1. Overview of all so far synthesized azabox ligands (with free NH) from the Reiser group. 
entry method R1 R2 ligand yield [%] 
1a) A iPr iPr 60 53 
2b) B iPr iPr 60 51 
3a) A tBu tBu 8 58 
4b) B tBu tBu 8 92 
5b,c) B tBu Ph 63 64 
5b,c) B Ph Ph 61 35 
6d) B Bn Bn 62 35 
7e) B iPr H 64 69 
8e) B iPr gem-di-Me 65 57 
9e,f) B tBu H 66 62 
10e,f) B tBu gem-di-Me 67 59 
11g) A indanyl indanyl 68 26 
12g) B indanyl indanyl 68 68 
a) ref. [62]; b) ref. [63]; c) reaction carried out at 50 °C due to thermal lability of 61; d) ref. [64]; e) ref. [85]; f) 
ref. [86]; g) ref. [87].  
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Figure 4. Overview of all so far synthesized azabox ligands (with free NH) from the Reiser group. 
 
Scheme 7 gives an overview of the exemplary synthesis of tert-butyl-azabox 8 following the 
improved methodology.[63] 
 
Scheme 7. Exemplary reaction scheme for the synthesis of tert-butyl substituted azabox ligand 8 following the 
improved methodology of Reiser et al., and functionalization of the central N-atom to yield 9 and 74. 
Reduction of the amino acid 69 according to a protocol of McKennon and Meyers[88] yields 
amino alcohols 70 in good to excellent yields,[89] which serve as starting point for both 
coupling partners. On the one hand, 70 is cyclized to the corresponding aminooxazoline 71 by 
the use of in situ prepared cyanogen bromide (protocol of Poos et al.).[90-92] On the other 
hand, amino alcohol 70 is transformed into ethoxyoxazoline 73 in a two-step procedure. First, 
70 is cyclized to the oxazolidinone 72 by the use of diethylcarbonate under basic conditions 
and then alkylated using Meerwein’s reagent[93-95] to yield 73. The final acid catalyzed step 
couples the aminooxazoline 71 with the ethoxyoxazoline 73 to yield azabox ligands in 
varying yields, strongly depending on the nature of the substituents (see table 1 for details). 
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Further functionalization of the central nitrogen atom can be readily achieved by 
deprotonation with n-butyl lithium, followed by trapping with a suitable electrophile (scheme 
7). As the new synthesis of azabox ligands by Reiser et al. (scheme 7; ref. [63]) was based on 
studies by Gawley et al., who investigated the reactivity of ethoxyoxazolines 75 toward amine 
nucleophiles (scheme 8),[96] the idea for developing a simpler approach without the need for 
an aminooxazoline came to our mind.  
 
Scheme 8. Reaction of ethoxyoxazoline 75 with secondary amine 76 investigated by Gawley et al.[96] 
As was already shown by Gawley and co-workers, ethoxyoxazolines are capable of reacting 
with secondary amines, thus, making use of the high reactivity of 78, they could be applied 
for a much more convenient synthesis of azabox ligands. Based on these results 78, should 
also react with ammonia or primary amines in order to form aminooxazolines of type 79. 
These could further react with a second molecule of ethoxyoxazoline 78 to form azabox 
ligands with free NH or substituted derivatives (80), respectively (scheme 9).  
 
Scheme 9. Proposed strategy for a more convenient synthesis of azabox ligands 80 based on the condensation of 
ammonia or primary amines with two equivalents of alkylated oxazolidinones 78. 
For the investigation of our proposed strategy we have applied two different nitrogen sources, 
namely a solution of ammonia in methanol (7 M) and N-benzylamine. Main criteria for the 
choice of amines were manageability (e.g. boiling point) and the potential resulting target 
molecules. Furthermore, all experiments were carried out with iso-propyl substituted 
ethoxyoxazoline 75, as its starting material L-valine is among the most abundant and 
inexpensive alternatives herein (compared for instance to tert-leucine 69). Table 2 
summarizes the experiments carried out to study the proposed strategy.   
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N
OO
R-NH2
N
N N
OO
R
75 60 (R = H)
81 (R = Bn)
solvent, temp. N
H
NO Ph
82
 
 
Table 2. Attempts for the preparation of azabox ligands by direct coupling with amines.1 
entrya) N-source product solvent catalyst temperature [°C] yield [%]d) 
1 NH3/MeOH 60 MeOH - 50 8 
2b) NH3/MeOH 60 MeOH - 50 12 
3 NH3/MeOH 60 MeOH - 80 16 
4 BnNH2 82 toluene - 125 17e) 
5 BnNH2 82 toluene p-TSA 125 84e) 
6c) 82 - toluene p-TSA 125 - 
a) 1.89 mmol (2 equiv) 75, 0.95 mmol (1 equiv) R-NH2, 0.09 mmol (0.1 equiv) p-TSA, 5 ml solvent, 24 h; b) 
ratio 75/R-NH2 (2:3); c) 0.95 mmol 82 (1 equiv), 4.75 mmol 75 (5 equiv), 0.10 mmol (0.1 equiv) p-TSA, 5 ml 
toluene, 24 h, reflux; d) isolated yields after column chromatography; e) no azabox formed, yield of 
mono-substitution product 82. 
 
Looking at table 2 it can be seen that the reaction did indeed work, but only in rather poor 
yields. Reactions employing a solution of ammonia in methanol (entries 1-3) resulted in 
unsubstituted azabox 60 with yields between 8% and 16%. Using N-benzylamine as the 
nucleophile, only the mono-substitution product 82 was obtained instead of the desired 
azabox 81 (entries 4-5). Moreover, an attempt of transforming secondary amine 82 into the 
desired N-benzyl-azabox 81 with an excess of ethoxyoxazoline 75 failed, probably due to the 
high steric demand of 82 (entry 6). In regard of the overall low yields for this approach no 
further investigations were conducted.  
 
Besides the well-known reactivity of ethoxyoxazolines toward nucleophiles, it is also known 
that 2-chloro- and 2-bromooxazolines are capable of undergoing substitution reactions with a 
variety of nucleophiles. This was first shown by Sam and Plampin in 1964 when they 
investigated the synthesis of new benzoxazole derivatives as skeletal muscle relaxants 
(scheme 10).[97] 
                                                           
1
 Results are partially taken from the Bachelors thesis of M. Halder (supervised by L. Pilsl). 
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Scheme 10. Synthesis of aza-bis-benzoxazole 84 from 2-chlorobenzoxazole 83 by Sam and Plampin. 
Although, the resulting double coupling product 84 was rather an unwanted by-product in 
their case, it nevertheless demonstrated the possibilities of such substrates. More recently, 
Bellemin-Laponnaz and Gade et al. were reacting 2-bromooxazolines 85 with imidazoles for 
the synthesis of N-heterocyclic carbene (NHC) ligands (scheme 11).[98] 
 
Scheme 11. Synthesis of NHC ligands from 2-bromooxazoline 85 by Bellemin-Laponnaz and Gade et al.[82] 
In terms of such a reactivity pattern, it seemed applicable to try substitution of 
2-bromooxazolines with ammonia in order to obtain azabox ligands (scheme 12). Direct 
lithiation of the 2-H-oxazoline 872 by the use of tert-butyllithium, followed by in situ 
bromination of the lithiated species with 1,2-dibromo-1,1,2,2-tetrafluoroethane is an 
established methodology for the preparation of bromooxazolines.[99-101] 
 
Scheme 12. Attempt for the direct lithiation-bromination-amination strategy for the synthesis of azabox 8 based 
on 2-H-oxazoline 87. 
Due to the fact that bromooxazolines are not permanently stable and tend to isomerize,[100] it 
was chosen to generate them in situ and directly convert them into the corresponding 
aminoxazolines/azabox ligands. Subsequent substitution of the bromide with methanolic 
ammonia was intended to yield an intermediary aminooxazoline of type 79, which could then 
further react to the desired azabox ligand 8 (scheme 12). However, this strategy did not lead 
to any product formation, and upon the failure of this approach no further efforts were made 
                                                           
2
 Oxazoline 87 was provided by M. Knorn. 
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to study such coupling reactions in more detail. In the course of this project the established 
synthesis procedure of Reiser et al.[63] was applied for the preparation of the required 
ligands.  
 
1.2 Asymmetric cyclopropanation of furan derivatives 
 
While cyclopropanation products of furan with diazoacetates have been shown to be rather 
unstable and tend to rearrange (see also introduction),[10, 12, 13, 102, 103] the 
enantioselective cyclopropanation of furan-2-carboxylic acid methyl ester 3 is a 
well-established process. It was developed in the Reiser group and is regularly performed on a 
multi-gram scale in our laboratories.[13-15, 31] Since then, this methodology was applied for 
a variety of γ-butyrolactone-containing natural product syntheses[32, 34-36, 39-41] and other 
synthetically useful compounds.[47, 60] In contrast, furan-3-carboxylic acid 88 was used as 
starting point for the synthesis of (-)-Paeonilide by Harrar and Reiser.[45] The key 
intermediate for their synthesis was cyclopropanated furoic ester 15 from which on they were 
able to synthesize 27 in ten steps and an overall yield of 14% (12 steps, 4.4% yield, 7.7% 
brsm, starting from commercially available furan-3-carboxylic acid 88). However, due to the 
lack of complete stereocontrol during the crucial cyclopropanation step, (-)-Paeonilide 27 
could only be prepared in a maximum of 83% enantiomeric excess. Scheme 13 depicts an 
overview of the synthesis of (-)-paeonilide 27 by Harrar and Reiser.  
 
 
Scheme 13. Enantioselective synthesis of (-)-Paeonilide 27 from 3-furoic acid 88 (via 15, 44, 89, 90) by Harrar 
and Reiser.[45]  
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Table 3 summarizes all so far reported attempts for the enantioselective cyclopropanation of 
91 (entries 1-8). When applying ethyldiazoacetate (R = Et) a maximum of 31% yield and 83% 
ee could be reached (entry 1), while for tert-butyl substituted analogue 15 38% yield and 
analogous 83% ee could be realized in the best case so far (entry 6). As these results display 
the state-of-the-art for this important molecule, we envisioned to find a reasonable solution to 
this problem.  
 
Table 3. Asymmetric cyclopropanation of furan-3-carboxylic acid methyl ester 91.[14, 39, 45] 
entrya) R ligand temperature [°C] 
ratio 
Cu/ligand 
yield [%]f) ee [%]g) 
1b) Et 6 0 0.8 31 83 
2c) Et 5 0 0.8 22 74 
3c) Et 7 0 0.8 27 74 
4d) Et 93 0 0.8 31 68 
5d) Et 94 0 0.8 19 40 
6b) tBu 6 0 0.8 38 83 
7b) tBu 7 0 0.8 38 65 
8b) tBu 92 0 0.8 34 19 
9 tBu 8 0 0.5 55 92 
10 tBu 9 0 0.5 38 94 
11 tBu 8 -10 0.5 31 93 
12 tBu 9 -10 0.5 21 92 
13e) tBu 8 0 0.5 47 89 (99)h) 
a) 3.97 mmol (500 mg) 91, 1 mol% Cu(OTf)2, 2.2 mol% ligand, 1 mol% PhNHNH2, 1.5 equiv diazoester, 3 ml 
DCM; b) ref. [45]; c) ref. [39]; d) ref. [14]; e) 102.4 mmol (12.91 g) 91; f) isolated yield; g) determined by chiral 
HPLC; h) 19%, > 99% ee after single recrystallization from n-pentane.  
 
From earlier studies with box and azabox ligands it is known that the derived copper 
complexes predominantly form 1:2 complexes with two ligand molecules bound to the metal 
center,[66, 104] thus the ratio for our experiments was set to 0.5 (1 mol% Cu/2.2 mol% 
  
ligand; entries 9-13) in contrast to the former investigations (0.8; entries 
applied ligands 8 and 9 are directly compared 
size of the substituent on the central nitrogen atom is 
selectivity (92-94% ee, entries 
shows significantly better results compared to its methylated analogue 
11/12). Furthermore, the substantial influence of temperature on the performan
reactions becomes obvious when comparing the yields of entries 
respectively. A significant drop of the yields for both catalysts becomes evident when the 
temperature is lowered from 0 °C to 
for 8, and 38% to 21% for 9). Best results were obtained when using 
NH at 0 °C, yielding 15 in thus far surpassing 55% and excellent 92% 
intrigued us to perform a large scale experiment u
entry 9. Fortunately, when upscaling the reaction only a low decrease in yield and 
enantioselectivity was observed, giving rise to 
89% ee. Most importantly, the product
enantiopure form (table 3, entry 
chromatogram of enantiopure 
 
Figure 4. Analytical HPLC chromatogram 
Cellulose-2, n-heptane/iPrOH = 99:1, flow = 1.0 ml/min, 
racemic data see ref. [45]).  
All in all, three significant parameters
modified compared to the original 
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1
to each other one clearly 
rather negligible
9-12). However, in terms of yield the ligand with the free NH 
9
9 with 11, and 10 with 12,
-10 °C, independent of the applied ligand (55% to 31% 
tBu-
ee
nder the very same conditions applied in 
cyclopropane 15 in 47% isolated yield and 
 could be recrystallized from n-pentane to yield 
13, and figure 4). Figure 4 depicts the analytical chiral HPLC 
(S,R,S)-(-)-15.  
for enantiomerically pure (S,R,S)-(-)-15
λmax = 254 nm (tr = 12.3 min (+)
 for the cyclopropanation reaction of 3
efforts by Harrar[45] in order to yield optimum results. 
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-8). When the two 
recognizes that the 
 with regard to 
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 (entries 9/10 and 
ce of the 
 
azabox 8 with free 
. This observation 
15 in 
 
. Phenomenex Lux 
, tr = 16.7 min (-); for 
-furoic acid were 
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The type of ligand was exchanged from box to azabox ligands, the ratio of metal to ligand 
(stoichiometry of catalyst) was changed from approximately 1:1 to 1:2, and finally – and also 
most importantly – suitable conditions for a recrystallization of crude 15 were found, giving 
access to enantiopure material in gram scale for the first time. Based on the herein presented 
results, the synthesis of enantiopure (-)-Paeonilide, as well as its natural enantiomer 
(+)-Paeonilide, is currently ongoing in the Reiser group. 
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1.3 Asymmetric cyclopropanation of N-Boc-pyrrole 
1.3.1 Synthesis of (S,S,S)-(-)-103 
 
In table 4 the state-of-art results for the asymmetric cylopropanation of N-Boc-pyrrole 101 are 
summarized. Eleven different ligands have been employed so far, among them azabox (8, 9, 
60, 95), regular box (7, 96, 97), as well as box ligands with secondary binding sites (93, 98, 
99), and a chiral ferrocene based ligand 100 (figure 5).  
 
N N
OO
R4 R4
R3R3
96 (R3 = Me, R4 = Ph)
7 (R3 = Ph, R4 = OH)
97 (R3 = Ph, R4 = OAc)
N N
OO
PhPh
OO
OO
R6
HN
R5
NH
R6 R5
93 (R5 = Me, R6 = Boc)
98 (R5 = Me, R6 = Ac)
99 (R5 = iPr, R4 = Cbz)
Fe
N
O
N
Ph
Me
H
100
N
N N
OO
R2 R2
R1
60 (R1 = H, R2 = iPr)
8 (R1 = H, R2 = tBu)
95 (R1 = Me, R2 = iPr)
9 (R1 = Me, R2 = tBu)  
Figure 5. Chemical structures of the employed ligands for asymmetric cyclopropanation approaches of 
N-Boc-pyrrole 101 reported so far.  
In all cases besides one (entry 9), methyldiazoacetate was used as the carbene source for those 
experiments (entries 1-8). When having a look at table 4 it becomes apparent that a level of 
enantioselectivity better than moderate has not been reached so far. Despite the relatively 
good yields (max. 63%), the best results in terms of selectivity were obtained when using 
azabox ligands 8 or 9 (giving 52 and 55% ee respectively). This is far from acceptable if one 
considers using 18 as starting material for amino acid or natural product synthesis.  
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3
 
Table 4. Literature results for the asymmetric cyclopropanation of N-Boc-pyrrole 101 (for the applied ligands 
see figure 5). 
entry R ligand yield [%]d) ee [%]e) 
1a) Me 60 63 25 
2a) Me 95 54 25 
3a) Me 8 61 52 
4a) Me 9 54 55 
5b) Me 7 52 46 
6b) Me 97 50 22 
7b) Me 99 57 28 
8b) Me 93 48 34 
9b) Me 98 46 27 
8c) Me 96 17 20 
9c) Et 100 34 5 
a) ref. [105]; b) ref. [14]; c) ref. [106]; d) isolated yield; e) determined by chiral HPLC. 
 
Interestingly, none of the investigators tried decreasing the temperature in order to improve 
selectivity, and only in one case an ester group other than methyl (ethyl, entry 9) was applied. 
Based on the results from table 4, it seems obvious that with the levels of enantioselectivity 
reached so far, the idea for the development of unnatural amino acids or natural products 
using said method was rendered meaningless. Nevertheless, it has to be noted that access to 
enantiomerically pure 18 (in either form) has been accomplished by other methods than 
asymmetric cyclopropanation. In a cooperation between the Reiser group and Merck 
Darmstadt, racemic (±)-18 could be separated by simulated moving bed chromatography 
(SMBC) to give about 75 g of either enantiomer and excellent enantiomeric excess (scheme 
14).[18, 107] This material was then used for a great variety of applications, especially the 
                                                           
3
 Several reports claimed that (R,R,R)-(+)-18 was formed with the presented ligands (derived from L-amino 
acids), which would be contrary to the results from furan derivatives. In chapter B 1.3.4, it is clearly 
demonstrated that these claims are wrong, and (S,S,S)-(-)-18 is the major product formed in these reactions.  
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synthesis of β-amino acids (β-ACCs) for the incorporation into artificial peptides, so-called 
foldamers (see introduction).   
 
 
Scheme 14. Resolution of racemic 18 via simulated moving bed chromatography (SMBC).[18] 
In addition, enantiomerically pure 18 could also be prepared by kinetic enzymatic resolution 
of racemic (±)-18 using lipase L-2.[51] However, due to significant limitations in scale this 
approach was not followed up intensively. On the other hand stock amounts of 
enantiomerically pure 18 in the Reiser group have almost vanished by now, but nonetheless 
18 is still of high importance.[60] These facts made us thinking about whether the initial idea 
of an asymmetric cylopropanation reaction of N-Boc-pyrrole was still the most reasonable 
strategy. As already mentioned in chapter B 1.2, our group has strong expertise in asymmetric 
cyclopropanation chemistry, facilitating the search for optimal conditions. In the following 
section the efforts toward enantiomerically pure cyclopropanated pyrrole are presented. Table 
5 summarizes all experiments carried out in this investigation. In our studies two major 
differences were made when compared to the original reports; first tert-butyldiazoacetate was 
used instead of methyl- or ethyldiazoacetate because it is known that the higher degree of 
steric bulk of the ester group can play a beneficial role for selectivity.[108]  Additionally, we 
reached excellent enantioselectivities using this compound in the furan cyclopropanation trials 
(chapter B 1.2). Secondly, temperatures lower than room temperature were investigated, as it 
is a well-known fact in catalysis that lower temperatures can have positive effects on 
selectivity. Other ligands than those applied before were investigated as well, but, as it will be 
explained later on, only tert-butyl substituted azabox ligands gave good results. Noteworthy, 
all of the herein reported experiments are not only enantioselective but also highly 
diastereoselective, forming the exo-products exclusively. In none of the cases any hint of 
endo-product formation was observed.  
 
  Main Part 
 
 
26 
 
 
Table 5. Asymmetric cyclopropanation of N-Boc-pyrrole using L-amino acid based azabox ligands (right). 
entrya) ligand temperature [°C] yield 103 [%]e) ee 103 [%]f) yield 104 [%]e) ee 104 [%]f) 
1b),c) - 25 35 0 7 0 
2c) 60 0 29 35 1 nd 
3 60 -10 24 37 2 nd 
4 8 25 23 83 31 27 
5 8 0 23 83 25 41 
6 8 -10 30 90 17 nd 
7c) 8 -15 37 68 17 4 
8 8 -20 37 93 - nd 
9 9 0 33 81 24 18 
10 9 -10 38 76 13 nd 
11c) 9 -15 34 83 15 37 
12 9 -20 26 64 2 nd 
13c) 74 0 43 72 - - 
14 74 -15 19 52 - - 
15 62 -10 29 33 10 0 
16d) 8 -15 44 (59 brsm) 87 (> 99)g) 12 41 
a) 2.99 mmol (500 mg) 101, 1 mol% Cu(OTf)2, 2.2 mol% ligand, 1 mol% PhNHNH2, 1.5 equiv diazoester, 3 ml 
DCM; b) 5.98 mmol 101; c) 1.2 equiv diazoester; d) 150.6 mmol (25.2 g) 101; e) isolated yield; f) determined by 
chiral HPLC; g) 18%, > 99% ee after recrystallization from hexanes. 
As can be seen from table 5, yields are in general rather moderate, with 43% being the 
maximum for N-benzyl substituted tBu-azabox 74 (entry 13). In terms of enantioselectivity, 
only tert-butyl substituted azabox ligands (8 and 9) gave satisfying results (up to 93% ee). 
Thus, after screening some of the other available ligands and temperatures, it seemed obvious 
that tert-butyl-azabox 8 was the ideal candidate for an upscaling experiment (entry 16). Not 
only that enantioselectivities > 90% are accessible with this ligand (entries 6 and 8), but also 
comparatively good yields of > 30% were achieved at different temperatures. Therefore, 
N-Boc-pyrrole 101 was cyclopropanated with tert-butyldiazoacetate under the conditions 
  
shown in entry 16. Noteworthy, on a 150 mmol scale cyclopropane 
remarkably good 44% yield (59% brsm) and 87% 
103 was found to crystallize from hexanes
(S,S,S)-(-)-103 from this reaction. 
molecule in good amounts and perfect enantiomeric excess. 
cyclopropanation conditions on monocyclopropanation product 
cyclopropanated pyrrole 104 
interesting. Unfortunately, only 
cyclopropanation product 104
explanation for this finding. Nevertheless, possible applications of 
chapter B 3. 
 
1.3.2 Structural investigations of the cyclpro
 
The absolute configuration of the two cyclopropanation products 
determined by X-ray analysis in combination with chiral HPLC and optical rotation 
measurements (see experimental section for data). Figure 
monocyclopropane 103 and biscyclopropane 
Figure 6. Single crystal X-ray structure
cyclopropanation product 104 (right
 
Especially for double cyclopropanation product 
exo-conformation of both cyclopropane rings, 
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103
ee. Even more important was the fact that 
, giving a multi-gram quantity of enantiopure 
This strategy enables ready access
Besides the effects of o
103, the fact that double 
is also formed in significant amounts during this process is 
very low to no degree of enantioselectivi
 (0-41% ee) was found. Until now there is no reasonable 
104 will be 
panation products 
103
6 illustrates
104 obtained by X-ray diffraction.
s of mono-cyclopropanation product (S,S,S)-(-)
). (C = grey, H = white, O = red, N = blue).  
104 the structure shows the strict 
resulting in a C2-symmetric molecule. The 
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 the structures for 
 
 
-103 (left), and double 
  
potential applications of this interesting 
in a single step from non-chiral 
thesis (chapter B 3.1). When examining 
immediately recognizes a strong signal b
corresponding signals. The signal broadening is presumably due to the occurrence of 
rotational energy barriers of the 
rotation around C-N bond due to s
isomers, so-called rotamers. The presence of rotamers can be proven, and distinguished
the existence of diastereomers
temperature-dependent NMR e
Figure 7. Excerpts from the 1H-NMR spectra of 
kryo). The presence of two distinct 
signals melt together, proving the existence of rotamers (rather than diastereomers). 
In this case three 1H-NMR spectra of 
At low temperature (278 K) it is clearly visible that two distinct sets of signals in a ratio of 
about 0.6:0.4 appear. This alone does not allow for any conclusions, but if one takes into 
account that the signals start broadening and melting together at h
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compound, where six stereogenic centers are formed 
N-Boc-pyrrole 101, are discussed in a later part of the present 
1H-NMR spectra of monocycl
roadening, accompanied by splitting of the 
one, or even both of the tert-butyl groups in 
teric hindrance), leading to the presence of rotational 
 by the dynamic behavior of the 1H
xperiments.[109-111]  
cyclopropane 103 at 278, 298, and 318 
sets of signals (ratio ~ 0.6:0.4) becomes obvious at 278
 
103 were recorded at different temperatures (Figure 
igher temperatures (298 K, 
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 K. Upon heating the 
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318 K) it is evident that 103 shows strong rotameric behavior, excluding the presence of 
diastereomers.  
 
1.3.3 Synthesis of (R,R,R)-(+)-103 
 
As already mentioned above, the synthesis of tert-butyl-azabox 8 (as well as 9 and 74) is 
based on the non-proteinogenic amino acid tert-leucine 69. From an economical point of 
view, access to the (R)-enantiomer of ligand 8 is not advisable (as D-tert-leucine is very 
expensive), and thus alternative strategies toward enantiopure (R,R,R)-(+)-103 need to be 
employed. Therefore, different ligands based on D-configurated amino acids were employed 
for the asymmetric cyclopropanation of N-Boc-pyrrole and the results were compared to the 
already obtained data (table 6, entries 1-7).  
 
 
Table 6. Asymmetric cyclopropanation of N-Boc-pyrrole using D-amino acid based ligands. 
entrya) ligand temperature [°C] yield 103 [%]f) 
ee 103 
[%]g) 
yield 104 
[%]f) 
ee 104 
[%]g) 
1b) 68 0 28 53 33 23 
2c) 68 0 17 57 19 26 
3 68 -10 28 32 0 nd 
4 61 0 28 39 33 1 
5 61 -10 34 56 27 1 
6d) 61 -20 18 41 1.5 5 
7e) (ent)-6 0 30 41 20 5 
a) 2.99 mmol (500 mg) N-Boc-pyrrole, 1 mol% Cu(OTf)2, 2.2 mol% ligand, 1 mol% PhNHNH2, 1.5 equiv 
diazoester, 3 ml DCM; b) defrosting ice-bath; c) cryostat; d) 1.2 equiv diazoester; e) 5.98 mmol (1.00 g) 
N-Boc-pyrrole; f) isolated yield; g) determined by chiral HPLC. 
As can be seen from table 6 results are rather poor, leading to a maximum of 57% ee for 
indanyl substituted azabox 68 (entry 2) and 56% ee for phenyl-azabox 61 (entry 5). With 
(R,R)-iso-propyl-bisoxazoline (iPr-box) (ent)-6 only 41% ee could be achieved (entry 7). 
Interestingly, only the indanyl-substituted azabox ligand 68 led to enantiomerically enriched 
double cyclopropanation product 104 (entries 1 and 2), while the other ligands yielded more 
  
or less racemic product (entries 
were found for phenyl derivative 
However, upon repeated recrystallization steps from hexanes it was possible to obtain 
(R,R,R)-(+)-103 in enantiomerically pure form
Figure 9. Analytical HPLC chromatograms 
(right). Phenomenex Lux Cellulose-
(-), tr = 19.9 min (+)).  
 
1.3.4 Investigations of the stereochemical outcome of the cyclopropanations reactions
 
Former reports claimed that the asymmetric cyclopropanation of 
methyldiazoacetate leads to inverted stereoinduction (giving (
L-(S,S)-derived ligands) compared to furan derivatives when using the identical 
stereochemistry of the ligand ((
This effect was somehow explained by attractive interactions between the oxygen atom of the 
furan ring with copper, and in the case of 
101, so that an inverted orientation of the substrate binding 
was true it would be a very interesting feature due to the fact that 
major product for the same substrate when using 
analogous experiments instead (prov
chapters B 1.3.2 and D 2). This would mean that only the size of the incoming ester group 
should be responsible for a complete inversion of the stereochemical outcome of the product, 
which is hardly believable. Thus, we aimed to reexamine the stereochemistry of the 
abovementioned cyclopropanation reaction (which is described in the following). The idea of 
our strategy was to approach methyl
sites, whilst comparing the stereochemical outcome and therefore proving, or disproving, the 
original claim (scheme 15). 
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4-7). The overall best results in terms of yield and selectivity 
61 at -10 °C with 34% isolated yield and 56% 
 (HPLC chromatograms shown in 
for (S,S,S)-(-)-103 (left), rac-(±)-103 (middle
2, n-heptane/iPrOH = 98:2, flow = 0.5 ml/min, λmax = 254 nm
N
R,R,R)
S,S,S)-(-)-product from L-(S,S)-derived ligands
18 with steric repulsion of the bulky Boc
to the catalyst was claimed. If this 
(S,S,S
tert-butyl substituted diazoacetate in the 
en by X-ray, chiral HPLC, and optical rotation; see 
-substituted cyclopropane 18 from two different synthetic 
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Scheme 15. Strategy for the clarification of the stereochemical outcome of the cyclopropanation of 
N-Boc-pyrrole with methyldiazoacetate. Methyl-substituted cyclopropane 18 was synthesized from two different 
directions in order to clarify matter. A: transesterification of 103 using NaOMe; B: asymmetric cylopropanation 
of 101 using methyldiazoacetate and ligand 8. 
As the absolute configuration of tert-butyl-cyclopropane 103 (derived from 
L-(S,S)-configured ligands) was reliably established to be (S,S,S)-(-)-103 using X-ray 
diffraction, chiral HPLC analysis and optical rotation, a transesterification of 103 into the 
methyl ester should result in a product 18 bearing the identical stereoinformation as its parent 
compound 103 (in the worst case epimerization of one stereocenter could occur under basic 
conditions). Several attempts of transforming the tert-butyl ester moiety of 103 into a methyl 
ester failed or only gave poor results.  
 
Scheme 16. Transesterification of tert-butyl-cyclopropane ester 105 via sodium methoxide by Fox et al. [112] 
However, a report of Fox et al. using sodium methoxide for the transesterification of 
cyclopropane ester 105 into its methyl derivative 106 (scheme 16)[112] prompted us to test 
such conditions for our substrate 103.  
 
Scheme 17. Transesterification of tert-butyl-cyclopropane ester 103 via sodium methoxide using the 
methodology of Fox et al. 
Thus, 103 was transformed into its methyl derivative using sodium methoxide in refluxing 
methanol to give 18 in 45% yield (scheme 17; A in scheme 15).4 Substrate 103 was chosen 
with a moderate degree of enantioselectivity (80% ee) on purpose in order to facilitate HPLC 
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 Due to the formation of side product 107 from methyl ester 18, where the Boc-group was transformed into the 
methyl carbamate, better yields of 18 were not accessible.  
  
analysis. As the transesterification product 
parent starting material, it can be concluded that no epimerization occurred during the 
progress of the reaction. Furthermore, the original cyclopropanation of 
with methyldiazoacetate was repeated with the aim of comparing the results 
from route A (B in scheme 15
yield and 55% enantiomeric excess.
Figure 8. Analytical HPLC chromatograms 
and from cyclopropanation with methyldiazoacetate (
ml/min, λmax = 240 nm (tr = 5.9 min (
When comparing the HPLC chromatograms for the (identical) product of both reactions (
and B; figure 8), it becomes apparent that in both cases the very same product was formed by 
the two orthogonal reactions, namely 
were verified by comparison to the original data of 
stereoinversion occurs while switching the substrates from furan derivatives to 
101. In contrast, it could be shown that for all investigated cyclopropanation reactions the 
(S,S,S)-(-)-product is forming from 
corresponding (R,R,R)-(+)-cyclopropanes form when using 
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 The original literature report for this reaction was: 61% yield, 52% 
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18 was obtained with an identical 
). In this attempt methylcyclopropane 18 was obtained in 35% 
5
  
for methyl-substituted cyclopropane 18 from transesterification
B). Chiralcel OD-H, n-heptane/iPrOH = 99:1, flow = 1.0 
-), tr = 9.3 min (+)).  
(S,S,S)-(-)-18. Furthermore, the newly obtained results 
Glos and it was thus concluded that no 
L-(S,S)-derived ligands. On the contrary, the 
D-(R,R)-derived ligands. 
ee (ref. [105]). 
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2 Transformations of monocyclopropanated pyrrole 103 
2.1 Synthesis of (S)-3-pyrrolidineacetic acid ((S)-(+)-homo-β-proline, (S)-(+)-109) 
2.1.1 Biological background 
 
The non-proteinogenic γ-amino acid γ-aminobutyric acid (GABA, 108) has been estimated to 
be present in 60-70% of all synapses in the mammalian central nervous system (CNS),[113] 
and represents a major inhibitory neurotransmitter in the CNS of man.[114-116] Since GABA 
inhibitory neuronal transmission is associated with several neurological disorders, such as 
anxiety, pain, epilepsy, Parkinson’s disease, and Huntington’s disease, there is a special 
interest in developing specific agonists of postsynaptic GABAA receptors, as well as in potent 
inhibitors of the GABA uptake mechanism.[117] 
 
 
Figure 10. Chemical structures of GABA 108 as well as racemic (±)-homo-β-proline 109 with its two 
enantiomers (S)-(+)- and (R)-(-)-109 (core structure of GABA highlighted in red).  
On the basis of cyclically constrained GABA analogues for pharmacological studies the non-
natural γ-amino acid 3-pyrrolidineacetic acid (homo-β-proline, 109), which can be classified 
as a structurally rigidified analogue of GABA was first prepared and analyzed for its 
pharmacological properties in 1981 by Schaumburg et al. (figure 10, see chapter B 2.1.2 for 
syntheses).[118, 119] Since then it was shown that racemic (±)-109 acts as an inhibitor of 
GABAA and GABAB receptor binding, as well as a glial and neuronal GABA uptake 
inhibitor.[119-122] Interestingly, the two enantiomers of homo-β-proline were shown to 
interact in a stereoselective manner with the two GABA receptors.6[123] While (S)-(+)-109 
binds selectively to the GABAB receptor, its enantiomer (R)-(-)-109 is more than one order of 
magnitude more potent at GABAA (compared to its enantiomer). On the other hand, both 
enantiomers show a remarkably low eudismic ratio (small potency difference) and, 
interestingly, similar potency compared to the racemate (±)-109 and the native ligand GABA 
                                                           
6
 Meanwhile a third type of GABA receptor, termed GABAC was identified representing a structural subtype of 
GABAA receptors: ref. [123]. 
  Main Part 
 
 
34 
 
itself toward synaptosomal GABA uptake inhibition.[114] Moreover, homo-β-proline 109 and 
its enantiomers have been widely used as model compounds for structural and functional 
investigations.[124] Nevertheless, these results only reflect on in vitro activity, which depicts 
the major disadvantage of compounds like 109: they do not readily cross the 
blood-brain-barrier,[125, 126] which renders their potential application as drugs rather 
meaningless. Therefore, a series of potential pharmaceuticals were developed containing the 
substructure of 109 bearing a lipophilic moiety (mostly anchored to the endocyclic N-atom), 
enabling the resulting compounds to cross the blood-brain-barrier and hence showing 
significantly increased pharmacological activities. One prominent example is the N-modified 
analogue of homo-β-proline SKF 100561 (110, figure 11), which shows significantly 
increased GABA uptake inhibition (IC50 = 0.12 µM compared to 1.5 µM of the parent amino 
acid 109). Furthermore, it displayed anticonvulsant activity upon oral or intraperitoneal 
administration to rats.[127-129] In addition, 110 was shown to exhibit antitussive 
properties,[130] whereas in a different study it was presented that 110 potently counteracts the 
enhancing effect of GABA on dopamine release in rat brain, allowing for the conclusion for 
coexistence of transporters of GABA and dopamine.[131] Reflecting on the remarkable 
properties of this molecule, Young and co-workers identified it to be a potent histamine 
H1-receptor antagonist as well.[132] In 2001, homo-β-proline derivative 111 was reported as 
the most potent compound in a series of 33 potential GABA uptake inhibitors (IC50 = 51 nM), 
however, its in vivo anticonvulsant properties were rather poor.[117] Figure 11 gives an 
exemplary overview of some recent pharmacologically active compounds containing 109 as 
structural motif.  
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Figure 11. Chemical structures of selected examples of derivatives of homo-β-proline that were designed for 
pharmaceutical purposes (core structure of 109 highlighted in red). 
 
Furthermore, a couple of very recent patents deal with pharmaceutical compounds that 
incorporate 109 as pharmacophore in a certain manner (figure 11). While derivatives of type 
112 act as P2Y12 receptor antagonists[133] and therefore display antitrombotic activity, 115 
was prepared as a potential prostaglandine D2 receptor antagonist.[134] On the other hand, 
113 acts as a protein kinase inhibitor (both isomers of 109 were incorporated),[135] and 114 
as an inhibitor of leukotriene production (inhibitor of leukotriene A4 hydrolase).[136, 137] 
Besides the presented examples in figure 11, many more substances containing units of either 
racemic or enantiopure 109 in their core structure have been reported recently. Moreover, 
both enantiomers of 3-pyrrolidineacetic acid 109 are not only biologically active by 
themselves, but also display a key structural element in a broad variety of natural products 
(figure 12). 
 
 
Figure 12. Chemical structures of some structurally related natural products (core structure of 109 highlighted in 
red).[138-140] 
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The examples shown in figure 12 (116-119) belong to the family of kainoid amino acids that 
are structurally based on glutamic acid and display significant biological effects, e.g. 
insecticidal,[141, 142] anthelmintic,[143-146] and (most importantly) neuroexcitatory 
properties.[147-151] The compounds presented in figures 11 and 12 clearly demonstrate the 
importance of homo-β-proline, thus making it an interesting target molecule. 
 
2.1.2 Literature syntheses of homo-β-proline 109 
 
Based on our positive results from the asymmetric cyclopropanation of N-Boc-pyrrole, we 
aimed to develop a more efficient synthesis route for (S)-3-pyrrolidineacetic acid 
((S)-(+)-109). The following chapter gives a brief overview of the strategies for the synthesis 
of 109 reported so far. While access to 2-substituted derivatives of pyrrolidine is pretty 
straightforward (most syntheses start from L- or D-proline and/or derivatives thereof), 
methods for the preparation of 3-substituted analogues, especially in enantiomerically pure 
form, are limited. So far there have been eight synthetic routes reported in literature for either 
racemic or enantiopure homo-β-proline, with only one of them being enantioselective. The 
first synthesis of racemic (±)-109 was reported by Schaumburg et al. in 1981, who 
synthesized 109 in 4% yield over 7 steps starting from glycine ethyl ester hydrochloride 
(120).[118] Key steps in their synthesis were a Dieckmann condensation to establish the 
pyrrolidine skeleton and a Knoevenagel condensation of 121 with cyanoacetic acid for the 
introduction of the side chain in 122 (scheme 18).  
 
Scheme 18. First racemic synthesis of (±)-109 by Schaumburg et al.[118] 
The first non-racemic synthesis of (R)-(-)-109 and (S)-(+)-109 was reported in 1990 by 
Krogsgaard-Larsen et al.[114] Based on the addition-cyclization reaction of itaconic acid 123 
with (R)-1-phenylethylamine and subsequent separation of the resulting diastereomers 124a 
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and 124b via preparative HPLC, they were able to obtain both enantiomers of 109 in 8 steps 
each and ~ 6% overall yield (scheme 19).7  
 
 
Scheme 19. First synthesis of (S)-(+)- and (R)-(-)-homo-β-proline from itaconic acid 123 by Krogsgaard-Larsen 
et al.[114] 
In 1996, Coldham and Hufton reported a very short and efficient synthesis of racemic 
homo-β-proline based on the cyclization reaction of stannane 127 (scheme 20).[152] Hereby a 
tin-lithium exchange of stannane 127, followed by an anionic cyclization reaction and 
subsequent trapping with an electrophile, represents the crucial step to yield 128 
(interestingly, the N-benzyl group was replaced by N-CO2Et during this reaction).  
 
 
Scheme 20. Synthesis of racemic (±)-109 according to Coldham and Hufton.[152] 
Within four synthetic steps they were able to obtain (±)-109 from commercially available 
4-bromobut-1-ene 125 in 15-27% yield (the authors did not give a yield for the first step; from 
literature it is recognized that 126 can be prepared by the referred strategy in 52-93% yield). 
However, based on the fact that organotin reagents are not too desirable nowadays, their 
synthesis strategy may not be of great importance for current studies. In a similar approach to 
the one reported by Krogsgaard-Larsen et al.,[114] Orena and co-workers developed several 
intramolecular cyclization reactions for the generation of the pyrrolidine ring with an 
appropriate substitution pattern.[153-155] Based on cyclization product 131, which was 
obtained in 75% yield and a diastereomeric ratio of 80:20 from 130, both enantiomers of 
homo-β-proline were synthezied in 7 steps each (scheme 21). In this way they were able to 
obtain (S)-(+)-109 in 11% and (R)-(-)-109 in 3% yield. 
                                                           
7
 The authors did not provide a yield for the last synthetic step for (S)-(+)-109.  
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Scheme 21. Synthesis of (S)-(+)- and (R)-(-)-homo-β-proline by Orena et al. 
In a slightly older communication, Orena et al. presented a formal synthesis of 109 with a 
Mn(III)-mediated intramolecular cyclization reaction as the key step. By this strategy they 
were able to prepare synthetic intermediate 135, the same that was used for the synthesis of 
109 by Krogsgaard-Larsen et al.[114] from chiral amine 132 in 6 steps and 17% yield 
(scheme 22).[153] 
 
 
Scheme 22. Formal synthesis of (S)-(+)-109 through Mn(III)-mediated intramolecular cyclization of 133 by 
Orena et al. 
On the way to conformationally restricted NO synthase inhibitors, Eustache and co-workers 
synthesized (S)-(+)-homo-β-proline 109 from intermediate 136 (obtained from aspartic 
acid)[156] in order to determine the absolute configuration of their compounds (Scheme 
23).[157] Key steps of the synthesis were the lactamization of a nitro-Michael-adduct, 
followed by transformation into the corresponding thiolactam by Lawesson’s reagent 
(including chromatographic separation of diastereomers), and subsequent desulfurization in 
order to establish the pyrrolidine ring system. Additionally, besides some 
protection/deprotection steps, a desamination-decarboxylation sequence had to be carried out 
to finally yield 109 in 9 steps and 5% yield starting from 136. 
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Scheme 23. Synthesis of (S)-(+)-homo-β-proline 109 from 136 by Eustache et al.[157] 
In the same year, Gmeiner et al. presented an efficient 11 step synthesis of 109 starting from 
(S)-aspartic acid 139 (scheme 24).[158] In this chiral pool approach, 1,4-bis-electrophile 140 
was rearranged to 141 through an aziridinium ion (not shown) and subsequently cyclized to 
form the pyrrolidine core. Inversion of the stereocenter by SN2 type substitution with 
diethylmalonate, followed by a decarboxylation gave rise to (R)-(-)-109 in an overall yield of 
23%. Importantly, (R)-aspartic acid could be applied as well for the synthesis of the 
enantiomeric (S)-(+)-109.  
 
 
Scheme 24. Synthesis of (R)-(-)-homo-β-proline 109 from aspartic acid 139 by Gmeiner et al.[158] 
In 2004, Felluga and co-workers[159] reported a chemoenzymatic synthesis of both 
enantiomers of homo-β-proline based on the desymmetrization reaction of prochiral 
nitrodiester 144 (scheme 25).[159] 
 
Scheme 25. Synthesis of both enantiomers of homo-β-proline via enzymatic desymmetrization of prochiral 
nitrodiester 144 according to Felluga et al.[159] 
For the selective saponification of only one of the two ester groups in 144, two different 
enzymes had to be applied, namely porcine pancreatic lipase (PPL) for the synthesis of 
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(S)-(+)-109, and crude pig liver esterase (PLAP, pig liver acetone powder)8 for (R)-(-)-109, 
respectively. With 38% for (S)-(+)-109, and 39% for (R)-(+)-109 in a total of 7 steps each, 
this methodology provides the most efficient strategy to prepare both enantiomers of 109 so 
far. However, the use of two different enzymes and the noticeable limitations in scale may 
make this not the most desirable way in terms of economics. The first enantioselective 
synthesis of (S)-(+)-109 was reported by the group of Tan in 2007.[160] During the 
investigation of organocatalyzed enantioselective Michael reactions of dithiomalonates and 
β-keto thioesters to N-substituted maleimides, they established a 7 step synthesis of 109 
(scheme 26). On the basis of Michael adduct 148, which was obtained in 92% ee from the 
guanidine catalyzed addition of 147 to N-benzyl maleimide 146, the following 6 steps were 
carried out to yield (S)-(+)-109 in 73% from 148. Unfortunately, no yield for the crucial 
addition step was given by the authors, making it difficult to evaluate the overall efficiency of 
the synthetic sequence.  
 
Scheme 26. Enantioselective synthesis of (S)-(+)-109 by Tan et al., including an organocatalyzed conjugate 
addition reaction as key step. 
However, only one enantiomer could be synthesized in a not fully enantioselective manner 
with this strategy and the use of toxic chromium reagents makes this surely not the method of 
choice in terms of sustainability. In addition, limitations in scale of the above reported method 
further restricts its feasibility. In summary, all of the above reported synthetic approaches 
require several steps, expensive or harmful reagents (Cr, Sn) and are limited in scale. 
Therefore, we aimed to develop a short and efficient synthesis route giving access to either 
enantiomer of 109 in enantiopure form and good quantity.  
2.1.3 Synthesis of (S)-(+)-109 
Based on the results from our cyclopropanation experiments, we chose 103 to be a good 
starting point for our enterprise. Cyclopropane (S,S,S)-(-)-103 can be obtained from 
N-Boc-pyrrole in multigram quantity and > 99% ee after recrystallization (see chapter B 
1.3.1), thus making it a perfect candidate for further synthetic efforts.  
                                                           
8
 Surprisingly, application of pure pig liver esterase (PLE) led to formation of 145b in only 92% ee. 
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Scheme 27. Enantioselective synthesis of 103 from pyrrole 50. 
Based on the experiments from chapter B 1.3.1 it is well-known that bicycle 103 can be 
prepared in moderate yield with full enantiocontrol (scheme 27). Now there are plenty of 
opportunities of how to apply this highly functionalized cyclopropane for further synthetic 
ventures. Obviously, the simplest modification of 103 would be the hydrogenation of the 
enecarbamate double bond to yield the fully saturated system 149. This can be carried out 
efficiently using standard conditions (hydrogen, palladium/charcoal) in order to yield 149 in 
satisfying 85% yield (scheme 28).  
 
 
Scheme 28. Hydrogenation of bicyclic enecarbamate 103 using standard conditions. 
However, an alternative to the conventional hydrogenation with hydrogen and 
palladium/charcoal would be the so-called ionic hydrogenation, which has been shown to 
work efficiently for enamides and enecarbamates.[161-164] In this methodology, the substrate 
is successively activated by an acidic compound (Brønsted or Lewis acids) and then reduced 
by the addition of hydride, mostly from silanes as hydride source. In order to test whether an 
ionic hydrogenation might produce even higher yields of 149 cyclopropane 103 was treated 
with trifluoroacetic acid (TFA) and triethylsilane at room temperature. Indeed, 
chemoselective ionic hydrogenation of the enecarbamate double bond of 103 occurred, 
accompanied by ring-opening of the donor-acceptor substituted cyclopropane moiety, to give 
a significant amount of by-product 150 (scheme 29). After six hours at ambient temperature 
33% of hydrogenation product 149 and 23% of ring-opened compound 150 were isolated.  
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new spots appeared on TLC. Thus, we examined the chemical behavior of cyclopropane 103 
upon treatment with TFA in order to identify these side-products. Interestingly it could be 
shown that 103 dimerizes upon treatment with TFA to form two diastereomers 151 in a ratio 
of ~ 3:1 (scheme 30).  
 
 
Scheme 30. Concentration-dependent acid-catalyzed dimerization of enecarbamate 103 (combined yields for 
both diastereomers). 
Logically, the reaction turned out to be concentration dependent, giving 42% yield (combined 
yield of both diastereomers) at a concentration of ~ 0.1 M, and 55% at ~ 0.4 M. In this case 
the yields could not be optimized due to partial decomposition occurring after prolonged 
reaction time, which makes sense since dimer 151 contains four tert-butyl groups that are 
regularly cleaved by TFA.[168] The formation of dimer 151 might seem exotic at first, 
however, it can be explained by having a closer look at the potential mechanism of 
dimerization for this type of enecarbamate, which was concluded on the basis of the general 
reactivity pattern of enamides and enecarbamates,[169-171] as well as extensive 
spectroscopic analyses of the products (scheme 31).  
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Scheme 31. General reactivity pattern of enamides and enecarbamates (upper part), and the proposed 
mechanism for the acid-catalyzed dimerization of enecarbamate 103, along with the chemical structure of 
PeramivirTM 157 (1,3-diamino moiety highlighted in red). 
In general, enamides (and enecarbamates) exhibit an ambivalent reactivity (two opposing 
reaction pathways), meaning that they can undergo reactions with both electrophiles and 
nucleophiles. Generally enamides of type 152 react as nucleophiles which attack a suitable 
electrophile (E+), generating an iminium ion 153 (and 155) that is then trapped by a 
nucleophile (Nu-) to yield a double functionalized amide or carbamate 154 (scheme 31, upper 
part). When having a look on the mechanism of dimerization of 103 it becomes obvious that 
first the protonation of 103 turns it into the iminium species 155 that acts as the electrophile 
for the dimer formation. A second molecule of 103 then reacts as nucleophile and attacks the 
iminium ion 155 to form the dimer 156. In the final step H+ is eliminated to close the catalytic 
cycle and yield dimer 151 as product (scheme 31, lower part). Dimer 151 could potentially be 
of synthetic interest as it bears a 1,3-diamine moiety in its core structure (highlighted in 
scheme 31). Optically active 1,3-diamines are valuable targets, as they represent key 
structural units in many natural products.[172, 173] Moreover, they can be used as chiral 
auxiliaries and ligands,[174, 175] catalysts in asymmetric synthesis,[176] as well as 
pharamcophores in medicinal chemistry.[177-181] One prominent example is the commercial 
drug PeramivirTM 157, which exhibits potent activity against influenza viruses (scheme 
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31).[182, 183] Furthermore, efficient synthetic strategies toward enantiopure 1,3-diamines are 
rather limited until now.[184-188] 
Coming back to the original purpose to investigate 103 as a promising precursor for the 
synthesis of homo-β-proline 109, one has to bear in mind that side reactions like the 
dimerization mentioned before are rather deleterious for our synthetic endeavor. As already 
mentioned it is rather likely that the ring-opened product 150 is formed from the 
hydrogenated compound 149 during the course of the reaction (traceable by TLC). Thus, one 
can envision carrying out the synthesis in a two-step manner, starting with hydrogenation of 
the double bond in 103 with conventional methods (H2, Pd/C) followed by acid catalyzed ring 
opening. In this way side reactions of the enamide can be suppressed and 150 should be 
accessible in improved yields. Scheme 32 presents the two-step approach for the synthesis of 
150.  
 
Scheme 32. Two-step synthesis approach of ring-opened product 150 from cyclopropane 103. 
From hydrogenation product 149, homo-β-proline derivative 150 was obtained in 50% yield. 
In this case, the yield could not be further optimized as at a certain point new very polar spots 
occurred on TLC, which might be assigned to partly and fully deprotected 150 (109). This 
observation again led us to the idea to use this feature in terms of directly converting 
hydrogenation product 149 into homo-β-proline (or its TFA salt). As the ionic 
hydrogenation/cyclopropane opening conditions already contain TFA, an in situ deprotection 
of the Boc-group and the tert-butyl ester seems plausible. Even a one-step procedure starting 
from cyclopropane 103, should in principle be possible; however the occurrence of 
side-products might influence the outcome of the reaction and also hamper the final 
purification of the desired polar amino acid 109.  
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Scheme 33. Synthesis of (S)-(+)-homo-β-proline 109 from 149.  
When 149 was treated with TFA and triethylsilane for 72 h at room temperature, the TFA salt 
of 109 was obtained, that was then transformed into the free amino acid 109 by the use of an 
acidic ion-exchange resin and elution with aqueous ammonia. (S)-(+)-homo-β-proline 
(S)-(+)-109 was obtained in quantitative yield from cyclopropane 149. Spectroscopic data of 
(S)-(+)-109 were in agreement with literature data.[114, 155, 158-160] However, the optical 
rotation value of 109 was slightly lower than reported before (+7.7 (c = 1, H2O) compared to 
+9.6 (c = 1, H2O)[114]). Upon investigation of the stereochemical outcome of the TFA 
mediated cyclopropane opening from 149 to 150, we found a significant degree of 
epimerization of the stereocenter in 150, and the enantiomeric excess was reduced from >99% 
ee for 149 to 73% ee for 150 (determined by chiral HPLC, see E 2). Further studies for 
achieving the synthesis of 109 from 103 without loss in stereoinformation are currently 
ongoing in the Reiser group. Nevertheless, it should also be noted that a synthesis of the 
enantiomeric (R)-(-)-109 from (R,R,R)-(+)-103 should be straightforward, following the very 
same synthetic sequence developed for (S)-(+)-109. 
 
Upon a closer look into literature, it seemed as if the use of 109 as a pharmacophore is rather 
limited, even though it is obvious that the compound itself and its derivatives are in many 
cases among the most potent derivatives tested.[117, 119, 122, 127, 131, 189] This fact might 
be due to the rather displeasing synthesis strategies for 109 thus far published. However, with 
our new methodology it is possible to get relatively simple access to either racemic or 
enantioenriched homo-β-proline, which can then be used as a key building block for the 
preparation of new (and established) pharmaceutically relevant compounds. Furthermore, it 
may stimulate further investigations with the involvement of 109 as pharmacophore, as before 
practical access was rather limited. In summary we have developed a short and efficient 
methodology for the preparation of either enantiomer of 3-pyrrolidineacetic acid (homo-β-
proline) 109 based on the enantioselective cyclopropanation of N-Boc-pyrrole 101. The 
abovementioned cyclopropanation can be carried out on a 150 mmol scale, thus giving rise to 
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a multigram quantity of enantiopure 103. In as few as three steps, (S)-(+)-109 (or 
(±)-109/(R)-(-)-109) can be prepared in 37% yield from N-Boc-pyrrole, giving facile access to 
such biologically and pharmaceutically relevant compounds.  
 
2.2 Further functionalization approaches of monocyclopropane 103 
 
It was demonstrated that cyclopropane 103 reacts efficiently with nucleophiles under acidic 
conditions (see chapter B 2.1.3). After discovery of such a mode of reactivity it was obvious 
to apply this methodology to other, more challenging nucleophiles besides the enamide 
(enecarbamate) itself, and the hydride ion (products 149 and 151), that might lead to an even 
higher degree of functionalization of this interesting building block.  
 
The Ugi multi-component reaction (MCR) is an extremely powerful method for the 
construction of rather complex molecules that has been applied extensively in organic 
synthesis and in particular for the generation of large compound libraries.[190] 
 
Scheme 34. General scheme for Ugi four-component reactions (different building blocks/subunits color coded).  
In general, four components are used in this reaction. At first, an imine (or iminium) species is 
formed by an amine 159 and a carbonyl compound 160 (aldehyde or ketone). However, this 
first intermediate can also be preformed. Then an isocyanide (isonitrile) 161 attacks the imine 
and is instantly trapped by the carboxylate 158. In the last step, an O,N-acyl shift occurs to 
yield the final products of type 162 (Scheme 34).  
A recent publication of Nenajdenko et al. attracted our attention,[191] where they presented a 
MCR with cyclic imines, isonitriles, and organic acids, giving rise to functionalized 
pyrrolidines in moderate to excellent yields (Scheme 35).  
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Scheme 35. Preparation of functionalized pyrrolidines 164 from cyclic imines 163 by a three-component 
reaction from Nenajdenko et al.[191] 
Best results were obtained when using TFA as acid, which is also beneficial if one thinks of in 
situ deprotection of tert-butyl-carbamates (Boc groups). In their publication, the isonitriles 
(red in scheme 35) are attacking the α-position of the pyrrolidine ring (iminium carbon atom) 
as expected, accompanied by the acylation of the nitrogen atom by TFA (pink in scheme 35). 
Hydrolysis of the isonitrile forms the final amide derivative. Interestingly, they found that the 
isonitrile acts as a dehydrating agent that transforms TFA into trifluoroacetic anhydride 
(TFAA), which subsequently acylates the nitrogen atom.[192] Based on the results of 
Nenajdenko et al.[191] in combination with the obtained reactivity of enecarbamate 103, it 
seemed plausible to investigate the behavior of 103 under the abovementioned conditions. 
Thus, it should be possible to obtain derivatives of 103 with additional functionalization at the 
α-position and, in principle, also a deprotection/acylation of the nitrogen atom. As 
enecarbamates (and enamides) are known to display a rather tempered reactivity compared to 
enamines, one could harness this feature for the selective functionalization of those. In the 
following, we attempted to perform TFA initiated Ugi-type reactions with cyclopropane 103 
and several different aliphatic and aromatic isonitriles. The obtained results are summarized in 
table 7. In order to avoid the above mentioned dimerization as undesired side-reaction and to 
favor the intermolecular over the intramolecular reaction, the concentration was kept rather 
low (c = 0.02 M). It has to be noted that all herein investigated reactions gave highly complex 
reaction mixtures with partly very poor TLC staining behavior of the products, which severely 
hampered monitoring of the reaction process as well as the analysis of the crude reaction 
mixtures. As TLC analysis was hardly comprehensible, and because MCRs with isonitriles 
usually take several days to progress, reactions were aborted after some days and the crude 
reaction mixtures were analyzed via NMR and LC-MS. Crude mixtures were purified via 
flash chromatography where appropriate.  
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Table 7. Attempts for the TFA initiated Ugi-type functionalization of cyclopropane 103.9 
entrya) R = product solvent time [d] yield [%]e) drh)  
1 tBu 165 DCM 5 6 nd 
2b) tBu 165 DCM 22 69 72:28 
3 Cy 166 DCM 5 5 71:29 
4b) Cy 166 DCM 22 traces nd 
5 
 
167 DCM 5 traces 62:38 
6c) 
 
167 THF 7 0f) nd 
7 
 
168 DCM 5 traces 77:23 
8d) 
 
168 (171) DCM 9 14 (6)g) nd 
9 
 
169 DCM 5 traces 55:45 
10 
 
170 DCM 5 nd nd 
a) 0.40 mmol 103, 1.2 equiv R-NC, 5.0 equiv TFA, 20 ml DCM, rt, 5 d; b) 0.68 mmol 103, 10 equiv R-NC, 4 
equiv TFA, 40 ml DCM; c) 0.50 mmol 103, 2.56 equiv TosMic, 2.0 equiv p-TSA, 25 ml THF; d) 1.0 equiv R-
NC, 1.0 equiv TFA, 5 ml DCM; e) isolated yield of both diastereomers (combined); f) large amounts of 
hydrolysis product N-(tosylmethyl)formamide isolated; g) 14% 168 + 6% acylation product 171 isolated; h) 
determined/estimated by LC-MS (ESI-EIC integration);[193] due to severe overlap a concise integration of 
1H-NMR signals was not possible. 
As can be quickly recognized from table 7, the proposed reaction worked efficiently for only 
one substrate, namely tert-butyl-isocanide (entry 2). Here, the two diastereomeric addition 
products were formed in 69% combined yield and a diastereomeric ratio of ~ 3:1. Detailed 
analysis of the products is described in a later part of this chapter. Interestingly, for all 
substrates besides 4-methyl-substituted isonitrile (entry 10), product formation could be 
                                                           
9
 Aromatic isonitriles of entries 7-10 were provided by M. Knorn. 
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identified by LC-MS, however, in most cases only in trace amounts. When comparing entries 
1 and 2, one might expect that the excess of isonitrile might have favored the outcome of the 
reaction (1.2 equiv vs. 10 equiv R-NC). On the other hand, the cyclohexyl-substituted 
isonitrile did not lead to the formation of significant amounts of product while employing the 
same conditions as in entry 2 (entry 4). This leads to the suspicion that hydrolysis of the 
isonitrile may not be the limiting factor. For the 2,4-dimethoxy-substituted residue also a 
minor amount of TFA acylated product 171 could be identified (entry 8), whereas no 
acylation product was found for the other substrates. Due to a lack of suitable 1H-NMR 
signals for integration, the values for the diastereomeric ratio of the obtained addition 
products were determined by integration of LC-MS signals, and should therefore be taken as a 
rough estimation rather than exact values. Nevertheless, when comparing the data of entry 2 
of table 7 with the isolated amounts of diastereomers of 165a and 165b it becomes evident 
that the ratio, at least for this reaction, is quite similar. However, due to limited access to non-
commercial isonitriles, no further efforts for optimizing the reaction conditions were carried 
out. As tert-butyl-isocanide was the only of the investigated isonitrile derivatives that worked 
properly for this kind of reaction, we investigated the structure of the resulting diastereomeric 
compounds in more detail (table 7, entry 2; scheme 36).  
 
Scheme 36. Synthesis of tert-butyl substituted addition products 165a and 165b from cyclopropane 103 and 
tert-butyl isocyanide.  
The two diastereoisomers 165a and 165b that were formed in a ratio of ~ 3:1 could be 
separated via flash chromatography, and the orientation of the newly formed stereocenter was 
unambiguously assigned using NOE experiments (minor diastereomer 165b). The herefore 
required NMR spectra had to be carried out at low temperature (223 K) because of strong 
rotameric behavior of 165a and 165b leading to significantly broadened signals at ambient 
temperature. Figure 14 illustrates these observations. As expected, the major product was the 
one with the new amide substituent in exo-position in regard of the cyclopropane ring (165a).  
  
Figure 14. 1H-NMR spectra of the 
323 K in CDCl3 (400 MHz). The presence of rotamers (ratio ~ 0.6:0.4) becomes obvious at 223 K.
In addition to the functionalizations via Ugi
directly add 1,3,5-trimethoxybenz
electrophilic aromatic substitution reaction 
N
Boc
H
H
CO2tBu
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Scheme 37. Synthesis of functionalized derivative
Scheme 37 shows that enamide 
substitution as well. The rather low yields may be explained by the high steric demand of
reactants. Nevertheless, almost any type of nucleophile may be employed for the 
functionalization of 103, giving rise
substituted pyrrolidine scaffold
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α-CH (in regard of N) region of minor diastereomer 
-type of mechanism, it was as well tested to 
ene as a nucleophile to the enecarbamate 
(scheme 37).  
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3 Transformations of double cyclopropanated pyrrole 
3.1 Introduction 
 
As doubly cyclopropanated pyrrole 
cyclopropanation reactions discussed 
possible applications for it. It was noted
it an interesting compound for further derivatizations
Figure 15. X-ray structure of bis-
C2-symmetrical arrangement of the tricyclic core structure
hydrogens – as well as the Boc protecting group a
demonstrating the hypothetical C2-symmetry axis
In the following chapters the investigated 
potentially biologically active pyrrolidin
ligand for metal catalysts are described. 
suitable way of opening the two cyclopropane rings in 
pyrrolidines of type 174 (scheme 
is well-known that donor-acceptor (DA) substituted cyclopropanes like 
selectively by cleaving the bond in between the donor (D) and the acceptor (A).
200] As an important fact to bear in mind, 
C2-symmetrical pyrrolidines like 
protease,[201] thus making such molecule
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104 
104 was accumulating in significant amounts during the 
before (chapter B 1.3), we were 
 before that 104 exhibits C2-symmetry, 
 (figure 15).  
cyclopropane 104 from front (left) and top view 
 (all hydrogen atoms – except for 
t nitrogen (blue) are omitted for the sake of clarity
).  
attempts for the transformation 
e derivatives, as well as into a chiral 
The initial task in this part of the thesis was to find a 
104, in order to give 
38).[194-198] This should be possible in principle
104
Diederich and co-workers could show that 
173 exhibit remarkable activity as inhibitors of HIV
s highly demanded (scheme 38). 
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Scheme 38. General structure of potent HIV-1 protease inhibitors, containing a 3,4-disubstituted C2-symmetrical 
pyrrolidine skeleton 173, along with potentially accessible compounds 174 from bis-cyclopropane 104 that are 
structurally related to 173.  
With this in mind, we started a series of experiments for the selective ring-opening of the 
DA-cyclopropane bonds in tricycle 104 (or derivatives thereof) by using orthogonal 
strategies. 
 
3.2 Opening of donor-acceptor substituted bis-cyclopropanes according to Werz et al. 
 
From the group of Werz it is known that furan based bis-cyclopropane dialdehydes like 176 
can be converted into annelated oligoacetals by collapse of the highly unstable push-pull 
cyclopropane system 176.[202, 203] Within a repeated three-step sequence of double 
cyclopropanation, reduction and oxidation of furan 35, all-anti-oligoacetals up to the nonamer 
175 have been constructed and their structures were thoroughly analyzed by means of X-ray 
crystallography and DFT calculations (scheme 39). It was shown that oxidation by 
2-iodoxybenzoic acid (IBX)[204] in dimethylsulfoxide (DMSO) was a proper method for 
oxidizing the bis-cyclopropane diol moiety, and thus inducing cyclopropane ring opening, 
followed by a ring-closure reaction to form cyclic enol ether compounds like 177.  
 
 
Scheme 39. Preparation of all-anti-fused oligoacetals 175 by a repeated three-step sequence starting from furan 
35, reported by Werz et al. (left). Key step is a ring enlargement reaction from tricyclic bis-cyclopropane 
aldehyde 176 to bis-enol ether 177 (right).  
As until then Werz and co-workers had only reported such kind of transformations for furan 
derivatives, it seemed as an attractive strategy to us to envision pyrrolidine based compounds 
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of that same type (bearing a nitrogen atom in the central ring, instead of oxygen). Thus 
reduction of the two tert-butyl ester moieties of 104 by lithium aluminum hydride (LAH) was 
straightforward, leading to diol 178 in 95% yield (scheme 40).  
 
 
Scheme 40. Synthesis of C2-symmetric tricyclic compound 179 from diester 104, attempted deprotection and 
proposed mechanism of the rearrangement from 178 to 179. However, calculations from Werz et al. suggested 
that – at least for furan derivatives – the ring enlargement step might occur in a concerted manner.  
The second step was the abovementioned oxidation using IBX in DMSO, which led to 
tricyclic molecule 179 in satisfying 52% yield. Unfortunately, soon after having 179 in hand, 
the Werz group brought out another publication, showing the synthesis of the very same 
compound (and some derivatives), however, in somewhat inferior yield (42%).[205] An 
attempt to deprotect the N-atom in 179 in order to yield a potential C2-symmetrical ligand for 
metal complexes 180, failed due to decomposition of the starting material. Another idea for 
turning this into something useful was to investigate the cylopropane opening behavior in a 
rearrangement reaction.  
 
 
Scheme 41. Proposed mechanism for a base induced rearrangement of acetylated cyclopropane derivatives 184 
for the formation of compounds like 186.  
It was thought that diol 178 could be protected by acetyl (Ac) groups and further undergo a 
rearrangement, which would open the cyclopropane bonds upon enolization with a suitable 
base. This would lead to interesting compounds like 186. Scheme 41 depicts the proposed 
strategy for this idea. A protocol of Pietruszka et al. was applied successfully for the 
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acetylation of diol 178,[206] giving rise to double acetylated pyrrole 187 in 91% yield within 
ten minutes reaction time (scheme 42). 
 
 
Scheme 42. Acetylation of diol 178 and unsuccessful attempt for the base-induced rearrangement of 187.  
However, the crucial step in this approach failed and only unreacted starting material, along 
with minor amounts of partially hydrolyzed 187, were isolated. With the recent publication of 
Werz et al. in mind, and the fact that the subsequent trials were not successful, we turned our 
attention to other strategies for the opening of the DA-cyclopropane bonds of 104.  
 
3.3 Hydrogenolysis of donor-acceptor substituted cyclopropanes 
 
Hydrogenolysis of carbon-carbon bonds is a well-known process in chemistry. Especially 
small rings with a high degree of ring strain, e.g. cyclobutanes or cyclopropanes, are 
somewhat prone to undergo ring opening reactions. Due to their intrinsic ring strain, catalytic 
opening of small rings by hydrogenolysis can be carried out at ‘rather mild’ conditions. 
Indeed, first examples go back to the early 20th century when Willstätter and Bruce first 
hydrogenated cyclopropane 189 and cyclobutane 191 to their corresponding aliphatic alkanes 
190 and 192 using a nickel catalyst (scheme 43).[207] Since then, several examples have 
appeared in literature revealing that this process is a valuable tool for synthetic chemistry. 
Scheme 43 presents some outstanding literature precedents for such reactions.  
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Scheme 43. Literature precedents for the catalytic hydrogenolysis of cyclopropane moieties (bonds to be cleaved 
are highlighted in red).  
De Meijere and co-workers presented the catalytic hydrogenolysis of multiple spiro-annelated 
cyclopropanes 193, using one atmosphere of hydrogen gas on a platinum(IV)-oxid catalyst. 
These highly strained compounds were shown to react smoothly even at low temperatures to 
form products like 194 (scheme 43).[208] Another interesting example is the catalytic 
hydrogenolysis of DA-cyclopropane 195 with palladium on charcoal at slightly elevated 
pressures to form 196 and 197, reported by Adams and Belley.[209] 
 
Therefore, it was tested whether such an approach could also be adapted for our doubly 
cyclopropanated pyrrole derivative 104. It seems plausible, that in our case, the bond between 
the donor and the acceptor should be the one to be cleaved most readily (red bonds in 104, 
scheme 44), due to the known fact that these bonds are typically the longest, and thus 
weakest, in such compounds.[210] In theory, one could obtain 3,4-disubstituted C2-symmetric 
pyrrolidines 199 in one step via this method. As already mentioned before, derivatives of such 
compounds exhibit significant biological properties and hence are reasonable target structures.  
 
Scheme 44. Theoretical scheme for the hydrogenolysis of DA-cyclopropane 104 and the expected products for 
this type of transformation 198 and 199 (bonds presumably cleaved are given in red; A = acceptor, D = donor).  
A first approach for screening several different catalyst systems was conducted using the 
ThalesNano H-Cube ProTM, a continuous flow system for hydrogenation reactions that allows 
for rapid screening of reaction conditions. Therefore, compound 104 was dissolved in 
methanol, passed through the reactor for one cycle (at variable conditions, e.g. temperature, 
  
pressure, flow). The crude reaction mixture was
16 illustrates the experimental
Figure 16. Illustration of the reaction setup for catalyst screening 
solvent; B: substrate in solvent (MeOH)
monitoring reaction parameters (temperature, pressure, flow, etc.)
cartridge (incl. heating block); F: waste drain
The obtained results of our screening attempts for the catalytic hydrogenolysis of 
summarized in table 8. It could be shown that the major product of such experiments 
none of the expected products (
discussion about the possible way of formation for 
chapter (scheme 45). Looking at entries 
10% Pd/C, nor 5% Pt/C were suitable catalysts for the investigated transformation, as there 
was absolutely no conversion of starting material observable after one cycle (even at 
temperatures and hydrogen gas pressures of up to 80 °C
when using 5% Rh/C, significant
NMR spectra (40 °C, 40 bar; entry 
forcing the conditions up to 80 °C
starting material was observed (entry 
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 analyzed by 1H-NMR spectroscopy. 
 setup used for these attempts.  
using the ThalesNano H
; C: HPLC pump; D: control element, display for 
; E: reaction chamber containing catalyst 
; G: recovered product mixture in solvent. 
198 or 199; scheme 44), but unsaturated derivative 
200 will be given in a later part of this 
1-6 of table 8, one immediately realizes that neither 
 and 80 bar, respectively). However, 
 amounts of product (< 10%) could be detected in the crude 
7, as well as at 60 °C, 60 bar; entry 8). Surprisingly, when 
, 80 bar with the same catalyst system, no conversion of 
9).  
H
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Table 8. Screening of reaction conditions for the catalytic hydrogenolysis of 104 under flow conditions using the 
H-CubeTM.  
entrya) catalyst temperature [°C] H2 pressure [bar] conversione) 
1 Pd/C (10%) 50 40 0 
2 Pd/C (10%) 60 60 0 
3 Pd/C (10%) 80 80 0 
4 Pt/C (5%) 40 40 0 
5 Pt/C (5%) 60 60 0 
6 Pt/C (5%) 80 80 0 
7 Rh/C (5%) 40 40 4.8 
8 Rh/C (5%) 60 60 8.5 
9 Rh/C (5%) 80 80 0 
10b) Rh/C (5%) 60 60 0 
11c) Rh/C (5%) 40 40 8.3 
12c) Rh/C (5%) 60 60 9.7 
13c) Rh/C (5%) 60 80 0 
14 Rh/C (5%) 50 50 0 
15 Rh/C (5%) 60 60 0 
16d) Rh/C (5%) 60 60 0 
a) 0.05 mmol (20 mg) 104, 4 ml MeOH; b) flow = 0.3 ml/min, 4 consecutive runs through system; c) fresh 
catalyst cartridge; d) flow = 0.3 ml/min; e) determined by 1H-NMR of the crude reaction mixture without 
internal standard. 
 
In order to enrich the amount of product for isolation and purification purposes, there are two 
obvious options: 1) reducing the flow rate, and 2) raising the amount of consecutive runs 
through the system in order to increase contact time of the reaction mixture with the catalyst 
cartridge (reaction chamber; E in figure 16). Hence, the flow rate was set to a minimum value 
of 0.3 ml/min and the reaction mixture was passed through the system for four consecutive 
cycles at conditions that gave superior conversion before (60 °C, 60 bar; entry 10). But again 
no conversion was detectable, which made us curious, as this result did not make any sense at 
all. Surprisingly, when using a fresh catalyst cartridge of Rh/C (5%), product formation was 
observed again (entries 11 and 12), indicating a possible, but rather unlikely deactivation of 
the catalyst system. Unfortunately, follow-up experiments again failed, leading to zero 
conversion (entries 13-16). This led us to resign from this approach and to rater focus on other 
methods. The product formed during these attempts could unfortunately not be isolated and 
fully characterized, due to the limited scale of the experiments and the almost identical Rf 
values of 200 and the starting material 104. However, figure 17 illustrates the strategy for its 
  
identification by comparison of 
help, as the starting material and the product 
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Figure 17. Identification of ring-opened product 
reaction mixture with those for starting material 
(green). Separation of the crude mixture was not possible
are identical (rearrangement).  
In scheme 45, a plausible mechanism for the formation of the obtained product is depicted. 
Starting from acid-mediated opening of the DA
enol moiety to the corresponding 
two orthogonal pathways: 1) Addition of hydride to the iminium ion would lead to an overall 
hydrogenolysis process (red in scheme 
would lead to the product of an acid
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Scheme 45. Plausible mechanism for the above investigated transformation of bis-cyclopropane 104. In principle 
two pathways can be envisioned, leading to different types of products. The classical strategy of hydrogenolysis 
(red) would lead to a product like 198, while an acid-catalyzed rearrangement (blue) would give rise to 200.  
Batch experiments were conducted in the following, as it was shown that catalyst deactivation 
was assumed to be a critical issue in the H-CubeTM experiments (table 8). Thus, in table 9 we 
tried to reproduce the results from the abovementioned flow experiments, and to accumulate 
product amount for complete characterization. To our surprise, we found that in these 
reactions not the unsaturated pyrrolidine 200 but ring-opened methanol adducts of type 203 
and 204 were formed, probably due to trapping of the intermediary iminium ion 202 by a 
molecule of methanol.  
 
 
Table 9. Attempts for the hydrogenolytic cleavage of cyclopropane 104 under batch conditions.  
entrya) H2 pressure [bar] temperature [°C] additive time [d] conversionf) 
1 1 25 - 2 0 
2b) 60 60 - 1 traces 
3 1 25 10% HOAc (v/v) 19 44 
4c) 1 25 10% HOAc (v/v) 19 32 
5d) 1 65 10% HOAc (v/v) 6 3 
6b) 60 60 10% HOAc (v/v) 6 6 
7e) - 25 10% HOAc (v/v) 7 7 
a) 0.50 mmol (198 mg) 104, 20 ml MeOH, 10 mol% Rh/C (5%); b) reaction carried out in a sealed autoclave; c) 
40 ml MeOH; d) no catalyst used; e) no hydrogen used; f) estimated from 1H-NMR of the crude reaction mixture 
without internal standard. 
 
The experiments described in table 9 were either performed in regular Schlenk flasks with a 
balloon of hydrogen gas (for ambient pressure experiments; entries 1, 3-5) or in a sealed 
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autoclave for reactions under pressure (entries 2 and 6). Monitoring of the reaction was 
severely hampered by the fact that TLC analysis was not sufficient to clearly indicate product 
formation (nearly identical Rf and staining behavior of starting material 104 and products 203 
and 204). Therefore, 1H-NMR analysis had to be carried out to follow the reaction progress. 
Without the addition of an additive, there was almost no conversion detectable, even when 
conditions were forced to 60 °C and 60 bar (entries 1 and 2). Looking at the reaction times, it 
is noticeable that these processes were extremely slow and the conversion of starting material 
reached some kind of plateau after a certain time and then stopped completely. Best results 
were obtained when using 10% (v/v) acetic acid as an additive at ambient temperature and 
pressure, giving rise to 44% of conversion after 19 days (entry 3). Lower concentrations led to 
reduced reaction rate (32%, entry 4), whereas higher concentrations were not accomplishable 
due to the poor solubility of 104. It could be shown by NMR and MS that methanol adducts 
203 and 204 were formed in these transformations, but due to the low conversion and nearly 
identical Rf values of starting material 104 and the products 203 and 204, it was practically 
impossible to completely purify and characterize the products. In none of the cases 
unsaturated elimination product 198 was observed. In order to check whether Rh/C is crucial 
for product formation, the attempt was made to convert 104 by simply refluxing it in 
methanol/acetic acid without catalyst addition (entry 5). However, only very little conversion 
was obtained after six days, indicating that rhodium indeed plays a role as catalyst. As 
described above, reaction rate seemed to be a limiting factor. Hence, we applied additional 
pressure and heat to the reaction conditions of entry 3 in order to accelerate the process. 
However, after six days of reaction at 60 °C and 60 bars of pressure only 6% conversion were 
determined (entry 6). When using Rh/C in MeOH/HOAc at room temperature without 
hydrogen gas, 7% conversion were observed after seven days (entry 7). If entries 5 and 7 are 
taken into account, it seems obvious that the investigated transformation is rather an acid-
catalyzed process than a hydrogenation of the cyclopropane bond. Therefore, we turned our 
focus from hydrogenation approaches to acid-promoted transformations of bis-cyclopropane 
104.  
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3.4 Acid-promoted transformations of DA-cyclopropane 104 
 
As demonstrated earlier in chapter B 3.3, hydrogenolysis of the push-pull cyclopropane bonds 
in 104 is not an efficient process as cyclopropane cleavage rather proceeds via an 
acid-catalyzed ring opening mechanism. Hence, we investigated the effects of different 
Brønstedt and Lewis acids on their cyclopropane opening propensities, as well as suitable 
trapping reagents for the proposed iminium species 202. Table 10 summarizes the attempts 
for such kind of transformations. From the previous experiments (entry 5 in table 9), it is clear 
that refluxing methanol/acetic acid is not sufficient to induce cyclopropane ring opening. This 
leads to the conclusion that a suitable catalyst, capable of cyclopropane ring opening, needs to 
be employed. Indeed, scandium(III)-trifluoromethanesulfonate (scandium triflate; Sc(OTf)3) 
was shown to be highly efficient in opening both DA-cyclopropane rings in 104 (entries 1-3, 
see also ref. [60]). After only 5 min of microwave irradiation (heating at 85 °C), full 
conversion of starting material was observed. Unfortunately, only rearomatization and 
deprotection products could be isolated in this case (scheme 47). The same was observed 
when bis-cyclopropane 104 was refluxed in methanol and activation with 
para-toluenesulfonic acid (p-TSA; entry 5). The ratio of the formed aromatic products 208 
strongly depended on the reaction times. Under the acidic conditions (and elevated 
temperatures) an initial deprotection of the Boc group is likely before the ring opening takes 
place. However, the deprotection may also happen at a later stage. Yet in 1998, Wenkert and 
Khatuya reported on acid-mediated ring opening, and subsequent aromatization of doubly 
cyclopropanated furans 205 to form furan-3,4-diacetates of type 207.[103] The authors 
proposed intermediates like 206, which were claimed to be prone toward elimination (scheme 
46).  
 
 
Scheme 46. Synthesis of furan-3,4-diacetates 207 from acid-mediated cyclopropane opening of 205 and 
subsequent elimination of HX from 206 by Wenkert and Khatuya.[103] 
The fact that mixtures of several different ester functionalities (tBu/Me and Me/Me) were 
isolated (208) leads to the assumption that the transesterification process takes place after the 
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formation of the pyrrole skeleton. Other Lewis acids (LiClO4, FeCl3, AlCl3) did also not yield 
products other than 208 (entries 6-8). In order to circumvent elimination, and thus 
rearomatization, the solvent was switched from methanol to less nucleophilic THF (entries 
9-17) and the addition of triethylsilane was intended to provide hydride as a suitable 
nucleophile, which would not undergo elimination once added (see also scheme 47 for a 
plausible mechanism). However, this approach, though nice on paper, turned out to yield only 
decomposition products or unreacted starting material.  
 
 
Table 10. Attempts for the acid-catalyzed cyclopropane opening of 104 (mw = microwave).  
entrya) solvent acid temperature [°C] 
additive 
(equiv) time 
conversion 
[%]h) product 
1 MeOH Sc(OTf)3 85 (mw) - 5 min > 90 208 
2 MeOH Sc(OTf)3 85 (mw) Et3SiH (5) 5 min > 90 208 
3 MeOH Sc(OTf)3 30-80 (mw) - 30 min (6x5) ~ 80 208 
4b) MeOH Sc(OTf)3 25 - 6 d 0 - 
5b) MeOH p-TSA 65 - 18 h 100 208 
6 MeOH LiClO4 25 - 72 h < 5 - 
7 MeOH FeCl3 25 - 72 h < 5 - 
8 MeOH AlCl3 25 - 72 h ~ 50 208 
9b) THF Sc(OTf)3 85 (mw) Et3SiH (5) 10 min 100 decomposition 
10 THFabs Sc(OTf)3 85 (mw) - 5 min 100 decomposition 
11c) THF Sc(OTf)3 85 (mw) Et3SiH (5) 5 min ~ 20 208 
12 THF Sc(OTf)3 25 Et3SiH (5) 30 min 0 - 
13 THF p-TSA 25 Et3SiH (5) 72 h < 5 - 
14 THF p-TSA 85 (mw) Et3SiH (5) 5 min < 5 - 
15d) THF p-TSA 25 Et3SiH (5) 24 h < 5 - 
16e) THF TFA 25 Et3SiH (5) 72 h > 90 decomposition 
17 THF Sc(OTf)3 30-80 (mw) C5H11-NH2 30 min (6x5) 0 - 
18 MeCN Sc(OTf)3 150 (mw) C5H11-OH 15 min 100 not identified 
19f) MeCN Sc(OTf)3 95 Hantzsch ester 24 h 0 - 
20f,g) MeCN Sc(OTf)3 95 Bn-NH2 3 h 32 (NMR) 208 
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21f) THF Sc(OTf)3 85-125 (mw) Bn-NH2 2 h < 5 208 
a) 0.05 mmol (20 mg) 104, 40 mol% acid, 1 ml solvent; b) 0.50 mmol (198 mg) 104, 40 ml solvent; c) 100 µl of 
water were added; d) 1.1 equiv p-TSA used; e) 5 equiv TFA were used; f) catalyst inhibition by amine; g) 
product inseparable from starting material (208: R = tBu, R’ = Bn); h) estimated from TLC. 
 
Formation of aromatic compounds 208 in such reactions indicates that there seems to be an 
intermediary ring-opened methanol adduct of type 203/204 present (chapter B 3.3), which 
undergoes subsequent elimination of methanol (and Boc deprotection) to yield ring-opened 
pyrrole derivatives. A plausible mechanism for this type of transformation is shown in scheme 
47.  
 
Scheme 47. Plausible mechanism for the acid-catalyzed ring opening and subsequent transformations of 
proposed intermediate 209. When methanol acts as the nucleophile (red) elimination, and simultaneous pyrrole 
formation is encouraged (upper row). On the other hand, when hydride is used as the nucleophile, no elimination 
can take place, allowing for maintenance of the stereocenter(s) (LA = Lewis acid, blue).  
After Lewis acid activation of the ester moiety a push-pull ring opening of the DA-substituted 
cyclopropane 209 takes place and the intermediary iminium ion 210 is trapped by a molecule 
of methanol. Intermediate 211 (or 212) is prone to undergo elimination of methanol again to 
finally form pyrrole derivatives of type 208 under the applied conditions (scheme 47, upper 
row). Ideally, one would envision using a nucleophile that is not able to undergo elimination. 
Thus, hydride may attack the iminium ion 210 to form products of type 213 (or 214), which 
cannot undergo elimination and still maintain their stereoinformation (scheme 47, lower row). 
Unfortunately, results from table 10 suggest that neither of the applied conditions were 
feasible for sufficient transformation of bis-cyclopropane 104 into the desired products 174 
without the occurrence of aromatization. Thus, no further efforts were carried out in this 
direction.  
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4 Investigations of peptide foldamers at high pressure 
4.1 High pressure as an alternative activation mode in organocatalysis 
 
A general, until now only partly solved problem in organocatalysis is the slow reactivity of 
many of the catalysts compared to classic metal catalysis, leading to low turnover frequencies 
and to an instantaneous need for higher catalyst loadings.[211-215] In order to overcome 
energy barriers for organic transformations, several different modes of activation are feasible, 
e.g. an increase in temperature, the application of Lewis acids, microwave irradiation or 
ultrasonic sounds.[216, 217] Pressure is an alternative that was somehow ignored by a great 
part of the scientific community so far (due to plausible reasons, see discussion later); 
although it bears significant advantages compared to standard activation modes. It is a mild 
and non-destructive method that allows for activating a broad variety of organic 
transformations even at low temperatures, giving distinct benefits for selectivity issues. 
Reactions prone for activation by pressure include aldol, Michael, Mannich and 
Baylis-Hillman reactions, as well as cycloaddition reactions and cross couplings. In principle, 
every reaction with a negative volume of activation (∆Vǂ), which is defined as the difference 
of the volume of the transition state and the volume of the reactants, can be accelerated by the 
influence of pressure.[218-221] Although literature precedents for pressure promoted 
reactions are rather limited, some remarkable transformations have been accomplished so 
far.[222-227] It can be assumed that the normally rather sophisticated experimental setup for 
such reactions excluded more intense application of high pressure in catalysis. However, 
people are creative and thus developed simple strategies for the generation of high pressures. 
For instance, Hayashi and co-workers reported a very elegant method by freezing water inside 
a sealed autoclave with a household refrigerator/freezer to -20 °C, which enabled them to 
generate pressures of up to 2000 bar.[228-231] Some very recent examples include high 
pressure catalysis combined with photochemistry,[232, 233] as well as the highly 
enantioselective construction of chiral quaternary stereocenters applying pressures up to 10 
kbar, which leads to products that are not accessible under ambient conditions.[234, 235] 
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4.2 Peptide based organocatalysts 
 
Short peptides have been shown to be remarkably efficient catalysts for organocatalytic 
transformations and have been applied in a broad scope of transformations. The field of 
peptide based organocatalysis has been pioneered by Miller et al.[236, 237] and extensively 
augmented by the group of Wennemers.[238, 239] Figure 18 depicts two prominent examples 
from the referred groups (215 and 216).  
 
 
Figure 18. Examples of peptidic organocatalysts from Miller et al. (215) and Wennemers et al. (216), along with 
tripeptide foldamers 217a and 217b from the Reiser group (▲ designates (+)-cis-β-ACC ((+)-33), and ▼ 
designates (-)-cis-β-ACC ((-)-33)).  
Various studies revealed that regular peptides are often too flexible to act efficiently, thus 
modification by e.g. N-methylation or introduction of conformationally constrained building 
blocks proved to be vital for the construction of efficient catalyst systems. Tripeptide 
foldamers like 217a and 217b, containing a β-ACC (▲ or ▼) building block in the central 
position were shown to be efficient catalysts for organocatalytic transformations, including 
aldol, Mannich, and Michael reactions.[58, 240] Making use of the rigidity of the central 
cyclopropane moiety the two functional groups responsible for catalysis, i.e. the secondary 
amine and the carboxylic acid function can be positioned in close proximity. This feature 
allows 217a (containing ▲) to act as a superior catalyst compared to its isomer 217b 
(containing ▼). In the following part a plausible explanation for the discrepancy in catalytic 
activity between 217a and its isomer 217b, based on high-pressure (HP) structural studies 
(including HP-NMR), compared with catalytic results at high- and ambient-pressure 
conditions is proposed. The synthesis of the two tripeptide foldamers is described in the 
following section. 
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4.3 Synthesis of the tripeptide foldamers 217a and 217b 
 
The synthesis of tripeptide foldamers 217a and 217b commences with the preparation of the 
central cyclopropane amino acid cis-β-ACC (▲/▼; (±)-220) following a method of Reiser et 
al.[50] In this case 33 is prepared in a racemic fashion, as the enantiomers can be separated at 
a later stage (as diastereomeric dipeptides 221), hence giving rise to both isomers at once. 
After N-Boc protection of pyrrole 50 using a slightly modified procedure of Grehn and 
Ragnarsson,[241] a racemic cyclopropanantion reaction of N-Boc-pyrrole 101 was carried out 
using methyldiazoacetate to form cyclopropane (±)-18 (scheme 48). The remaining double 
bond was subsequently cleaved via ozonolysis and treatment with dimethylsulfide (DMS) to 
form aldehyde 218. In the next step, the aldehyde function was oxidized to the carboxylic acid 
following a procedure of Dalcanale and Montanari.[242, 243] After a deformylation step 
mediated by the organic base N,N-diethylaminoethylamine (DEAEA), benzyl protection of 
the free acid concludes the synthesis of racemic (±)-220.  
 
 
Scheme 48. Synthesis of (±)-220 from pyrrole 50 following the procedure of Reiser et al.[50] 
Single crystals of the racemic mixture of 33, suitable for X-ray analysis could be grown, 
allowing for a structural proof of the cis-relationship of the amine and the carboxylic acid 
moieties in 33 (figure 19).  
  
Figure 19. Single crystal X-ray structure of Boc
and the carboxylic acid function. This structural feature is crucial for further approaches into catalysis
allows for spatial proximity of the functional groups responsible for catalytic a
After successful synthesis of racemic 
another report of Reiser et al.
substituted cyclopropanes are known to undergo rapid ring opening reactions
N-terminus is deprotected, β
coupling approaches.[48, 244
type 221 by the deprotection of the 
ethylacetate.[54] The resulting 
them into the corresponding dipeptides
(3-dimethylaminopropyl)carbodiimide hydrochloride
separation of the two diastereomeric dipeptides, it is necessary to deprotect the Boc group
first, as chromatographic separation proved to be much more convenient at thi
the two diastereomerically pure dipeptides could be obtained in 43% (
yield from racemic (±)-220, respectively. 
both isomeric compounds. After Boc protection
groups, the dipeptides are coupled with a second molecule of 
protected tripeptides 222a and 
HCl/EtOAc with subsequent basic work
benzyl esters. In this way tripeptide H
over 13 steps (from N-Boc-pyrrole)
49).  
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-▼-OH (33), clearly showing the cis-relationship of the amine 
ctivity. 
220, the preparation of the tripeptide catalysts
,[58] which is presented in scheme 49. 
-ACC derivatives proved to be tricky substrates for peptide 
, 245] Nevertheless, it is possible to synthesize dipeptides of 
N-Boc group with a solution of HCl in dry 
ammonium derivatives are stable enough to directly convert 
 via solution phase peptide coupling with 
 (EDC) and N-Boc-
221a
The next steps are then performed in parallel for 
 and hydrogenolytic cleavage of the benzyl 
L-proline to form orthogonally 
222b. Final deprotection steps were carried out using 
-up, followed by hydrogenation in order to cleave 
-Pro-▲-Pro-OH (217a) was prepared in 5.0% yield 
, and its isomer H-Pro-▼-Pro-OH (217b
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, as it 
 followed 
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 once the 
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s stage. Thus, 
) and 33% (221b) 
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Scheme 49. Synthesis of tripeptide organocatalysts 217a and 217b from (±)-220, following the procedure of 
Reiser et al. (solely L-proline was used for peptide coupling).[58] 
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4.4 Structural investigations of the tripeptide foldamers 217a and 217b 
 
In order to gain insight into the possible conformations of the two peptidic organocatalysts 
217a and 217b, we performed detailed structural investigations, including NMR studies 
combined with molecular modeling approaches. The findings from our structural studies were 
then compared to the results obtained from catalysis experiments (chapter B 4.5). From 
former studies it is know that H-Pro-▲-Pro-OH (217a) is a superior catalyst compared to its 
isomer H-Pro-▼-Pro-OH (217b).[58, 59] With the experiments discussed in the following 
part we aimed to create a reasonable explanation for the catalytic discrepancy of the two title 
compounds, and to propose a plausible way of catalytic action for the active species.  
 
When having a look at the proton NMR spectra of the two isomeric compounds 217a and 
217b, one immediately recognizes a significant difference.[58] While the spectrum looks tidy 
for 217b, with nice sharp and separated signals, there is a vast overlap of mostly broadened 
signals visible for 217a. Furthermore, one can see multiple distinct sets of signals, which 
might be assigned to minor populated state conformations. These first insights led to the 
postulation that 217a is conformationally highly flexible, while its isomer 217b is rather fixed 
to one major conformation, which may be due to an internal hydrogen bond. In order to test 
our hypothesis, 1H-NMR spectra of both compounds were recorded at varying pressures (30, 
1000, 2000 bar), and the relative shifts of the characteristic amide proton (red NH in figure 
20) were compared. In general, amide protons of peptides and proteins tend to shift much 
higher upon an external stimulus (e.g. temperature, solvent titration), when they are not 
hydrogen bonded. Thus, a minor shift of the amide signal may give hints for H-bonding of the 
amide proton in question.[246] Figure 20 presents the results of the conducted experiments.  
  
Figure 20. 1H-NMR spectral region of the 
pressures (30, 1000, 2000 bar). The relatively low shift of the signal of 
structure are clear hints for strong intramolecu
It is clearly visible from the stacked 
signal shifts to a much larger extent for 
= 0.058 ppm, B). Furthermore, it has to be noticed that the signals are much sharper and start 
to split into the characteristic doublet
these observations confirm our hypothesis
intramolecular hydrogen bond fixes the conformation of 
C-terminal benzyl ester of 217b
tripeptide is the one showing poor catalytic performance, it is suggested that the internal 
H-bond separates the two functional groups responsible for catalytic activity, thus leading to 
an inactive catalyst. On the other hand, H
for positioning of the functional groups into the desired conformation. It was already show
by Reiser et al. that 217a exists in predominantly two major conformations.
temperature 217a was shown to exist in a 1:3 
minor cis-amide conformer was pr
of peptide 217a was not possible due to the high
crystallized but the obtained crystals were unfortunately not measurable)
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signal of the amide proton (red) of 217a (A) and 
217b and the occurrence of 
lar H-bonding (800 MHz, CD3OH, 0.18 M, 298 K)
1H-NMR spectra depicted in figure 
217a (∆δNH = 0.105 ppm, A) compared to 
 of backbone amide protons in peptides (
 and lead us to the conclusion that a strong 
217b. Structural calculations on the 
 also revealed potential H-bond formation
-Pro-▲-Pro-OH (217a) is highly flexible, allowing 
cis/trans ratio in methanol
oposed to be the catalytically active species. 
 intrinsic flexibility (tripeptide 
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217b (B) at varying 
peak fine 
.  
20 that the amide 
217b (∆δNH 
B). All together, 
.[59, 247] As this 
n 
[58] At ambient 
-d3, whereas the 
X-ray analysis 
217b could be 
. Moreover, this 
  
would only lead to solid state insight
in this case. Therefore, we attempted to generate molecular models of the tripeptides
would allow a more detailed perception into the structural preferences of 
molecular modeling software package 
and energy calculations. Figure 
217b obtained from a conformational search using six rotatable 
distance restraints. The resulting structures (324) were 
afterwards. Due to severe overlap of the NMR signals, precise integration of all nuclear 
Overhauser effect (NOE) cross peaks could not 
found for all of the proposed conformations
sorting the conformers. Regarding this aspect, it has to be noted that the conformations of 
tripeptides 217a and 217b present
reflections of what actually happens in solution. 
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Figure 21. Low energy models of tripeptides 
assumed that 217b is stabilized by a
functions (NH1 and HO19) from each other (
(cis and trans), from which only the minor conformation with a 
species (center), while the trans-conformation has some kind of 
structures the groups responsible for catalytic activity are highlighted
NH7-OC13, and NH1-HO19 in Å; H-bonds with corresponding distances are indicated in 
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s, whereas the solution structure is much more important 
Spartan 06 was used for the conformational 
21 presents low energy structures of tripeptides 
backbone bonds each without 
then minimized in energy and sorted 
be achieved, however, distinct NOEs were 
 and were taken into account in the process of 
ed in figure 21 are rather ideal model structures than exact 
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CO2Me
O
N
H
O
N CO2H cis(active)
H-Pro--Pro-OH
(217a)
HO2C
H-Pro-
217b (left) and 217a (center, right) generated by 
 strong intramolecular H-bond (green), which separates the two crucial 
left).  In contrast, 217a exists in predominantly two conformations 
cis-amide bond would be the catalytically active 
resting state character
 in red; blue arrows give distances between 
green
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the latter. The 
sampling 
217a and 
 
NH
CO2Me
O
N
H
O
N trans
(inactive)
-Pro-OH
(217a)  
Spartan 06. It is 
 (in the chemical 
).  
  
The low energy structure of tripeptide 
between NH7 and OC13, which ha
In such a conformation the two functional groups responsible for efficient catalysis are 
spatially separated (7.094 Å); a structural feature
organocatalysis, and therefore
figure 21). In contrast to 217b
changes of conformation. The two major conformations are proposed to be 
of the C-terminal amide bond (OC
and the trans-amide conformation (
(3.422 Å and 3.464 Å, respectively)
similar to 217b. The minor populated 
the catalytically active functional groups with two weak H
(NH7-CO18: 1.899 Å, HN1-HO
217a (right) represents a kind of 
interconversion of the conformers. 
Figure 22. 1H-NMR spectral region of the amide
While the amide signal of the major conformer (
increasing pressure, the region of minor populated conformational states (
(800 MHz, CD3OH, 0.18 M, 298 K)
In order to investigate whether pressure can influence the conformational equilibrium of our 
catalyst, we investigated the 
                                                          
10
 For the conformations of proline amide bonds see:
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217b shows a potential hydrogen bond (d = 1.994 Å) 
s also been predicted by the abovementioned experiments. 
 which would disallow
 explain the poor catalytic performance of 
, 217a is suggested to be rather flexible, allowing for rapid 
13
-N).10[248] In both, the cis-amide conformation (
right) the distances between NH7 and OC
 and out of plane, thus avoiding a restraining H
cis-conformer (center) shows close spatial proximity of 
-bonds arranging them 
19: 1.821 Å). On the other hand, the trans
resting state of the catalyst, but though allows for rapid 
 
 signal of tripeptide 217a at varying pressures (30
left) only shows shifting and marginal line sharpening upon 
red frame) reveals distinct changes
.  
1H-NMR amide region of H-Pro-▲-Pro
 ref. [248] 
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varying pressures (figure 22). While the amide NH signal for the major conformer (trans, left 
part of the spectra) only showed shifting and rather insignificant line sharpening upon 
increasing pressure, the region of the minor populated conformational states revealed distinct 
effects (red frame). Indeed it seems that some of the signals are completely vanishing at 
higher pressures. This suggests a substantial effect of pressure on the conformational 
preferences of such a small peptide, which is remarkable. In order to provide more 
experimental proof for the proposed mechanism of action, we conducted experiments using 
tripeptides 217a and 217b as catalysts for aldol reactions at ambient- and high-pressure 
conditions.  
 
4.5 Organocatalysis under high pressure 
 
It is a well-known fact that pressure influences the dissociation of water.[249] As it is also 
known that water plays a vital role in a plethora of organocatalytic transformations, it seems 
plausible to apply high pressure for the acceleration of said reactions. Despite of the effect on 
reactivity, it should also be investigated whether pressure can have an influence on the 
conformational equilibrium of the peptides, and thus could affect selectivity. Hence, tripeptide 
catalyst H-Pro-▲-Pro-OH (217a) was tested in the model reaction between acetone 223 and 
para-nitrobenzaldehyde 224 under ambient- and high-pressure conditions (table 11).  
 
 
Table 11. Organocatalyzed aldol reactions under ambient- and high-pressure conditions.  
entrya) catalyst [mol%] time [h] pressure [bar]d) conversione) yield [%]f) ee [%]g) 
1 - 24 1 40 17 0 
2 - 24 4600 14 9 0 
3 10 24 1 84 68 69 (R) 
4 10 16 5200 100 81 65 (R) 
5 10 4 4800 97 73 67 (R) 
6b) 20 24 1 n.d. 89 78 (R) 
7b),c) 20 24 1 n.d. 77 6 (R) 
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a) 0.20 mmol (30 mg) 224, 2 ml acetone/water (10:1 (v/v)); b) taken from ref. [58]; c) H-Pro-▼-Pro-OH,  
acetone/water (5:1 (v/v)); d) deviations of pressure are due to the experimental setup; e) determined by TLC 
analysis/isolated starting material; f) isolated yield after column chromatography; g) determined by chiral HPLC 
(Chiralcel AS-H, n-heptane/iPrOH = 99:1, flow = 0.5 ml/min, λmax = 254 nm, rt = 18.97 min (R), rt = 22.38 min 
(S)). 
 
In order to see the potential effects of pressure on selectivity, a benchmark reaction with a 
moderate degree of enantioselectivity was chosen on purpose. From entries 1 and 2 it can be 
concluded that uncatalyzed background reactions indeed occur, but to a significantly lower 
extent at 5 kbar. When comparing entries 3 and 5, it becomes obvious that a pressure of 5 
kbar leads to a sixfold increase in reaction rate (reaction time reduced from 24 h to 4 h). 
However, no significant effects on enantioselectivity were observed. Comparison of entries 6 
and 7 reveals that H-Pro-▼-Pro-OH (217b) is still an active catalyst (leading to 77% yield), 
but conveys extremely poor selectivity (entry 7). This result nicely fits our proposed model, 
where the secondary amine (NH1) is widely separated from the acid function (OH19), but still 
is able to catalyze the reaction. It is assumed that the chiral information is transferred by the 
H-bonding capability of OH19 (orienting the transition state), thus explaining the low 
enantioselectivity value for 217b (6% ee). Although it was stated before that rigidity plays a 
crucial role in peptide catalyst activity, this example clearly demonstrates that a certain degree 
of conformational freedom can be essential for efficient catalytic performance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
4.6 Structural investigations of longer 
 
High pressure is a valuable tool in protein biochemistry
folding/unfolding mechanisms of proteins
like Altzheimer’s disease, Parkinson
most cases it is a non-invasive method that allows for tracking of folding intermediates
giving insight into conformational
following, we attempted structural stu
spectroscopy in order to explore the 
than proteins.  
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Figure 23. Three-letter coded sequence and
including H-bonds (Cpe = cispentacin; digits
rings; top). NMR solution structures of 
9/12/9/10 helix in methanol solution. In contrast the helix is distorted to some extent in aqueous media
due to hydropobic interactions and pi
of the helix (blue), and formation of a sal
Mixed α/β-peptide foldamers
stereochemical patterning approach
exhibit stable helical structures, even in aqueous media (figure 
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α,β-peptide foldamers under high pressure
 as it enables the investigation of 
, which are of major concern with regard to diseases 
’s disease or amyotrophic lateral sclerosis
 preferences of proteins and poly-peptides.
dies of peptide foldamers with HP-NMR
feasibility of such methods for systems much smaller 
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226
4
-Ala5-Cpe6-Cpe7-Lys8-Ala9-Cpe10-Cpe11-Glu12-Ala13
 chemical structure of 13-residue α/β-peptide foldamer 
 on arrows indicate the number of atoms forming the H
226 in methanol (left) and water (right). Foldamer 
-stacking between the unsaturated rings (Cpe-2, Cpe-
t-bridge between Lys-8 and Glu-12 on the opposite side
[253, 254] like 226 were designed using the so
 of Martinek and Fülöp et al.[255] and were shown to 
23).[256, 257
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226, 
-bonded 
226 adopts a regular 
, possibly 
6, Cpe-10) on one face 
 (orange).  
-called 
] In order to test 
  
the power of HP-methods for structural studies of relatively short peptidic foldamers, we 
investigated the behavior of foldamer 
and HP-FTIR (up to 6.5 kbar). The results of our experiments are summarized in the 
following section.  
 
4.6.1 High-pressure NMR experiments of foldamer 
 
NMR spectra of 13-residue peptide foldamer 
pressures ranging from ambient pressu
backbone amide signals – which 
NMR spectra in terms of structural studies, as 
analyzed (figure 24).  
Figure 24. Left: 1H-NMR spectral region of the amide signals of foldamer 
bar). Comparison of the signals for 
shifts of the amide signals, which 
foldamer. Right: Overlay of excerpts
indicate pressure induced cross-peak shifts
according to the blue crosspeaks. (800 MHz, 
mixing time).[258] 
Obviously, the general trend upon increasing pressure is a low
signals of 226. However, some of the backbone amide proton signals do not move to a 
significant extent (∆δNH = 0.007 ppm for 
0.060 ppm for Ala-13). This feature is clear evidence that structural changes in the backbone 
conformation of the helical peptide occur
would result in a constant shift
protons of the minor shifting signals show almost no changes of the 
upon increasing pressure (Cpe
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226 as a model compound with HP-NMR (up to 2 kbar) 
226 
226 were recorded in aqueous buffer at 
re (30 bar) to 2040 bar. The chemical shifts of the 
are generally the most meaningful part of peptide or 
they reflect the backbone conformation 
226 at varying pressures (30
Ala-13 (left red frame) and Cpe-3 (right red frame
indicates conformational changes of the helical backbone of the 
 from NOESY spectra of 226 at 30 bar (blue) and 1830 bar (red). Arrows 
. 1D projection represents the 1H-NMR spectra of 
20 mM aqueous phosphate buffer pH 7.4, 
-field shift of most of the amide 
Cpe-3), while others shift quite 
, rather than solely compression of the helix, wh
ing of all amide signals in question. Furthermore, the amide 
J-
-3: 3JHH (30 bar) = 8.49 Hz, 3JHH (2040 bar) = 8.41 Hz; Cpe
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3JHH (30 bar) = 8.11 Hz, 3JHH (2040 bar) = 8.24 Hz). Based on the low chemical shift 
differences and almost constant J-coupling values of such signals one can assume that these 
residues are rather buried in the interior of the helical structure and keep their strong hydrogen 
bonding character. On the other hand, terminal residues that are not incorporated within a 
strong hydrogen bonding network (e.g. Ala-13) tend to be more flexible. 
 
 
4.6.2 High-pressure FTIR experiments of foldamer 226 
 
Infrared (IR) spectroscopy is a well-established technique for studying protein 
conformations.[259-262] In order to get a deeper insight into the conformational behavior of 
our model peptide 226, we conducted HP-FTIR measurements, as it is known that protein 
secondary structures can be reliably assigned by using such methods.[263] Figure 25 depicts 
the amide-I band of the FTIR spectra (1600-1700 cm-1) – which is mostly associated with the 
carbonyl stretching vibration – of foldamer 226 in D2O under varying external perturbations 
(e.g. temperature and pressure). An approach for the cautious interpretation of the obtained 
data is described in the following.  
 
 
  Main Part 
 
 
79 
 
 
Figure 25. Results from the pressure (A and B) and temperature (C and D) dependent FTIR measurements of 
foldamer 226 in D2O at 298 K. Structural changes are reversible in regard of pressure (B) and temperature (D). 
FTIR spectra of 226 in D2O and MeOH (E), and pressure dependency of secondary structure motifs (F; black = 
turn-like structures, red = helical structures, green = unordered structures, blue = usually associated with 
β-sheets, but in the present case may be assigned to short extended chains connecting the helical segments). 
The FTIR amide-I band of 226 at ambient pressure shows a narrow band at around 1672 cm-1, 
usually associated with turn-like secondary structures (figure 25 A). The broad band centered 
at around 1640 cm-1 is an overlapping component between unordered motifs (at 1638-45 cm-1) 
and α-helical structures (1650-55 cm-1). Since the H-bonding pattern in the foldamer is 
different from that of a traditional α-helix, differences in the wavenumbers are expected. For 
example, foldamer 226 likely forms 9/12/9/10 membered rings (compared with a 13 
membered ring in an α-helix), thus the helical structure formed by 226 is probably tighter and 
so the wavenumber is expected to be lower (similar to a 310-helix which exhibits an IR band 
around 1641±3 cm-1).[262] Upon pressurization, the broadening of the amide-I band suggests 
a loss of well-defined structural motifs, and shifting of the peak associated with turns to 
higher wavenumber suggests weakened H-bonding (figure 25 A). The peak-position 
dependent quantitative fits of the amide-I band with pressure (figure 25 F) reveals a reduction 
in the contribution of the band at 1650 and 1672 cm-1 (most likely: the loss of helical folds 
and turns), and a concomitant increase of the unordered structures (1636-1640 cm-1). Figure 
25 B shows that the changes prompted by pressure are reversible. The temperature-dependent 
measurements reveal a similar trend for the turn-like structures, but the changes in the 
helical/unordered region show an opposite behavior (figure 25 C). Temperature induces a 
narrowing of the amide band at the low wavenumber side and a minor shift in the peak 
position. This could again arise due to a different H-bonding pattern at higher temperatures 
(also indicative of changes in the conformational equilibrium), but the changes are reversible 
(figure 25 D). Figure 25 E shows the amide-I band in methanol is blue shifted compared with 
the aqueous solution (probably mainly owing to the different solvent composition). Due to 
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less effective H-donor abilities of methanol, a blue-shift by about 10 cm-1 in helical peptides 
has been reported.[264] In the present case, turn-like and helical structures exhibit shifts by 6 
and 9 cm-1, respectively. In addition, a change of solvent from methanol to water causes a 
hydrophobic-collapse leading to partial loss of helical geometry, also evident by the shape of 
the amide-I band. These results suggest that the broad band centered at 1640 cm-1 most likely 
reflects the conformational equilibrium between purely helical and partially collapsed 
conformations, which is changed reversibly by pressure, temperature and solvent.
In conclusion, both, NMR and IR measurements of α/β-peptide foldamer 226 indicate a 
partial unfolding of the helical conformation upon increasing pressure, which was shown to 
be of a reversible nature. 
  
4.6.3 Temperature-dependent CD spectroscopy of foldamer 226 
 
 
Circular dichroism (CD) spectroscopy has been shown to be an invaluable methodology for 
the analysis of secondary structures of proteins and peptides.[265] Although the characteristic 
CD signals for regular α-peptides do vary significantly from those of β-peptides or mixed 
α/β-peptide foldamers, CD has nevertheless been shown to be appropriate for conformational 
studies of the latter.[266, 267] CD spectroscopy under high-pressure conditions has been 
realized,[268] but unfortunately, due to limitations in the experimental setup such 
measurements could not be conducted in the present work. Nevertheless, variable temperature 
(VT) CD spectroscopy has the potential to reveal insights into the thermal stability of 
secondary structures and can also indicate changes in secondary structure upon the external 
stimulus. Furthermore, the obtained data from temperature-dependent CD can directly be 
compared to those from temperature-dependent FTIR spectroscopy (chapter B 4.6.2). The CD 
spectrum of α/β-peptide foldamer 226 in water shows a strong positive Cotton effect at 206 
nm (figure 26), which was assigned to a right-handed helix (confirmed by NMR solution 
structure and theoretical calculations).[256] In order to investigate the structural behavior of 
foldamer 226 under thermal ‘stress’, CD spectra of 226 in water at varying temperatures were 
collected and analyzed (figure 26). 
  
Figure 26. Left: Temperature-dependent circular dichroism spectra of peptid
temperatures ranging from 10 °C to 90 °C (arrow indicates the decrease of 
206 nm with increasing temperature). 
temperature-induced variation of the maximum at 206 nm.
GmbH & Co. KGaA. Reproduced with permission).
As expected, the characteristic maximum at 206 nm 
from 10 °C to 90 °C (left part
the CD maximum at 206 nm against temperature reveals a linear behavior and gives insight 
into the thermal unfolding of foldamer 
stability of 226 with only 35% unfolding at 90 °C was 
analogy to the abovementioned structural features of 
VT-IR, the thermal unfolding behavior of foldamer 
CD spectroscopy. 
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Right: Thermal unfolding behavior of 
 (Data from ref. [256]. Copyright: Wiley
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 in figure 26). Plotting of the temperature-induced variation of 
226. In these experiments, a remarkably high 
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C Summary 
 
Cyclopropanated heterocycles have been shown to be invaluable building blocks for the 
synthesis of a broad variety of natural products and other biologically relevant compounds. 
The first part of the present thesis describes the enantioselective cyclopropanation of furan 
and pyrrole derivatives, as well as their further transformations of the derived compounds. 
Furan-3-carboxylic acid methyl ester 91 was used as starting material for the total synthesis of 
(-)-Paeonilide 27, however, only in 83% ee, as enantiopure material was not accessible at that 
time. In the course of this project an enantioselective cyclopropanation reaction of 91 was 
developed, which leads to cyclopropane 15 in > 99% ee and multi-gram quantity (scheme 50).  
 
 
Scheme 50. Enantioselective cyclopropanation of furan-3-carboxylic acid methyl ester 91 on 100 mmol scale. 
 
Key features for the success were the application of azabox ligand 8 as the chiral ligand and 
the modification of the ratio of catalyst to ligand from 1:1 to 1:2. On the other hand, 
cyclopropanation products of N-Boc-pyrrole 101, which already have been applied for various 
synthetic endeavors, could not be accessed by enantioselective cyclopropanation so far. In the 
present work, a strategy for the enantioselective cyclopropanation of 101 with the use of 
tert-butyl diazoacetate as carbene source and again azabox ligand 8 was developed (scheme 
51). 
 
 
Scheme 51. Enantioselective cyclopropanation of N-Boc-pyrrole 101 on 150 mmol scale. 
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Cyclopropane 103 can be obtained in > 99% ee and multi-gram quantity, along with doubly 
cyclopropanated 104 (max. 41% ee). The application of tert-butyl diazoacetate and the ligand 
8 turned out to be crucial for achieving high enantiomeric excess of the product. In the course 
of this project tert-butyl substituted azabox ligand 8 was identified to be superior to a great 
variety of other ligands for the asymmetric cylopropanation of both 91 and 101. Cyclopropane 
103 was applied for a short and efficient synthesis of the biologically active GABA analogue 
(S)-(+)-homo-β-proline 109 (scheme 52).  
 
 
Scheme 52. Synthesis of (S)-(+)-homo-β-proline 109 from cyclopropane 103. 
 
Starting from N-Boc-pyrrole 101, (S)-(+)-109 could be prepared in three steps and 37% yield. 
However, the occurrence of epimerzation during the acid catalyzed cyclopropane ring 
opening step prohibited access to enantiomerically pure 109.  
 
In the second part of the present thesis the structural and conformational behavior of 
α/β-peptide foldamers were investigated by the application of high-pressure NMR (up to 2 
kbar) and FTIR (up to 6.5 kbar) spectroscopic methods. Short tripeptides 217a and 217b 
containing a central cyclopropane amino acid, were analyzed in terms of their catalytic 
performance related to the application of pressure (figure 27).  
 
 
Figure 27. Chemical structures of tripeptide organocatalysts 217a and 217b for the intermolecular aldol reaction 
of acetone 223 and para-nitrobenzaldehyde 224. 
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The fact that 217a acts as a highly efficient organocatalyst for intermolecular aldol reactions, 
while its enantiomer 217b gives poor results, led us to the investigation of this feature. A 
plausible model for explaining the discrepancy of catalytic performance of 217a and 217b 
was proposed. While 217b shows clear indications for a strong internal hydrogen bond that 
separates the two catalytic functional groups, 217b shows a significantly higher degree for 
flexibility that allows it for reaching an optimal conformation for catalysis. Experiments under 
high-pressure conditions revealed a sixfold increase in reaction rate upon a pressure jump 
from 1 bar to 5 kbar, but this was rather assigned to the general effect of pressure than to a 
change of the equilibrium of conformations of 217a. In addition to short tripeptides 217a and 
217b, the 13-residue α/β-peptide foldamer 226 was examined under variable pressure and 
temperature. Conformational studies by NMR, FTIR and CD spectroscopy revealed a partial 
unfolding of the helical structure of 226 at elevated pressures and temperatures, which was 
shown to be reversible. 
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D Zusammenfassung 
 
Cyclopropanierte Heterocylen haben sich als unschätzbare Bausteine für die Synthese einer 
großen Vielfalt an Naturstoffen und anderen biologisch relevanten Molekülen bewährt. Der 
erste Teil der vorliegenden Arbeit behandelt die enantioselektive Cyclopropanierung von 
Furan- und Pyrrolderivaten, sowie die weitere Umsetzung der hierbei erhaltenen 
Verbindungen. Furan-3-carbonsäuremethylester 91 wurde als Grundlage für die Totalsynthese 
von (-)-Paeonilid 27 eingesetzt, jedoch nur in 83% ee, da enantiomerenreines 15 zum 
Zeitpunkt der Veröffentlichung noch nicht zugänglich war. Im Laufe dieser Arbeit wurde eine 
enantioselektive Cyclopropanierungsreaktion von 91 entwickelt, welche Cyclopropan 15 in > 
99% ee und Multigrammmaßstab liefert (Schema 1).  
 
O
MeO2C
N2 CO2tBu
Cu(OTf)2, 8
PhNHNH2
DCM, 0 °C
O
MeO2C
CO2tBu
H
H
91 15
H
N
N N
OO
tBu tBu
8
47% Ausbeute, 89% ee
> 99% ee nach Umkristallisation
100 mmol Maßstab  
Schema 1. Enantioselektive Cyclopropanierung von Furan-3-carbonsäuremethylester 91 im 100 mmol Maßstab. 
 
Die Kernpunkte für den Erfolg waren der Einsatz von Azabox Ligand 8 als chiralen Liganden, 
sowie die Veränderung des Verhältnisses von Katalysator zu Ligand von 1:1 zu 1:2. Neben 
Furanen sind auch die Cyclopropanierungsprodukte von Pyrrolen von Interesse, jedoch 
konnte bisher keine Möglichkeit zur asymmetrischen Cyclopropanierung von N-Boc-Pyrrol 
101 gefunden werden. In der vorliegenden Arbeit wurde eine Strategie zur enantioselektiven 
Cyclopropanierung von 101 unter der Verwendung von tert-Butyldiazoester als Carbenquelle 
und wiederum 8 als chiralem Liganden entwickelt (Schema 2).  
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Schema 2. Enantioselektive Cyclopropanierung von N-Boc-Pyrrol 101 im 150 mmol Maßstab. 
 
Cyclopropan 103 kann hierbei in > 99% ee und Multigrammmaßstab, zusammen mit doppelt 
cyclopropaniertem 104 (max. 41% ee) erhalten werden. An dieser Stelle erwies sich die 
Kombination von tert-Butyldiazoester und Ligand 8 als essentiell, um hohe 
Enantiomerenüberschüsse des Produktes 103 zu erhalten. Im Laufe dieser Untersuchungen 
kristallisierte sich der tert-Butyl substituierte Azabox Ligand 8 als herausragend für die 
asymmetrische Cyclopropanierung von 91 und 101 heraus. Desweiteren wurde Cyclopropan 
103 für eine kurze und effiziente Synthese des biologisch aktiven GABA Analogons 
(S)-(+)-homo-β-Prolin 109 verwendet (Schema 3). 
 
 
Schema 3. Synthese von (S)-(+)-homo-β-Prolin 109 ausgehend von Cyclopropan 103. 
 
Das Zielmolekül (S)-(+)-109 konnte in nur drei Stufen und 37% Ausbeute ausgehend von 
N-Boc-Pyrrol 101 erhalten werden. Nichtdestotrotz verhinderte das Auftreten von 
Epimerisierung während der säurekatalysierten Cyclopropanöffnung die vollständig 
enantiomerenreine Darstellung von 109. 
 
Im zweiten Teil der vorliegenden Arbeit wurden die strukturellen und konformativen 
Eigenschaften von gemischten α/β-Peptidfoldameren unter Anwendung von Hochdruck-
NMR (bis zu 2 kbar) und Hochdruck-IR (bis zu 6.5 kbar) Spektroskopie untersucht. Kurze 
Tripeptide mit einem zentralen Cyclopropanbaustein 217a und 217b wurden hierbei 
bezüglich ihrer katalytischen Aktivität unter dem Einfluss von Druck untersucht (Abbildung 
27).  
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Abbildung 1. Chemische Strukturformeln von Tripeptid-Organokatalysatoren 217a und 217b für die 
intermolekulare Aldolreaktion von Aceton 223 und para-Nitrobenzaldehyd 224. 
 
Die Tatsache, dass 217a ein hocheffizienter Organokatalysator für intermolekulare 
Aldolreaktionen ist, während sein Enantiomer 217b nur mäßigen Erfolg einbringt, wurde als 
Grundlage für die Untersuchungen dieser Arbeit genommen. Ein plausibles Modell für die 
Erklärung des unterschiedlichen katalyischen Verhaltens von 217a und 217b wurde hierin 
vorgestellt. Während 217b klare Anzeichen für eine starke interne Wasserstoffbrücke zeigt, 
welche die beiden für die Katalyse notwendigen funktionellen Gruppen räumlich separiert, ist 
sein Isomer 217a deutlich flexibler und kann dadurch leichter eine ideale Konformation für 
die Katalyse erreichen. Katalysen unter Hochdruckbedingungen zeigen einen sechsfachen 
Anstieg der Reaktionsgeschwindigkeit bei einem Druckanstieg von 1 bar nach 5 kbar, was 
jedoch eher auf den generellen Einfluss des Drucks, als eine Änderung des 
Konformationsgleichgewichts von 217a zurückzuführen ist. Zusätzlich zu den kurzen 
Tripeptiden 217a und 217b wurde auch ein längeres α/β-Peptidfoldamer (13 
Aminosäurebausteine) unter druck- und temperaturabhängigen Bedingungen untersucht. 
Konformative Untersuchungen mittels NMR, FTIR und CD Spektroskopie zeigen eine 
partielle Entfaltung der helikalen Struktur von 226 bei hohen Drücken und Temperaturen, 
welche aber reversibel ist. 
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E Experimental part 
 
1 Instruments and general techniques 
 
1H-NMR spectra were recorded on Bruker Avance 300 (300 MHz), Bruker Avance 400 (400 
MHz) and Bruker Avance III 600 TCI Cryo (600 MHz). The chemical shifts are reported in δ 
(ppm) relative to chloroform (CDCl3, 7.26 ppm), methanol-d3 or methanol-d4 (CD3OH, 3.34 
ppm). The spectra were analyzed by first order, the coupling constants (J) are reported in 
Hertz (Hz). Characterization of the signals: s = singlet, bs = broad singlet, d = dublet, t = 
triplet, q = quartet, quin = quintet, m = multiplet, dd = double dublet, ddd = double double 
dublet, dt = double triplet, dquin = double quintet, po = pseudo octet. Integration is 
determined as the relative number of atoms.  
13C-NMR spectra were recorded on Bruker Avance 300 (75.5 MHz) and Bruker Avance 400 
(100.6 MHz). The chemical shifts are reported in δ (ppm) relative to chloroform (CDCl3, 77.0 
ppm) or methanol-d4 (MeOD, 49.0 ppm). 13C-NMR resonance assignment was aided by the 
use of HSQC, DEPT 135 and DEPT 90 techniques (DEPT = distorsionless enhancement by 
polarization transfer) to determine the number of hydrogens attached to each carbon atom and 
is declared as: + = primary or tertiary (CH3, CH, positive DEPT signal), - = secondary (CH2, 
negative DEPT signal), Cq = quarternary (no DEPT signal) carbon atoms.  
High-pressure NMR was performed on Bruker Avance 800 (800 MHz) in the group of Prof. 
H. R. Kalbitzer in the Institute of Biophysics and Physical Biochemistry at the University of 
Regensburg. A ceramic cell containing the sample solution was inserted into a titanium 
autoclave and external pressure was applied via a flexible polyethylene terephthalate (PET) 
membrane and water as compression fluid. Pressure was generated and maintained via a 
manually operated piston compressor. For a detailed description of the experimental setup 
see: [258] 
Infrared spectroscopy (IR) in form of ATR-IR spectroscopy was carried out on a Biorad 
Excalibur FTS 3000 spectrometer, equipped with a Specac Golden Gate Diamond Single 
Reflection ATR-System. Pressure- and temperature dependent FTIR spectra were collected by 
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Prof. Roland Winter in the Faculty of Chemistry and Chemical Biology at the TU Dortmund. 
A diamond anvil cell served as the reaction vessel for the measurements. For a detailed 
description of the experimental setup see: [269]  
Mass spectrometry (MS) was performed in the Central Analytic Department of the 
University of Regensburg on Finnigan MAT 95, ThermoQuest Finnigan TSQ 7000, Agilent 
Q-TOF 6540 UHD and Finnigan MAT SSQ 710 A. 
Elemental analysis was measured on a Vario EL III or Mikro-Rapid CHN (Heraeus) 
(Microanalytic section of the University of Regensburg). 
Optical rotations were determined in a Perkin Elmer 241 polarimeter at 589 nm wavelength 
(sodium-d-line) in a 1.0 dm measuring cell and the specified solvent.   
Lyophilization was carried out with a Christ alpha 2-4 LD equipped with a vacuubrand RZ 6 
rotary vane vacuum pump.  
X-ray analysis of single crystals was performed in the X-ray crystallographic Department of 
the University of Regensburg on Agilent Technologies SuperNova, Agilent Technologies 
Gemini R Ultra or Stoe IPDS I.  
High performance liquid chromatography (HPLC). Analytical HPLC was performed on a 
Varian 920-LC with DAD. Phenomenex Lux Cellulose-1 and 2, Chiralcel OD-H and AS 
served as chiral stationary phase, and mixtures of n-heptane and iPrOH were used for elution. 
Thin layer chromatography (TLC) was performed on alumina plates coated with silica gel 
(Merck silica gel 60 F 254, d = 0.2 mm). Visualization was accomplished by UV light (λ = 
254 nm or 366 nm), iodine, ninhydrin/acetic acid solution, vanillin/sulfuric acid solution, 
potassium permanganate solution, Seebach’s Magic Stain, or Dragendorff-Munier reagent.  
Circular dichroism spectroscopy (CD) was performed on a JASCO model J-710/720 at 
temperatures between 10 °C and 90 °C and wavelengths between 280 and 190 nm in water, 
by using the following parameters: 0.2 nm resolution, 1.0 nm band width, 100 mdeg 
sensitivity, 0.25 s response, 20 nm/min speed, 5 scans. The length of the cuvette was 1.0 mm. 
The CD spectrum of the sole solvent was recorded and subtracted from the raw data. The 
peptide concentration of the samples was 1 mM. The CD intensity is given as mean-residue 
molar ellipticity (deg cm2 dmol-1). 
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Molecular modeling. Molecular mechanical simulations were carried out using the 
Wavefunctions Spartan 06 programme. For the conformational searches and energy 
calculations, the Tripos Sybyl force field was used. Six rotatable backbone bonds of 
tripeptides 217a and 217b were used, leading to 324 conformations each that were 
subsequently minimized in energy for both conformers. The resulting low energy structures 
were then sorted and analyzed.  
Solvents and chemicals. DCM, ethyl acetate and hexanes (petroleum ether, PE (60/40)) were 
distilled prior to use for column chromatography. Dry solvents were prepared according to 
standard procedures. Commercially available chemicals were used as received, without 
further purification. A saturated solution of HCl in ethylacetate was prepared by inserting 
gaseous HCl (predried wit conc. H2SO4) into a cooled solution of dry ethylacetate. The 
concentration of the solution was determined by titration against NaOH (1 M) with 
bromothymol blue as indicator to be 4.2 M. The solution was stored under nitrogen 
atmosphere at -20 °C.  
High-pressure reactions up to 5 kbar were performed using a self-made hydraulic 
high-pressure apparatus from Unipress (Warsaw) using melted polytetrafluororethylene 
(PTFE) tubes as reaction vessels. A 1:1 (v/v) mixture of decahydronaphthalene (decalin, 
cis/trans mixture) and 2,2,4-trimethylpentane (iso-octane) was used as pressurizing medium. 
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2 Synthesis of compounds 
 
Following compounds were synthesized according to literature known procedures and 
spectroscopic data matched well with those reported: 
4-Methylbenzenesulfonyl azide (tosyl azide),[270] methyl-2-diazoacetate,[271] ethyl-2-
diazoacetate,[272] (S)-2-amino-3,3-dimethylbutan-1-ol ((S)-tert-leucinol 70),[88] (S)-2-
amino-3-methylbutan-1-ol ((S)-valinol),[89] (S)-4-isopropyl-4,5-dihydrooxazol-2-amine,[62] 
(S)-4-isopropyloxazolidin-2-one,[63] (S)-2-ethoxy-4-isopropyl-4,5-dihydrooxazole 75,[63] 
2-iodoxybenzoic acid (IBX).[273] 
 
Azabox ligands other than 8, 9, 60 and 74 were either on stock in the laboratory or were 
prepared in analogy to the described synthesis of 8 (main part chapter B 1.1, scheme 7), 
following the improved methodology of ref. [63]. 
 
 
tert-Butyl-2-diazoacetate[274] 
n-Pentane (900 ml) was cooled to 0 °C and tert-butyl acetoacetate (52.8 ml, 318 mmol, 1.0 
equiv), tosyl azide (62.6 g, 318 mmol, 1.0 equiv), and TBAB (2.05 g, 6.46 mmol, 0.02 equiv) 
were added. The mixture was treated with a precooled solution of NaOH (36 g in 300 ml 
water, 0.9 mol, 2.8 equiv) over a period of 15 min. Afterwards, the cooling bath was removed 
and the solution was stirred for 15 h at room temperature. The reaction mixture was then 
filtered through a plug of Celite to remove precipitates and the filtrate was transferred into a 
separating funnel. After separation of the phases the aqueous layer was extracted with 
n-pentane (3 x). The combined organic layers were washed with water (2 x) and brine (1 x), 
dried over Na2SO4 and finally concentrated under reduced pressure (15 °C water bath) to 
yield the title compound tert-butyl-2-diazoacetate (43.3 g, 308 mmol, 96%) as a yellow oil 
that was diluted with DCM to the required concentration.  
1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.48 (s, 9 H), 4.61 (s, 1 H). 
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tert-Butyl-1H-pyrrole-1-carboxylate (101)[241] 
N-Boc protected pyrrole 101 was synthesized following a slightly modified procedure of 
Grehn et al. Freshly distilled pyrrole 50 (68.0 g, 1.01 mol, 1.0 equiv) was dissolved in DCM 
(450 ml) and DMAP (9.9 g, 0.08 mol, 0.08 equiv) was added. Boc2O (246.3 g, 1.13 mol, 1.1 
equiv) was added portionwise and the mixture was stirred at room temperature until gas 
evolution stopped (48 h). The reaction mixture was treated with DEAEA (38 ml, 0.27 mol, 
0.3 equiv) and stirred for further 30 min. Afterwards, the reaction mixture was concentrated to 
half its volume, washed with KHSO4 (1 M, 3 x), NaHCO3 (sat., 1 x), and the organic layer 
was dried over Na2SO4. After evaporation of the solvent, the crude residue was distilled under 
reduced pressure to yield 101 (139.6 g, 0.83 mol, 82%) as a colorless liquid. 
Rf = 0.60 (PE/EA = 5:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.60 (s, 9 H), 6.20-6.23 
(m, 2 H), 7.22-7.25 (m, 2 H). – bp = 80 °C/8 hPa. 
 
 
Methyl-furan-3-carboxylate (15)[45] 
Furan-3-carboxylic acid 88 (10.0 g, 89.2 mmol, 1.0 equiv) was dissolved in MeOH (45 ml) 
and cooled to 0 °C. H2SO4 (conc., 10 ml) was added dropwise and the solution was stirred 
overnight at room temperature. The mixture was treated with water and extracted with Et2O (3 
x). The combined organic layers were washed with NaHCO3 (sat., 1 x), dried over Na2SO4 
and concentrated under reduced pressure. The crude residue was distilled under reduced 
pressure to yield 15 (7.8 g, 61.7 mmol, 69%) as a colorless liquid. 
Rf = 0.69 (PE/EA = 3:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 3.84 (s, 3 H), 6.74 (dd, 1 
H, J = 1.9 Hz, 0.8 Hz), 7.41-7.43 (m, 1 H), 8.00-8.02 (m, 1 H). – bp = 55 °C/8 hPa. 
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(S)-4-(tert-Butyl)-4,5-dihydrooxazol-2-amine (71)[62] 
NaCN (2.57 g, 52.42 mmol, 1.05 equiv) was added portionwise to solution of Br2 (2.69 ml, 
52.42 mmol, 1.05 equiv) in MeOH (40 ml) at 0 °C. To that solution a solution of 70 (5.85 g, 
49.92 mmol, 1.0 equiv) in MeOH (80 ml) was added and the mixture was stirred at 0 °C for 1 
h. Aqueous ammonia (25% (m/m), 25 ml) was added and the mixture was concentrated in 
vacuo. The resulting residue was treated with NaOH (20% (m/m), 50 ml) and extracted with 
EA (4 x, 60 ml). After drying over MgSO4 and filtration, the solvent was evaporated under 
reduced pressure to give 71 (5.17 g, 36.39 mmol, 73%) as a white solid.  
Rf = 0.04 (PE/EA = 2:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.87 (s, 9 H), 2.75 (bs, 2 
H), 3.74 (dd, 1 H, J = 9.3 Hz, 7.1 Hz), 4.07 (dd, 1 H, J = 8.3 Hz, 7.1 Hz), 4.22 (dd, 1 H, J = 
9.2 Hz, 8.3 Hz). 
 
 
(S)-4-(tert-Butyl)oxazolidin-2-one (72)[63] 
Sodium metal (0.58 g, 25.60 mmol, 1.0 equiv) was dissolved in EtOH (37 ml), the solution 
was treated with aminoalcohol 70 (3.00 g, 25.60 mmol, 1.0 equiv) and diethylcarbonate (3.41 
ml, 28.16 mmol, 1.1 equiv), and the mixture was refluxed for 20 h. The solution was then 
concentrated under reduced pressure, treated with DCM and NH4Cl (sat.), and extracted with 
DCM (2 x). After drying over MgSO4 and filtration the solvent was evaporated under reduced 
pressure to give a white solid that was recrystallized from Et2O to yield 72 (3.00 g, 20.93 
mmol, 82%) as a white solid.  
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Rf = 0.15 (PE/EA = 2:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.91 (s, 9 H), 3.59 (ddd, 
1 H, J = 8.9 Hz, 5.8 Hz, 0.9 Hz), 4.20 (dd, 1 H, J = 9.0 Hz, 5.8 Hz), 4.34-4.41 (m, 1 H), 5.71 
(bs, 1 H). 
 
 
(S)-4-(tert-Butyl)-2-ethoxy-4,5-dihydrooxazole (73)[63] 
A solution of oxazolidinone 72 (1.73 g, 12.06 mmol, 1.0 equiv) in dry DCM (15 ml) was 
cooled to 0 °C and a solution of triethyloxonium tetrafluoroborate (2.75 g, 14.47 mmol, 1.2 
equiv) in DCM (9 ml) was added dropwise. The reaction was allowed to warm to room 
temperature and was stirred for 44 h. The reaction mixture was then poured into an ice-cold 
solution of Na2CO3 (50 ml) and extracted with DCM (3 x). After drying over Na2SO4 and 
filtration the solvent was evaporated under reduced pressure to give 73 (1.94 g, 11.33 mmol, 
94%) as a pale yellow oil that was used without further purification. 
Rf = 0.67 (PE/EA = 2:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.88 (s, 9 H), 1.35 (t, 3 
H, J = 7.1 Hz), 3.76 (dd, 1 H, J = 9.4 Hz, 6.7 Hz), 4.18 (dd, 1 H, J = 8.5 Hz, 6.7 Hz), 4.23-
4.34 (m, 3 H). 
 
 
(S)-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)amine (8)[63] 
Ethoxyoxazoline 73 (1.94 g, 11.33 mmol, 1.2 equiv) was dissolved in dry toluene (20 ml) and 
aminooxazoline 71 (1.34 g, 9.44 mmol, 1.0 equiv) was added. After addition of p-TSA (163 
mg, 0.94 mmol, 0.1 equiv) the reaction mixture was refluxed under nitrogen for 16 h. The 
crude mixture was concentrated under reduced pressure and purified via flash 
chromatography (silica, PE/EA = 1:9) to yield 8 (2.27 g, 8.50 mmol, 90%) as a colorless 
crystalline solid that can be recrystallized from acetone. 
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Rf = 0.33 (EA) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.86 (s, 18 H), 3.77 (dd, 2 H, J = 
9.4 Hz, 6.7 Hz), 4.11 (dd, 2 H, J = 8.8 Hz, 6.6 Hz), 4.21-4.31 (m, 2 H), 8.61 (bs, 1 H). – 
13C-NMR (101 MHz, CDCl3): δC (ppm) = 25.3 (+, CH3), 33.6 (Cq), 67.4 (-, CH2), 68.7 (+, 
CH), 165.9 (Cq). 
 
 
(S)-4-(tert-Butyl)-N-((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)-N-methyl-4,5-dihydrooxazol-
2-amine (9)[62] 
Ligand 8 (300 mg, 1.12 mmol, 1.0 equiv) was dissolved in dry THF (10 ml) and cooled to -78 
°C. nBuLi (1.6 M solution in n-hexane; 769 µl, 1.23 mmol, 1.1 equiv) was added slowly and 
the solution was stirred for 20 min at -78 °C, before MeI (351 µl, 5.61 mmol, 5.0 equiv) was 
added and the reaction was stirred in the defrosting cooling bath overnight (17 h). Volatiles 
were removed in vacuo and the residue was treated with DCM and NaHCO3 (sat.). After 
phase separation the aqueous layer was extracted with DCM (3 x) and the organic layer was 
dried over MgSO4. Evaporation of the solvent yielded pure 9 (269 mg, 0.96 mmol, 85%) as a 
white solid.  
Rf = 0.18 (PE/EA = 1:2) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.88 (s, 18 H), 3.41 (s, 3 
H), 3.79 (dd, 2 H, J = 9.5 Hz, 6.7 Hz), 4.23 (dd, 2 H, J = 8.5 Hz, 6.7 Hz), 4.34 (dd, 2 H, J = 
9.4 Hz, 8.6 Hz). – 13C-NMR (101 MHz, CDCl3): δC (ppm) = 25.5 (+, CH3), 34.0 (Cq), 37.4 
(+, CH3), 70.3 (-, CH2), 73.2 (+, CH), 157.8 (Cq). 
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(S)-N-Benzyl-4-(tert-butyl)-N-((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)-4,5-dihydrooxazol-
2-amine (74)11 
Ligand 8 (276 mg, 1.03 mmol, 1.0 equiv) was dissolved in dry THF (10 ml) and cooled to -78 
°C. nBuLi (1.6 M solution in n-hexane; 644 µl, 1.03 mmol, 1.0 equiv) was added slowly and 
the solution was stirred for 20 min at -78 °C, before BnBr (122 µl, 1.03 mmol, 1.0 equiv) was 
added and the reaction was stirred in the defrosting cooling bath overnight (20 h). Volatiles 
were removed in vacuo and the residue was treated with DCM and NaHCO3 (sat.). After 
phase separation the aqueous layer was extracted with DCM (3 x) and the organic layer was 
dried over MgSO4. Evaporation of the solvent yielded pure 74 (357 mg, 1.00 mmol, 97%) as a 
white solid.  
1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.73 (s, 18 H), 3.74 (dd, 2 H, J = 9.5 Hz, 6.6 Hz), 
4.15 (dd, 2 H, J = 8.5 Hz, 6.5 Hz), 4.24-4.29 (m, 2 H), 4.91 (d, 1 H, J = 15.0 Hz), 5.10 (d, 1 
H, J = 15.0 Hz), 7.12-7.27 (m, 3 H), 7.35-7.40 (m, 2 H). – 13C-NMR (101 MHz, CDCl3): δC 
(ppm) = 25.4 (+, CH3), 34.0 (Cq), 53.2 (-, CH2), 70.1 (-, CH2), 73.4 (+, CH), 127.1 (+, CH), 
128.1 (+, CH), 137.8 (Cq), 157.2 (Cq). 
 
 
(S)-Bis((S)-4-iso-propyl-4,5-dihydrooxazol-2-yl)amine (60) 
Ethoxyoxazoline 75 (297 mg, 1.89 mmol, 2.0 equiv) was dissolved in dry MeOH (5 mL) 
under a nitrogen atmosphere. A solution of gaseous NH3 in MeOH (7 M, 0.14 ml, 0.95 mmol, 
1.0 equiv) was added slowly and the reaction mixture was heated to 80 °C for 24 h. The 
reaction mixture was allowed to cool to ambient temperature and was then extracted with 
                                                           
11
 Ligand 74 was prepared in analogy to 9, with benzyl bromide as alkylating agent. So far, different methods 
have been employed for the synthesis of 74 in literature. 
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DCM (3 x). The organic layers were dried over Na2SO4, filtered and the solvent was 
evaporated under reduced pressure. The crude mixture was purified via flash chromatography 
(silica, EA) to yield azabox 60 (36 mg, 0.15 mmol, 16%) as a colorless crystalline solid.  
Rf = 0.35 (EA) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.88 (d, 6 H, J = 6.8 Hz), 0.96 (d, 
6 H, J = 6.7 Hz), 1.70 (po, 2 H, J = 6.7 Hz), 3.75-3.85 (m, 2 H), 4.03 (dd, 2 H, J = 8.5 Hz, 7.1 
Hz), 4.32-4.51 (m, 2 H), 8.47 (bs, 1 H). – 13C-NMR (75 MHz, CDCl3): δC (ppm) = 18.1 (+, 
CH3), 18.7 (+, CH3), 33.0 (+, CH), 65.4 (+, CH), 69.4 (-, CH2), 165.8 (Cq). 
 
 
(S)-N-Benzyl-4-iso-propyl-4,5-dihydrooxazol-2-amine (82) 
To a solution of 75 (300 mg, 1.89 mmol, 2.0 equiv) in dry toluene p-TSA (16 mg, 0.09 mmol, 
0.1 equiv) and N-benzylamine (103 µl, 0.95 mmol, 1.0 equiv) were added and the mixture 
was heated to reflux for 1.5 h. The solvent was evaporated and the crude mixture was purified 
via flash chromatography (silica, EA) to yield 82 (174 mg, 0.80 mmol, 84%) as colorless 
crystals. 
Rf = 0.17 (PE/EA = 1:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.79 (d, 3 H, J = 6.7 
Hz), 0.87 (d, 3 H, J = 6.7 Hz), 1.62 (po, 1 H, J = 6.7 Hz), 3.68-3.78 (m, 1 H), 3.89 (dd, 1 H, J 
= 7.9 Hz, 6.8 Hz), 4.17 (dd, 1 H, J = 8.7 Hz, 8.1 Hz), 4.29 (d, 1 H, J = 14.8 Hz), 4.36 (d, 1 H, 
J = 14.8 Hz), 4.90 (bs, 1 H), 7.16-7.33 (m, 5 H). – 13C-NMR (101 MHz, CDCl3): δC (ppm) = 
17.8 (+, CH3), 18.9 (+, CH3), 33.2 (+, CH), 47.0 (-, CH2), 70.0 (+, CH), 70.4 (-, CH2), 127.2 
(+, CH), 127.4 (+, CH), 128.5 (+, CH), 139.1 (Cq), 160.5 (Cq). – mp = 95 °C. – IR (neat): ṽ 
(cm-1) = 3230, 3027, 2954, 2879, 1643, 1552, 1494, 1454, 1348, 1286, 1242, 1113, 1078, 
1027, 974, 935, 729, 694, 585, 458. – [α]

 = -38.3 (c = 1, DCM). – LRMS (ESI): m/z = 219.1 
[M+H]+. – HRMS (ESI): m/z = 219.1493 [M+H]+; calc. for [C13H19N2O]+ = 219.1492. 
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General procedure for small scale cyclopropanations of furan-3-carboxylic acid methyl 
ester 91 (GP-1): 
Under nitrogen atmosphere a flame dried flask was charged with Cu(OTf)2 (14.3 mg, 0.04 
mmol, 0.01 equiv) and ligand (0.09 mmol, 0.022 equiv) in dry DCM (1 ml) and stirred for 30 
minutes at room temperature. In a second flask under nitrogen atmosphere a solution of 
3-methyl furoate 91 (500 mg, 3.97 mmol, 1.0 equiv) in dry DCM (2 ml) was prepared. This 
flask was cooled to the specified temperature and the solution of flask one was added in one 
portion through a syringe filter. A 5% (v/v) solution of phenylhydrazine in DCM (78 µl, 0.04 
mmol, 0.01 equiv) was added to the reaction mixture. tert-Butyldiazoacetate (solution in 
DCM; 1.5 equiv) was added by syringe pump. The mixture was stirred overnight, filtered 
through basic alumina and washed with DCM (200 ml). The solvent was evaporated in vacuo 
and the crude product was purified by flash chromatography (silica, PE/EA = 15:1) to provide 
15 as a white solid that was recrystallized from n-pentane or n-heptane. 
 
Cyclopropanation reactions on larger scale were performed according to GP-1 with the 
exception that an electronically controlled dropping system was applied for the addition of 
larger amounts of the diazo compound, and PhNHNH2 was added in pure form. 
 
 
 
 (1S,5R,6S)-6-tert-Butyl-4-methyl-2-oxabicyclo[3.1.0]hex-3-ene-4,6-dicarboxylate 
((S,R,S)-(-)-15) 
According to GP-1 91 (12.91 g, 102.37 mmol, 1.0 equiv) was cyclopropanated with 
tert-butyldiazoacetate (171 g, 12.8 wt%, 1.5 equiv), Cu(OTf)2 (370 mg, 1.02 mmol, 0.01 
equiv), ligand 8 (602 mg, 2.25 mmol, 0.022 equiv) and neat PhNHNH2 (101 µl, 1.02 mmol, 
0.01 equiv) in dry DCM (75 ml) to yield 15 (11.56 g, 448.13 mmol, 47%) as white solid. 
Rf = 0.30 (PE/EA = 15:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.00-1.04 (m, 1 H), 
1.42 (s, 9 H), 3.00 (dd, 1 H, J = 5.6 Hz, 2.9 Hz), 3.73 (s, 3 H), 4.90-4.94 (m, 1 H), 7.16 (s, 1 
H). – 13C-NMR (101 MHz, CDCl3): δC (ppm) = 22.5 (+, CH), 28.1 (+, CH3), 29.1, (+, CH), 
51.5 (+, CH3), 68.9 (+, CH), 81.4 (Cq), 115.8 (Cq), 156.4 (+, CH), 164.2 (Cq), 170.8 (Cq). – 
  Experimental part 
 
 
99 
 
mp = 76 °C (Lit.: 72 °C) – IR (neat): ṽ (cm-1) = 3109, 3062, 2976, 1699, 1598, 1444, 1367, 
1323, 1269, 1158, 1097, 1044, 974, 830, 792, 760, 720, 663, 558, 509, 468, 425. – [α]

 = 
-27.2 (c = 1, DCM, > 99% ee) (Lit.: -20.5 (c = 1, DCM, 83% ee)[45]). – HPLC analysis 
(Phenomenex Lux Cellulose-2, n-heptane/iPrOH 99:1, 1.0 ml/min, 254 nm): tr = 13.81 min, tr 
= 19.50 min; > 99% ee. – LRMS (ESI): m/z = 185.0 [M+H-C4H8]+, 241.1 [M+H]+, 258.1 
[M+NH4]+, 263.1 [M+Na]+. – HRMS (ESI): m/z = 241.1074 [M+H]+; calc. for [C12H17O5]+ = 
241.1071. 
  
General procedure for small scale cyclopropanations of N-Boc-pyrrole 101 (GP-2): 
Under nitrogen atmosphere a flame dried flask was charged with Cu(OTf)2 (10.8 mg, 0.03 
mmol, 0.01 equiv) and ligand (0.06 mmol, 0.022 equiv) in dry DCM (1 ml) and stirred for 30 
minutes at room temperature. In a second flask under nitrogen atmosphere a solution of 
N-Boc-pyrrole 101 (500 mg, 2.99 mmol, 1.0 equiv) in dry DCM (2 ml) was prepared. This 
flask was cooled to the specified temperature and the solution of flask one was added in one 
portion through a syringe filter. A 5% (v/v) solution of phenylhydrazine in DCM (59 µl, 0.03 
mmol, 0.01 equiv) was added to the reaction mixture. tert-Butyldiazoacetate (solution in 
DCM; 1.5 equiv) was added by syringe pump. The mixture was stirred overnight, filtered 
through basic alumina and washed with DCM (200 ml). The solvent was evaporated in vacuo 
and the crude product was purified by flash chromatography (silica, PE/EA = 50:1) to provide 
103 as a white solid that was recrystallized from PE. 
 
Cyclopropanation reactions on larger scale were performed according to GP-2 with the 
exception that an electronically controlled dropping system was applied for the addition of 
larger amounts of the diazo compound, and PhNHNH2 was added in pure form. 
 
 
(1S,5S,6S)-di-tert-Butyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate ((S,S,S)-(-)-103) 
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According to GP-2 101 (25.20 g, 150.60 mmol, 1.0 equiv) was cyclopropanated with 
tert-butyldiazoacetate (32.0 g, 11.1 wt%, 1.5 equiv), Cu(OTf)2 (543 mg, 1.51 mmol, 0.01 
equiv), ligand 8 (885 mg, 3.31 mmol, 0.022 equiv) and neat PhNHNH2 (148 µl, 1.51 mmol, 
0.01 equiv) in dry DCM (30 ml) at -15 °C to yield 103 (18.64 g, 66.26 mmol, 44%) as white 
solid. In addition, starting material 101 (3.78 g, 22.59 mmol, 15%) could be reisolated.  
Rf = 0.45 (PE/EA = 10:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.87-0.88 (m, 1 H), 
1.41 (s, 9 H, CH3), 1.47 (s, 9 H, CH3), 2.62-2.75 (m, 1 H), 4.12-4.40 (m, 1 H), 5.24-5.40 (m, 1 
H), 6.32-6.58 (m, 1 H). – 13C-NMR (101 MHz, CDCl3): δC (ppm) = 23.9 (+, CH), 28.1 (+, 
CH3), 28.2 (+, CH3), 30.6 + 31.6 (+, CH), 43.7 + 44.0 (+, CH), 80.6 (Cq), 81.5 (Cq), 110.0 (+, 
CH), 129.4 + 129.6 (+, CH), 151.0 + 151.3 (Cq, CO), 172.0 +172.3 (Cq, CO). Signal 
doubling due to rotamers. – mp = 77-79 °C – IR (neat): ṽ (cm-1) = 2978, 2934, 1703, 1590, 
1454, 1391, 1367, 1346, 1292, 1248, 1135, 1018, 930, 866, 831, 759, 721, 547, 468. – [α]

 = 
-253.0 (c = 1, DCM, > 99% ee) – Elemental analysis calcd. (%) for C15H23NO4 (281.16): C 
64.03, H 8.24, N 4.98, found: C 64.03, H 8.22, N 4.73. – HPLC analysis (Phenomenex Lux 
Cellulose-2, n-heptane/iPrOH 98:2, 0.5 ml/min, 254 nm): tr = 11.25 min, tr = 19.86 min; > 
99% ee. – LRMS (ESI): m/z = 282.2 [M+H]+, 304.2 [M+Na]+. – HRMS (ESI): m/z = 
282.1704 [M+H]+; calc. for [C15H24NO4]+ = 282.1700. 
 
 
(1R,5R,6R)-di-tert-Butyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate ((R,R,R)-(+)-103) 
Compound (R,R,R)-(+)-103 was prepared according to GP-2 with (ent)-6, 61 or 68 as chiral 
ligand. Enantiopure material was obtained upon recrystallized from PE. Spectroscopic data 
were identical to those for its enantiomer (S,S,S)-(-)-103. – [α]

 = +246.5 (c = 1, DCM, > 
99% ee) – HPLC analysis (Phenomenex Lux Cellulose-2, n-heptane/iPrOH 98:2, 0.5 ml/min, 
254 nm): tr = 11.25 min, tr = 19.86 min; > 99% ee. 
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di-tert-Butyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate ((rac)-(±)-103) 
Racemic (±)-103 was prepared according to GP-2 with the exception that no ligand was used 
for the cyclopropanation reaction. Spectroscopic data were identical to those of its 
enantiomers (S,S,S)-(-)-103 and (R,R,R)-(+)-103. – HPLC analysis (Phenomenex Lux 
Cellulose-2, n-heptane/iPrOH 98:2, 0.5 ml/min, 254 nm): tr = 11.25 min, tr = 19.86 min. 
 
 
(1S,2S,3S,4S,6S,7S)-tri-tert-Butyl-5-azatricyclo[4.1.0.02,4]heptane-3,5,7-tricarboxylate (104) 
Doubly cyclopropanated 104 was obtained as a side product of 103. After purification via 
flash chromatography (silica, PE/EA = 50:1), 104 was recrystallized from EA to obtain fine 
white needles (6.86 g, 17.34 mmol, 12%, 41% ee).  
Rf = 0.71 (PE/EA = 5:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.42 (bs, 18 H), 1.47 (s, 
9 H), 1.67 (dd, J = 3.5 Hz, 1.8 Hz, 2 H), 2.19-2.36 (m, 2 H), 3.24 (d, J = 5.9 Hz, 1 H), 3.49 (d, 
J = 5.9 Hz, 1 H). – 13C-NMR (101 MHz, CDCl3): δC (ppm) = 27.4 (+), 28.1 (+), 28.4 (+), 
28.9 (+), 42.1 (+), 80.8 (Cq), 81.1 (Cq), 154.7 (Cq), 169.6 (Cq), 169.9 (Cq). – mp = 175 °C – 
IR (neat): ṽ (cm-1) = 2984, 2936, 1692, 1397, 1369, 1329, 1299, 1252, 1148, 1125, 1043, 841, 
763, 734, 707, 553, 460. – Elemental analysis calcd. (%) for C21H33NO6 (395.23): C 63.78, 
H 8.41, N 3.54, found C 63.81, H 8.19, N 3.49. – [α]

 = +43.2 (c = 1, DCM, 41% ee). –
HPLC analysis (Phenomenex Lux Cellulose-2, n-heptane/iPrOH 98:2, 0.5 ml/min, 215 nm): 
tr = 27.46 min, tr = 36.10 min. – LRMS (ESI): m/z = 362.2 [M+Na-C4H8]+, 396.2 [M+H]+, 
418.2 [M+Na]+, 791.5 [2M+H]+, 813.5 [2M+Na]+. – HRMS (ESI): m/z = 396.2381 [M+H]+; 
calc. for [C21H34NO6]+ = 396.2381. 
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2-(tert-Butyl)-6-methyl-(1S,5S,6S)-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate (18)[17] 
Method A: Following GP-2 N-Boc-pyrrole (500 mg, 2.99 mmol, 1.0 equiv) was 
cyclopropanated using methyl diazoacetate and ligand 8. After purification via flash 
chromatography (silica, PE/EA = 10:1) 18 (250 mg, 1.05 mmol, 35%) was obtained as a 
white solid. 
Method B: To a solution of (S,S,S)-(-)-103 (1.05 g, 3.73 mmol, 1.0 equiv) in dry MeOH (50 
ml) a solution of freshly prepared NaOMe in MeOH (2 M, 2.13 ml, 4.47 mmol, 1.2 equiv) 
was added and the reaction mixture was refluxed under nitrogen for 6 h. The solvent was 
removed under reduced pressure and the crude mixture was purified via flash chromatography 
(silica, PE/EA = 15:1) to yield 18 (413 mg, 1.73 mmol, 46%) as a white solid, along with 
reisolated starting material 103 (99 mg, 0.35 mmol, 9%). 
Rf = 0.36 (PE/EA = 10:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.93-1.01 (m, 1 H), 
1.49-1.53 (m, 9 H), 2.76-2.85 (m, 1 H), 3.63-3.74 (m, 3 H), 4.24-4.50 (m, 1 H), 5.30-5.45 (m, 
1 H), 6.39-6.66 (m, 1 H). – 13C-NMR (101 MHz, CDCl3): δC (ppm) = 22.8 + 22.9 (+, CH), 
28.2 (+, CH3), 31.0 + 32.3 (+, CH), 44.2 + 44.3 (+, CH), 51.8 (+, CH3), 81.7 (Cq), 109.9 (+, 
CH), 129.7 + 129.9 (+, CH), 151.0 + 151.3 (Cq), 173.3 + 173.6 (Cq). Signal doubling due to 
rotamers. – HPLC analysis (Phenomenex Lux Cellulose-1, n-heptane/iPrOH = 99:1, 1.0 
ml/min, 240 nm): tr = 6.20 min, tr = 10.15; 55% ee.  
 
 
2-(tert-Butyl)-6-methyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate ((rac)-(±)-18)[50] 
Racemic (±)-18 was prepared according to GP-2 with methyl diazoacetate (653 g, 5.5 wt%, 
1.2 equiv), 101 (50.0 g, 299.0 mmol, 1.0 equiv), Cu(OTf)2 (2.16 g, 5.98 mmol, 0.02 equiv) 
and neat PhNHNH2 (0.59 ml, 5.98 mmol, 0.02 equiv) in dry DCM (100 ml) at room 
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temperature to yield (±)-18 (32.2 g, 135.6 mmol, 45%) as white solid. No ligand was used for 
the cyclopropanation reaction. Spectroscopic data were identical to those of its enantiomer 
(S,S,S)-(-)-18. – HPLC analysis (Phenomenex Lux Cellulose-1, n-heptane/iPrOH = 99:1, 1.0 
ml/min, 240 nm): tr = 6.20 min, tr = 10.15. 
 
 
(1S,5R,6S)-di-tert-Butyl-4-((1S,5S,6S)-2,6-bis(tert-butoxycarbonyl)-2-
azabicyclo[3.1.0]hexan-3-yl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate (151) 
103 (209.5 mg, 0.75 mmol, 1.0 equiv) was dissolved in DCM (2 ml) at room temperature and 
TFA (68 µl, 0.89 mmol, 1.2 equiv) was added. The mixture was stirred for 3 h until starting 
material vanished completely (TLC control). Volatiles were removed in vacuo and the crude 
mixture was purified via flash chromatography (silica, PE/EA = 10:1) to afford 151 as a white 
solid (115.6 mg, 0.21 mmol, 55%, mixture of 2 diastereoisomers; dr ~ 3:1). 
Rf = 0.44 + 0.37 (PE/EA = 5:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.92-1.01 (m, 1 
H), 1.36-1.50 (m, 36 H), 1.50-1.55 (m, 1 H), 2.05-2.34 (m, 3 H), 2.57-2.71 (m, 1 H), 3.58-
3.74 (m, 1 H), 4.09-4.38 (m, 2 H), 6.18-6.42 (m, 1 H). – 13C-NMR (101 MHz, CDCl3): δC 
(ppm) = 23.3 (+, CH), 24.5 (+, CH), 28.1 (+, CH3), 28.2 (+, CH3), 28.2 (+, CH3), 28.3 (+, 
CH3), 29.0 (+, CH), 30.2 (+, CH), 33.2 (-, CH2), 43.3 + 43.9 (+, CH), 45.3 (+, CH), 56.9 + 
57.2 (+, CH), 80.2 (Cq), 80.7 (Cq), 80.8 (Cq), 81.5 (Cq), 124.3 (+, CH), 124.5 + 124.7 + 
125.2 (Cq), 151.0 + 151.2 (Cq), 155.0 (Cq), 169.9 (Cq), 172.2 + 172.5 (Cq). Signal doubling 
due to rotamers. – IR (neat): ṽ (cm-1) = 2977, 2934, 1702, 1635, 1477, 1457, 1407, 1391, 
1366, 1301, 1255, 1144, 1121, 1024, 948, 837, 752, 667, 623, 545, 464. – [α]

 = -99.2 (c = 1, 
DCM) – LRMS (ESI): m/z = 563.3 [M+H]+, 580.4 [M+NH4]+, 585.3 [M+Na]+, 1147.6 
[2M+Na]+. – HRMS (ESI): m/z = 563.3328 [M+H]+; calc. for [C30H47N2O8]+ = 563.3327. 
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(1S,5S,6S)-di-tert-Butyl-2-azabicyclo[3.1.0]hexane-2,6-dicarboxylate (149) 
Method A: In a Schlenk flask 103 (143.5 mg, 0.51 mmol, 1.0 equiv) was dissolved in THF (6 
ml) and Pd/C (10 wt%) was added. A balloon with hydrogen (1 atm) was attached and the 
atmosphere in the flask was flushed twice with hydrogen gas. The mixture was stirred under a 
hydrogen atmosphere at ambient temperature for 1.5 h. After completion the crude mixture 
was filtered through a plug of celite and concentrated in vacuo. The crude product was 
purified via flash chromatography (silica, PE/EA = 15:1) to afford 149 (122.5 mg, 0.43 mmol, 
85%) as a white solid that can be recrystallized from PE. 
Method B: To a solution of 103 (167.6 mg, 0.60 mmol, 1.0 equiv) in DCM Et3SiH (0.48 ml, 
2.98 mmol, 5.0 equiv) and TFA (92 µl, 1.19 mmol, 2.0 equiv) were added and the solution 
was stirred at ambient temperature for 6 h. After completion the volatiles were removed in 
vacuo and the crude mixture was purified via flash chromatography (silica, PE/EA = 15:1) to 
afford 149 (55.0 mg, 0.19 mmol, 33%) as a white solid. 
Rf = 0.23 (PE/EA = 10:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.41 (s, 9 H, CH3), 1.44 
(s, 9 H, CH3), 1.61 (dd, J = 3.7 Hz, 1.6 Hz, 1 H), 1.94-2.24 (m, 3 H), 2.79-3.01 (m, 1 H), 
3.49-3.95 (m, 2 H). – 13C-NMR (101 MHz, CDCl3): δC (ppm) = 24.7 (+, CH), 25.9 (-, CH2, 
4), 26.9 (+, CH), 28.1 (+, CH3), 28.4 (+, CH3), 43.9 (-, CH2), 44.1 (+, CH), 79.9 (Cq), 80.6 
(Cq), 154.6 (Cq), 170.3 (Cq). – mp = 62 °C – IR (neat): ṽ (cm-1) = 2970, 2935, 1689, 1388, 
1364, 1322, 1287, 1257, 1150, 1121, 1049, 1019, 911, 877, 846, 768, 717, 552, 466. – [α]

 = 
-10.3 (c = 1, DCM, > 99% ee). – Elemental analysis calcd. (%) for C15H25NO4 (283.18): C 
63.58, H 8.89, N 4.94, found: C 63.90, H 8.69, N 4.87. – HPLC analysis (Phenomenex Lux 
Cellulose-2, n-heptane/iPrOH 70:30, 0.5 ml/min, 215 nm): tr = 6.95 min, tr = 10.79 min. – 
LRMS (ESI): m/z = 284.2 [M+H]+, 301.2 [M+NH4]+, 306.2 [M+Na]+, 589.3 [2M+Na]+. – 
HRMS (ESI): m/z = 284.1857 [M+H]+; calc. for [C15H26NO4]+ = 284.1856. 
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(S)-tert-Butyl-3-(2-(tert-butoxy)-2-oxoethyl)pyrrolidine-1-carboxylate (150) 
Method A: To a solution of 103 (167.6 mg, 0.60 mmol, 1.0 equiv) in DCM Et3SiH (0.48 ml, 
2.98 mmol, 5.0 equiv) and TFA (92 µl, 1.19 mmol, 2.0 equiv) were added and the solution 
was stirred at ambient temperature for 6 h. After completion the volatiles were removed in 
vacuo and the crude mixture was purified via flash chromatography (silica, PE/EA = 10:1) to 
afford 150 (38.4 mg, 0.14 mmol, 23%) as a colorless crystalline solid. 
Method B: To a solution of hydrogenation product 149 (65.3 mg, 0.23 mmol, 1.0 equiv) in 
DCM Et3SiH (0.11 ml, 0.69 mmol, 3.0 equiv) and TFA (35 µl, 0.46 mmol, 2.0 equiv) were 
added and the solution was stirred at ambient temperature for 65 h. Volatiles were removed in 
vacuo and the crude mixture was purified via flash chromatography (silica, PE/EA = 10:1) to 
afford 150 (32.5 mg, 0.11 mmol, 50%) as a colorless crystalline solid. 
Rf = 0.14 (PE/EA = 10:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.39-1.46 (m, 18 H, 
CH3), 1.47-1.60 (m, 1 H), 1.95-2.10 (m, 1 H), 2.18-2.37 (m, 2 H), 2.50 (sept, 1 H, J = 7.6 Hz), 
2.82-2.99 (m, 1 H), 3.17-3.33 (m, 1 H), 3.33-3.63 (m, 2 H). – 13C-NMR (101 MHz, CDCl3): 
δC (ppm) = 28.1 (+, CH3), 28.5 (+, CH3), 30.8 (-, CH2), 31.5 (-, CH2), 34.7 (+, CH), 35.5 (+, 
CH), 39.0 (-, CH2), 45.0 (-, CH2), 45.4 (-, CH2), 50.8 (-, CH2), 51.2 (-, CH2), 79.1 (Cq), 80.6 
(Cq), 154.5 (Cq), 171.5 (Cq), 171.6 (Cq). (Signal doubling due to rotamers). – mp = 54-56 °C 
– IR (neat): ṽ (cm-1) = 2975, 2930, 2878, 1722, 1685, 1457, 1406, 1365, 1307, 1253, 1219, 
1149, 1062, 942, 884, 842, 772, 581, 548, 463. – [α]

 = +18.6 (c = 1, DCM). – HPLC 
analysis (Phenomenex Lux Cellulose-1, n-heptane/iPrOH 99:1, 0.5 ml/min, 200 nm): tr = 
17.03 min, tr = 19.25 min. – LRMS (ESI): m/z = 286.2 [M+H]+, 308.2 [M+Na]+, 553.4 
[2M+Na]+. – HRMS (ESI): m/z = 286.2013 [M+H]+; calc. for [C15H28NO4]+ = 286.2013. 
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(S)-2-(Pyrrolidin-3-yl)acetic acid ((S)-(+)-109) 
Cyclopropane 149 (103.5 mg, 0.37 mmol, 1.0 equiv) was dissolved in dry DCM (5 ml) and 
Et3SiH (0.23 ml, 1.46 mmol, 4.0 equiv) and TFA (56 µl, 0.73 mmol, 2.0 equiv) were added. 
The reaction mixture was stirred at room temperature for 24 h. Then more TFA (112 µl, 1.46 
mmol, 4.0 equiv) was added and the mixture stirred for another 48 h. After completion of the 
reaction (TLC) the volatiles were removed in vacuo to yield 109 as TFA salt. For removal of 
the counterion 109 was loaded onto a column with Dowex 50WX8-400 (preactivated with 0.1 
M HCl). The resin was washed with water and finally eluted with 15% NH3 (aq.). The 
fractions were then concentrated under reduced pressure and lyophilized to yield 109 (47.4 
mg, 0.37 mmol, quant.) as a slightly beige-colored amorphous solid.  
1H-NMR (300 MHz, D2O): δH (ppm) = 1.47-1.65 (m, 1 H), 2.05-2.21 (m, 1 H), 2.43 (d, 1 H, 
J = 5.6 Hz), 2.45 (d, 1 H, J = 3.8 Hz), 2.47-2.68 (m, 1 H), 2.82 (dd, 1 H, J = 11.3 Hz, 8.9 Hz), 
3.07-3.23 (m, 1 H), 3.23-3.34 (m, 1 H), 3.43 (dd, 1 H, J = 11.7 Hz, 7.4 Hz). – 13C-NMR (101 
MHz, D2O): δC (ppm) = 29.5 (-, CH2), 33.7 (+, CH), 36.4 (-, CH2), 45.1 (-, CH2), 49.5 (-, 
CH2), 176.4 (Cq). – [α]

 = +7.7 (c = 1, H2O; Lit.: +9.6 (c = 1, H2O)[114]). – LRMS (ESI): 
m/z = 130.1 [M+H]+. – HRMS (ESI): m/z = 130.0866 [M+H]+; calc. for [C6H12NO2]+ = 
130.0863. 
 
 
(1S,3S,5S,6S)-di-tert-Butyl-3-(tert-butylcarbamoyl)-2-azabicyclo[3.1.0]hexane-2,6-
dicarboxylate (165a major) 
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(1S,3R,5S,6S)-di-tert-Butyl-3-(tert-butylcarbamoyl)-2-azabicyclo[3.1.0]hexane-2,6-
dicarboxylate (165b minor) 
To a solution of 103 (193.6 mg, 0.69 mmol, 1.0 equiv) in DCM (40 ml) tert-butyl-isocyanide 
(0.78 ml, 6.88 mmol, 10.0 equiv) and TFA (0.22 ml, 2.75 mmol, 4.0 equiv) were added and 
solution was stirred at ambient temperature for 5 d. After completion of the reaction volatiles 
were removed in vacuo and the crude mixture was purified via flash chromatography (silica, 
PE/EA = 5:1) to yield diastereoisomers 165a (133.1 mg, 0.35 mmol, 51%) and 165b (46.9 
mg, 0.12 mmol, 18%) as white solid compounds. 
165a (major): Rf = 0.36 (PE/EA = 5:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 0.74-0.94 
(m, 1 H), 1.33 (s, 9 H), 1.42 (s, 9 H), 1.46 (s, 9 H), 2.07-2.18 (m, 1 H), 2.24-2.43 (m, 1 H), 
2.43-2.67 (m, 1 H), 3.54-3.68 (m, 1 H), 3.80-3.96 (m, 1 H), 6.26 (bs, 1 H). – 13C-NMR (151 
MHz, CDCl3): δC (ppm) = 25.1 (+, CH), 28.1 (+, CH3), 28.2 (+, CH3), 28.6 (+, CH3), 29.6 (-, 
CH2), 31.7 (+, CH), 45.5 (+, CH), 50.9 (Cq), 62.9 (+, CH), 80.8 (Cq), 81.4 (Cq), 156.3 (Cq), 
169.6 (Cq), 170.2 (Cq). – mp = 139 °C – IR (neat): ṽ (cm-1) = 3347, 3312, 2975, 2933, 2033, 
1719, 1698, 1677, 1655, 1550, 1479, 1455, 1392, 1365, 1310, 1278, 1257, 1224, 1148, 1125, 
1019, 985, 961, 913, 857, 842, 796, 758, 663, 644, 616, 561, 486, 466, 408. – [α]

 = -47.2 (c 
= 1, DCM) – LRMS (ESI): m/z = 327.2 [M+H-C4H8]+, 383.3 [M+H]+, 405.2 [M+Na]+. – 
HRMS (ESI): m/z = 383.2542 [M+H]+; calc. for [C20H35N2O5]+ = 383.2540. 
165b (minor): Rf = 0.50 (PE/EA = 5:1) – 1H-NMR (400 MHz, CDCl3, 223 K): δH (ppm) = 
1.26 (s, 9 H), 1.39 (s, 9 H), 1.47 (s, 9 H), 1.69 (dd, 1 H, J = 3.6 Hz, 1.6 Hz), 1.95-2.04 (m, 1 
H), 2.12-2.22 (m, 1 H), 2.64 (dd, 1 H, J = 13.5 Hz, 1.8 Hz), 3.81 (dd, 1 H, J = 6.6 Hz, 1.6 Hz), 
4.45 (dd, 1 H, J = 10.5 Hz, 1.6 Hz), 7.05 (s, 1 H, NH). – 13C-NMR (101 MHz, CDCl3, 223 
K): δC (ppm) = 24.7 (+, CH), 26.1 (-, CH2), 27.4 (+, CH), 27.9 (+, CH3), 28.0 (+, CH3), 28.2 
(+, CH3), 44.2 (+, CH), 50.8 (Cq), 59.3 (+, CH), 80.9 (Cq), 81.5 (Cq), 154.9 (Cq), 170.7 (Cq), 
171.2 (Cq). (Signal doubling due to rotamers; peaks of major rotamer given only). – mp = 
152 °C – IR (neat): ṽ (cm-1) = 3316, 2972, 2936, 1698, 1657, 1549, 1455, 1396, 1365, 1328, 
1261, 1223, 1147, 1029, 1001, 842, 765, 728, 559. – [α]

 = +42.6 (c = 1, DCM). – LRMS 
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(ESI): m/z = 327.2 [M+H-C4H8]+, 383.3 [M+H]+, 405.2 [M+Na]+. – HRMS (ESI): m/z = 
383.2539 [M+H]+; calc. for [C20H35N2O5]+ = 383.2540. 
 
 
di-tert-Butyl-(1S,5S,6S)-3-(2,4,6-trimethoxyphenyl)-2-azabicyclo[3.1.0]hexane-2,6-
dicarboxylate (172) 
To a solution of 103 (152.8 mg, 0.54 mmol, 1.0 equiv) and 1,3,5-trimethoxybenzene (109.6 
mg, 0.65 mmol, 1.2 equiv) in dry DCM TFA (50 µl, 0.65 mmol, 1.2 equiv) was added and the 
reaction mixture was stirred for one hour at room temperature. Volatiles were removed in 
vacuo and the crude mixture was purified via flash chromatography (silica, PE/EA = 5:1) to 
yield 172 (32.7 mg, 0.07 mmol, 13%) as a pale yellow oil.  
Rf = 0.23 (PE/EA = 5:1) – 1H-NMR (400 MHz, CDCl3): δH (ppm) = 0.81-0.94 (m, 1 H), 
1.02-1.31 (m, 9 H), 1.43 (s, 9 H), 2.09-2.31 (m, 2 H), 2.39 (dd, 1 H, J = 12.8 Hz, 9.8 Hz), 
3.72-3.83 (m, 9.4 H), 3.85-4.00 (m, 0.6 H), 4.94-5.31 (m, 1 H), 6.03-6.11 (m, 2 H). – 
13C-NMR (101 MHz, CDCl3): δC (ppm) = 25.3 (+, CH), 28.2 (+, CH3), 30.7 (+, CH), 34.9 (-, 
CH2), 46.1 (+, CH), 52.8 (+, CH), 55.3 (+, CH3), 55.6 (+, CH3), 79.1 (Cq), 80.2 (Cq), 90.5 (+, 
CH), 112.5 (Cq), 154.9 (Cq), 158.6 (Cq), 160.1 (Cq), 170.8 (Cq). – IR (neat): ṽ (cm-1) = 
2972, 2935, 2843, 1689, 1593, 1497, 1458, 1401, 1370, 1321, 1252, 1228, 1201, 1147, 1119, 
1060, 1041, 978, 961, 951, 931, 918, 879, 845, 812, 754, 666. – [α]

 = +23.5 (c = 1, CHCl3). 
– LRMS (ESI): m/z = 450.2 [M+H]+, 472.2 [M+Na]+, 921.5 [2M+Na]+. – HRMS (ESI): m/z 
= 450.2493 [M+H]+; calc. for [C20H35N2O5]+ = 450.2486. 
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(1S,2S,3S,4S,6S,7S)-tert-Butyl-3,7-bis(hydroxymethyl)-5-azatricyclo[4.1.0.02,4]heptane-5-
carboxylate (178)[205] 
To a suspension of LAH (285 mg, 10.14 mmol, 2.0 equiv) in dry THF (65 ml) 104 (2.01 g, 
5.07 mmol, 1.0 equiv) was added portion wise at 0 °C and the solution was stirred for 22 h in 
the defrosting ice bath. After complete consumption of the starting material the reaction was 
quenched by the addition of EA and NH4Cl (sat.) solution. The aqueous layer was extracted 
with EA and the organic layers combined and dried over Na2SO4. After evaporation of the 
solvent the crude mixture was purified by a short silica column (100% EA → 100% MeOH; 
hereby dissolved silica was filtered from the product from a CHCl3 solution) to yield 178 as a 
white solid12 (1.22 g, 4.79 mmol, 95%). 
Rf = 0.14 (EA) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.17-1.30 (m, 2 H), 1.42 (s, 9 H, 
Boc), 1.59 (dd, 1 H, J = 6.4 Hz, 3.7 Hz), 1.69 (dd, 1 H, J = 6.4 Hz, 3.7 Hz), 2.78 (d, 1 H, J = 
6.3 Hz), 2.87 (d, 1 H, J = 6.3 Hz), 3.15 (dd, 1 H, J = 11.6 Hz, 8.4 Hz), 3.25 (dd, 1 H, J = 11.4 
Hz, 7.7 Hz), 3.33-3.56 (m, 3 H), 4.24 (bs, 1 H, OH). – 13C-NMR (101 MHz, CDCl3): δC 
(ppm) = 23.9 (+, CH), 25.4 (+, CH), 28.5 (+, CH3), 29.3 + 29.5 (+, CH), 39.2 + 39.8 (+, CH), 
61.9 + 62.0 (-, CH2), 80.3 (Cq), 155.9 (Cq). – mp = 78 °C – LRMS (ESI): m/z = 256.2 
[M+H]+, 278.1 [M+Na]+, 511.3 [2M+H]+, 533.3 [2M+Na]+. – HRMS (ESI): m/z = 256.1536 
[M+H]+; calc. for [C13H22NO4]+ = 256.1543. 
 
 
((1S,2S,3S,4S,6S,7S)-5-(tert-Butoxycarbonyl)-5-azatricyclo[4.1.0.02,4]heptane-3,7-
diyl)bis(methylene) diacetate (187) 
                                                           
12
 Reported as colorless foam (no mp given). 
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Diol 178 (77.4 mg, 0.30 mmol, 1.0 equiv) was dissolved in DCM (5 ml) and cooled to 0 °C. 
DMAP (7 mg, 0.06 mmol, 0.2 equiv), Ac2O (172 µl, 1.82 mmol, 6.0 equiv) and NEt3 (252 µl, 
1.82 mmol, 6.0 equiv) were added and the reaction mixture was stirred for 15 min at 0 °C. 
After quenching the reaction mixture with sat. NH4Cl solution, the aqueous layer was 
extracted with DCM (4 x). Finally, the combined organic layers were washed with sat. 
NaHCO3 (1 x) and brine (1 x) and dried over Na2SO4. After evaporation of the solvent the 
crude product was purified by flash chromatography (silica, PE/EA = 5:1 → 100% EA) to 
yield 187 (93.6 mg, 0.28 mmol, 91%) as a colorless oil that crystallizes slowly. 
Rf = 0.16 (PE/EA = 5:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.22-1.34 (m, 2 H), 1.42 
(s, 9 H, CH3, Boc), 1.65-1.74 (m, 2 H), 2.01 (s, 6 H, CH3), 2.83 (d, 1 H, J = 6.4 Hz), 3.03 (d, 1 
H, J = 6.43 Hz), 3.70 (dd, 1 H, J = 11.7 Hz, 8.3 Hz), 3.81 (dd, 1 H, J = 7.7 Hz, 2.4 Hz), 3.97 
(dd, 1 H, J = 11.8 Hz, 6.5 Hz). – 13C-NMR (101 MHz, CDCl3): δC (ppm) = 21.0 (+, CH3), 
24.3 (+, CH), 25.4 + 25.7 (+, CH), 26.0 (+, CH), 28.4 (+, CH3), 39.3 (+, CH), 63.8 + 63.9 (-, 
CH2), 79.9 (Cq), 155.2 (Cq), 171.0 + 171.1 (Cq). – IR (neat): ṽ (cm-1) = 2976, 1737, 1695, 
1435, 1393, 1365, 1328, 1226, 1176, 1123, 1030, 972, 851, 763, 632, 539, 497, 462, 399. – 
LRMS (ESI): m/z = 284.1 [M+H-C4H8]+, 340.2 [M+H]+, 362.2 [M+Na]+, 701.3 [2M+Na]+. – 
HRMS (ESI): m/z = 340.1754 [M+H]+; calc. for [C17H26NO6]+ = 340.1755. 
 
  
(3aR,3bR,6aR,7aR)-tert-Butyl-6a,7a-dihydro-3aH-difuro[2,3-b:3',2'-d]pyrrole-7(3bH)-
carboxylate (179)[205] 
Diol 178 (476 mg, 1.87 mmol, 1.0 equiv) was dissolved in DMSO (32 ml) and IBX (1.15 g, 
4.10 mmol, 2.2 equiv) was added. The reaction mixture was stirred at room temperature for 
64 h until the starting material vanished completely (TLC control). The mixture was treated 
with water and extracted with EA (5 x). The combined organic layers were washed with water 
and dried over Na2SO4. After evaporation of the solvent the crude product was purified by 
flash chromatography (silica, PE/EA = 7:1) to yield 179 (242 mg, 0.96 mmol, 52%) as a 
colorless oil. 
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Rf = 0.38 (PE/EA = 5:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.48 (s, 9 H, CH3), 3.43 
(d, 2 H, J = 6.6 Hz), 4.85-4.89 (m, 2 H), 5.95-6.16 (m, 2 H), 6.21 (bs, 2 H). – 13C-NMR (101 
MHz, CDCl3): δC (ppm) = 28.2 (+, CH3), 51.3 + 51.4 (+, CH), 81.2 (Cq), 92.4 (+, CH), 102.9 
(+, CH), 144.6 + 144.7 (+, CH), 153.3 (Cq). – LRMS (ESI): m/z = 196.1 [M+H-C4H8]+, 252.1 
[M+H]+, 274.1 [M+Na]+, 525.2 [2M+Na]+. – HRMS (ESI): m/z = 252.1237 [M+H]+; calc. for 
[C13H18NO4]+ = 252.1230. 
 
 
Methyl-2-(N-(tert-butoxycarbonyl)formamido)-3-formylcyclopropane-1-carboxylate 
((±)-218)[275] 
Cyclopropane (±)-18 (402 mg, 1.68 mmol, 1.0 equiv) was dissolved in DCM (45 ml) and 
cooled to -78 °C. Then ozone was bubbled through the solution until a characteristic blue 
color persisted (~ 15 min). After completion, oxygen was bubbled through the solution to 
displace excess ozone until the blue color vanished (~ 10 min). The gas inlet was removed, 
DMS (0.61 ml, 8.40 mmol, 5.0 equiv) was added and the solution was stirred overnight in the 
defrosting cooling bath. The reaction mixture was then concentrated under reduced pressure 
and purified via flash chromatography (silica, PE/EA = 3:1) to yield (±)-218 (440 mg, 1.62 
mmol, 97%) as a colorless oil that slowly crystallized in the freezer. 
Rf = 0.35 (PE/EA = 3:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.52 (s, 9 H, CH3), 2.75 
(dd, 1 H, J = 5.9 Hz, 4.8 Hz), 2.92-2.99 (m, 1 H), 3.21 (dd, 1 H, J = 8.0 Hz, 4.8 Hz), 3.75 (s, 3 
H, CH3), 9.07 (s, 1 H), 9.54 (d, 1 H, J = 2.4 Hz). 
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2-(N-(tert-Butoxycarbonyl)formamido)-3-(methoxycarbonyl)cyclopropane-1-carboxylic acid 
((±)-219)[275] 
Cyclopropane (±)-218 (440 mg, 1.62 mmol, 1.0 equiv) was dissolved in MeCN (5 ml) and 
cooled to 0 °C. After that KH2PO4 (132 mg, 0.97 mmol, 0.6 equiv) in water (1 ml), H2O2 
(0.16 ml, 5.35 mmol, 3.3 equiv) and NaClO2 (322 mg, 3.56 mmol, 2.2 equiv) in water (3 ml) 
were added and the reaction mixture was stirred for 2.5 h at 0 °C until gas evolution ceased. 
Then Na2SO3 (0.8 equiv) was added and the solution was stirred for one additional hour at 0 
°C. The reaction mixture was then acidified with 1 M KHSO4 (pH 1-2), the phases were 
separated and the aqueous layer was extracted with EA (5 x). The combined organic layers 
were dried over Na2SO4, filtered and concentrated in vacuo to yield (±)-219 (467 mg, 1.63 
mmol, quant.) as a white solid. 
Rf = 0.11 (PE/EA = 2:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.52 (s, 9 H, CH3), 2.56-
2.68 (m, 2 H), 3.22 (dd, 1 H, J = 7.7 Hz, 5.1 Hz), 3.77 (s, 3 H, CH3), 7.86 (bs, 1 H), 9.13 (s, 1 
H). 
 
 
2-((tert-Butoxycarbonyl)amino)-3-(methoxycarbonyl)cyclopropane-1-carboxylic acid 
((±)-33)[275] 
Cyclopropane (±)-219 (467 mg, 1.63 mmol, 1.0 equiv) was dissolved in MeCN (5 ml), 
DEAEA (0.47 ml, 3.34 mmol, 2.05 equiv) was added and the reaction mixture was stirred at 
room temperature for 28 h. The mixture was concentrated under reduced pressure, EA was 
added and the pH of the solution was adjusted to pH 2 with 1 M KHSO4. The aqueous layer 
was extracted with EA (4 x) and the combined organic layers were dried over Na2SO4, filtered 
and concentrated in vacuo to yield (±)-33 (348 mg, 1.34 mmol, 82%) as a white solid.  
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1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.46 (s, 9 H, CH3), 2.22-2.57 (m, 2 H), 3.62-3.99 
(m, 4 H), 5.45 + 6.54 (bs, 1 H). 
 
 
1-Benzyl-2-methyl-3-((tert-butoxycarbonyl)amino)cyclopropane-1,2-dicarboxylate 
((±)-220)[275] 
Cyclopropane (±)-33 (348 mg, 1.34 mmol, 1.0 equiv) was dissolved in DMF (5 ml), NaHCO3 
(225 mg, 2.68 mmol, 2.0 equiv) and BnBr (175 µl, 1.47 mmol, 1.1 equiv) were added and the 
mixture was stirred at room temperature for 48 h. EA (10 ml) and water (10 ml) were added, 
the phases separated and the aqueous layer was extracted with EA (4 x). The combined 
organic layers were washed with water (2 x), dried over Na2SO4, filtered and concentrated in 
vacuo. Flash chromatography (silica, PE/EA = 5:1) yielded pure (±)-220 (429 mg, 1.23 mmol, 
92%) as a white solid. 
Rf = 0.27 (PE/EA = 5:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.44 (s, 9 H, CH3), 2.24-
2.31 (m, 1 H), 2.52 (dd, 1 H, J = 8.3 Hz, 5.2 Hz), 3.69 (s, 3 H, CH3), 3.76-3.95 (m, 1 H), 5.12 
(d, 1 H, J = 12.2 Hz), 5.21 (d, 1 H, J = 12.2 Hz), 5.53 (bs, 1 H), 7.30-7.42 (m, 5 H). 
 
 
 
1-Benzyl-2-methyl-(1R,2R,3S)-3-((S)-pyrrolidine-2-carboxamido)cyclopropane-1,2-
dicarboxylate (221a) 
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1-Benzyl-2-methyl-(1S,2S,3R)-3-((S)-pyrrolidine-2-carboxamido)cyclopropane-1,2-
dicarboxylate (221b) 
Racemic β-ACC (±)-220 (4.38 g, 12.54 mmol, 1.0 equiv) was dissolved in dry EA (10 ml) 
and cooled to 0 °C. A solution of HCl in EA (4.2 M, 45 ml) was added and the reaction 
mixture was stirred at 0 °C until starting material was fully consumed (4 h; TLC analysis). 
Volatiles were removed in vacuo and the resulting white (pinkish) residue was treated with a 
premixed solution of N-Boc-L-proline (3.37 g, 15.68 mmol, 1.25 equiv) and EDC•HCl (3.00 
g, 15.68 mmol, 1.25 equiv) in DCM. Finally, triethylamine (2.17 ml, 15.68 mmol, 1.25 equiv) 
was added and the reaction was stirred at room temperature overnight (17 h). The crude 
reaction mixture treated with water (50 ml), the pH was adjusted to pH 3 by the addition of 
1M KHSO4 and the aqueous layer was extracted with DCM (4 x). The combined organic 
layers were then washed with NaHCO3 (sat. 1 x) and brine (1 x), dried over Na2SO4, filtered 
and concentrated in vacuo. The crude was purified via flash chromatography (silica, PE/EA = 
2:1) to yield a mixture of two N-Boc protected diastereomeric dipeptides Boc-Pro-▲/▼-OBn 
(4.13 g, 9.24 mmol, 74%) as a white foam. The mixture of diastereomers Boc-Pro-▲/▼-OBn 
(4.70 g, 10.53, mmol, 1.0 equiv) was deprotected with a solution of HCl in EA (4.2 M, 50 ml) 
at 0 °C and the two diastereomers were separated via flash chromatography (silica, 
DCM/MeOH = 15:1) to yield 221a (1.57 g, 4.54 mmol, 43%) and 221b (1.21 g, 3.49 mmol, 
33%). 
221a (major): Rf = 0.49 (DCM/MeOH = 9:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 
1.50-1.69 (m, 2 H), 1.73-1.91 (m, 1 H), 1.94-2.08 (m, 2 H), 2.26-2.34 (m, 1 H), 2.45-2.54 (m, 
1 H), 2.71-2.96 (m, 2 H), 3.53-3.68 (m, 4 H), 3.94-4.08 (m, 1 H), 5.00-5.17 (m, 2 H), 7.23-
7.33 (m, 5 H), 8.36 (d, 1 H, J = 8.4 Hz). 
221b (minor): Rf = 0.29 (DCM/MeOH = 9:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 
1.44-1.64 (m, 2 H), 1.69-1.83 (m, 1 H), 1.93-2.10 (m, 2 H), 2.30-2.36 (m, 1 H), 2.48-2.55 (m, 
1 H), 2.65-2.67 (m, 1 H), 2.84-2.96 (m, 1 H), 3.60-3.71 (m, 4 H), 3.94-4.03 (m, 1 H), 5.04-
5.15 (m, 2 H), 7.25-7.34 (m, 5 H), 8.41 (d, 1 H, J = 8.2 Hz). 
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tert-Butyl-(S)-2-(((1R,2R,3R)-2-((S)-2-((benzyloxy)carbonyl)pyrrolidine-1-carbonyl)-3-
(methoxycarbonyl)cyclopropyl)carbamoyl)pyrrolidine-1-carboxylate (222a) 
Dipeptide 221a (271 mg, 0.78 mmol, 1.0 equiv) and Boc2O (179 mg, 0.82 mmol, 1.05 equiv) 
were dissolved in dry DCM (5 ml). A solution of DMAP (10 mg, 0.08 mmol, 0.1 equiv) and 
NEt3 (81 µl, 0.59 mmol, 0.75 equiv) in dry DCM (5 ml) was added dropwise, and the reaction 
mixture was stirred at room temperature for 16 h. The reaction was quenched with water and 
then acidified with 1 M KHSO4 (pH 2-3). After extraction with DCM (3 x), the combined 
organic layers were washed with brine (1 x), dried over Na2SO4, filtered and concentrated in 
vacuo to yield the N-Boc protected dipeptide Boc-Pro-▲-OBn (328 mg, 0.73 mmol, 94%). 
The protected dipeptide Boc-Pro-▲-OBn (1.78 g, 3.98 mmol, 1.0 equiv) was dissolved in 
MeOH (50 ml), Pd/C (10%) was added and a balloon of hydrogen gas (1 atm) was mounted to 
the flask. The atmosphere was flushed with hydrogen gas to remove air and the mixture was 
stirred at room temperature for 5 h. After filtration of the reaction mixture through a plug of 
Celite and washing with MeOH, the solvent was removed in vacuo to yield the free acid 
Boc-Pro-▲-OH (1.44 g, quant.). Boc-Pro-▲-OH (284 mg, 0.76 mmol, 1.0 equiv) and 
EDC•HCl (153 mg, 0.80 mmol, 1.05 equiv) were dissolved in dry DCM (12 ml) and stirred 
for 30 min at room temperature. H-Pro-OBn•HCl (221 mg, 0.91 mmol, 1.2 equiv) and NEt3 
(127 µl, 0.91 mmol, 1.2 equiv) were added and the reaction mixture was stirred for 48 h. 
Water (10 ml) and DCM (10 ml) were added and the pH was adjusted to pH 4 with 1 M 
KHSO4. The organic layer was then washed with NaHCO3 (sat. 1 x) and brine (1 x), dried 
over Na2SO4, filtered and concentrated in vacuo. The crude mixture was purified via flash 
chromatography (silica, DCM/MeOH = 49:1) to yield 222a (255 mg, 0.47 mmol, 62%) as a 
colorless foam. 
Rf = 0.36 (DCM/MeOH = 19:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.43 (s, 9 H), 
1.74-2.29 (m, 8 H), 2.29-2.42 (m, 1 H), 2.49-2.71 (m, 1 H), 3.22-3.59 (m, 2 H), 3.59-3.90 (m, 
5 H), 4.01-4.35 (m, 2 H), 4.41-4.63 (m, 1 H), 5.04-5.29 (m, 2 H), 7.28-7.83 (m, 6 H). 
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tert-Butyl-(S)-2-(((1S,2S,3S)-2-((S)-2-((benzyloxy)carbonyl)pyrrolidine-1-carbonyl)-3-
(methoxycarbonyl)cyclopropyl)carbamoyl)pyrrolidine-1-carboxylate (222b) 
Dipeptide 221b (1.21 g, 3.49 mmol, 1.0 equiv) and Boc2O (800 mg, 3.67 mmol, 1.05 equiv) 
were dissolved in dry DCM (20 ml). A solution of DMAP (43 mg, 0.35 mmol, 0.1 equiv) and 
NEt3 (0.36 ml, 2.62 mmol, 0.75 equiv) in dry DCM (20 ml) was added dropwise, and the 
reaction mixture was stirred at room temperature for 24 h. The reaction was quenched with 
water and then acidified with 1 M KHSO4 (pH 2-3). After extraction with DCM (3 x), the 
combined organic layers were washed with brine (1 x), dried over Na2SO4, filtered and 
concentrated in vacuo to yield the N-Boc protected dipeptide Boc-Pro-▼-OBn (1.49 g, 3.33 
mmol, 95%). The protected dipeptide Boc-Pro-▼-OBn (570 mg, 1.28 mmol, 1.0 equiv) was 
dissolved in MeOH (15 ml), Pd/C (10%) was added and a balloon of hydrogen gas (1 atm) 
was mounted to the flask. The atmosphere was flushed with hydrogen gas to remove air and 
the mixture was stirred at room temperature for 1 h. After filtration of the reaction mixture 
through a plug of Celite and washing with MeOH, the solvent was removed in vacuo to yield 
the free acid Boc-Pro-▼-OH (485 mg, quant.). Boc-Pro-▼-OH (458 mg, 1.28 mmol, 1.0 
equiv) and EDC•HCl (257 mg, 1.34 mmol, 1.05 equiv) were dissolved in dry DCM (20 ml) 
and stirred for 30 min at room temperature. H-Pro-OBn•HCl (370 mg, 1.53 mmol, 1.2 equiv) 
and NEt3 (212 µl, 1.53 mmol, 1.2 equiv) were added and the reaction mixture was stirred for 
48 h. Water (10 ml) and DCM (10 ml) were added and the pH was adjusted to pH 4 with 1 M 
KHSO4. The organic layer was then washed with NaHCO3 (sat. 1 x) and brine (1 x), dried 
over Na2SO4, filtered and concentrated in vacuo. The crude mixture was purified via flash 
chromatography (silica, DCM/MeOH = 49:1) to yield 222b (395 mg, 0.73 mmol, 57%) as a 
colorless foam. 
Rf = 0.32 (DCM/MeOH = 19:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 1.45 (s, 9 H), 
1.73-1.93 (m, 3 H), 1.93-2.25 (m, 5 H), 2.28-2.39 (m, 1 H), 2.49-2.65 (m, 1 H), 3.18-3.55 (m, 
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2 H), 3.56-3.76 (m, 4 H), 3.78-3.95 (m, 1 H), 4.04-4.34 (m, 2 H), 4.46-4.58 (m, 1 H), 5.03-
5.26 (m, 2 H), 7.28-7.61 (m, 6 H). 
 
 
(S)-1-((1R,2R,3R)-2-(Methoxycarbonyl)-3-((S)-pyrrolidine-2-
carboxamido)cyclopropanecarbonyl)pyrrolidine-2-carboxylic acid (217a)[58, 240] 
Orthogonally protected tripeptide 222a (154 mg, 0.28 mmol, 1.0 equiv) was deprotected with 
a solution of HCl in EA (4.2 M, 4 ml) at 0 °C for 1.5 h. The volatiles were removed in vacuo 
and the residue was treated with water (5 ml) and extracted with Et2O (2 x). The pH of the 
aqueous layer was adjusted to pH 9 by the use of NaHCO3 (sat.) and then extracted with 
DCM (4 x). The combined organic layers were dried over Na2SO4, filtered and concentrated 
in vacuo to yield H-Pro-▲-Pro-OBn (116 mg, 0.26 mmol, 93%) as white foam. 
H-Pro-▲-Pro-OBn (116 mg, 0.26 mmol, 1.0 equiv) was dissolved in MeOH (5 ml), Pd/C 
(10%) was added and a balloon of hydrogen gas (1 atm) was mounted to the flask. The 
atmosphere was flushed with hydrogen gas to remove air and the mixture was stirred at room 
temperature for 1 h. After filtration of the reaction mixture through a plug of Celite and 
washing with MeOH, the solvent was removed in vacuo to yield 217a (106 mg, quant.) as 
white amorphous solid. 
Rf = 0.04 (DCM/MeOH = 4:1) – 1H-NMR (300 MHz, MeOD): δH (ppm) = 1.75-2.13 (m, 6 
H), 2.13-2.43 (m, 2 H), 2.43-2.72 (m, 2 H), 3.36-3.46 (m, 1 H), 3.53 (dd, 1 H, J = 7.9 Hz, 4.5 
Hz), 3.55-3.66 (m, 1 H), 3.63-4.01 (m, 5 H), 4.19-4.68 (m, 2 H). – 13C-NMR (101 MHz, 
MeOD): δC (ppm) = 25.0 (-, CH2), 25.4 (-, CH2), 26.7 (+, CH), 28.0 (+, CH), 28.7 (+, CH), 
30.9 (+, CH), 31.0 (-, CH2), 31.2 (-, CH2), 36.1 (+, CH), 36.6 (+, CH), 47.6 (-, CH2), 49.1 (-, 
CH2), 53.1 (+, CH3), 60.8 (+, CH), 62.2 (+, CH), 167.7 (Cq, CO), 171.1 (Cq, CO), 171.4 (Cq, 
CO, minor), 172.1 (Cq, CO, minor), 172.3 (Cq, CO), 175.8 (Cq, COOH). (signal doubling 
due to rotamers). 
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(S)-1-((1S,2S,3S)-2-(Methoxycarbonyl)-3-((S)-pyrrolidine-2-
carboxamido)cyclopropanecarbonyl)pyrrolidine-2-carboxylic acid (217b)[58, 240] 
Orthogonally protected tripeptide 222b (322 mg, 0.59 mmol, 1.0 equiv) was deprotected with 
a solution of HCl in EA (4.2 M, 10 ml) at 0 °C for 3 h. The volatiles were removed in vacuo 
and the residue was treated with water (10 ml) and extracted with Et2O (1 x). The pH of the 
aqueous layer was adjusted to pH 8-9 by the use of NaHCO3 (sat.) and then extracted with 
DCM (4 x). The combined organic layers were dried over Na2SO4, filtered and concentrated 
in vacuo to yield H-Pro-▼-Pro-OBn (259 mg, 0.58 mmol, 99%) as white foam. 
H-Pro-▼-Pro-OBn (259 mg, 0.58 mmol, 1.0 equiv) was dissolved in MeOH (10 ml), Pd/C 
(10%) was added and a balloon of hydrogen gas (1 atm) was mounted to the flask. The 
atmosphere was flushed with hydrogen gas to remove air and the mixture was stirred at room 
temperature for 1.5 h. After filtration of the reaction mixture through a plug of Celite and 
washing with MeOH, the solvent was removed in vacuo to yield 217b (223 mg, quant.) as 
white amorphous solid. 
Rf = 0.07 (DCM/MeOH = 4:1) – 1H-NMR (300 MHz, MeOD): δH (ppm) = 1.82-1.94 (m, 1 
H), 1.94-2.10 (m, 6 H), 2.31-2.42 (m, 1 H), 2.62 (dd, 1 H, J = 5.2 Hz, 4.3 Hz), 2.71 (dd, 1 H, J 
= 8.2 Hz, 5.3 Hz), 3.32-3.42 (m, 2 H), 3.65-3.71 (m, 2 H), 3.72 (s, 3 H), 3.92-4.02 (m, 1 H), 
4.18 (dd, 1 H, J = 8.6 Hz, 6.9 Hz), 4.36 (dd, 1 H, J = 8.4 Hz, 2.3 Hz). – 13C-NMR (101 MHz, 
MeOD): δC (ppm) = 25.2 (-, CH2), 25.3 (-, CH2), 25.9 (+, CH), 30.6 (-, CH2), 30.7 (-, CH2), 
31.0 (+, CH), 36.1 (+, CH), 47.5 (-, CH2), 48.5 (-, CH2), 52.9 (+, CH3), 61.2 (+, CH), 61.8 (+, 
CH), 166.2 (Cq), 171.6 (Cq), 172.4 (Cq), 177.2 (Cq). (signal doubling due to rotamers). 
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General procedure for organocatalyic aldol reactions under ambient- and high-pressure 
conditions: 
 
 
To a solution of para-nitrobenzaldehyde 224 (30.2 mg, 0.2 mmol, 1.0 equiv) in 2 ml of 
acetone/water (10:1 (v/v)) catalyst 217a (7.1 mg, 0.02 mmol, 0.1 equiv) was added and the 
solution was stirred for the indicated time at room temperature. Acetone was removed in 
vacuo and the residue was treated with EA (5 ml) and water (2 ml). After separation of the 
phases the organic layer was washed with water (1 ml), dried over Na2SO4, filtered and 
evaporated under reduced pressure. The aqueous layer was washed with diethylether (2 ml) 
and then lyophilized in order to recover the catalyst. On the other hand, the crude reaction 
mixture was purified via flash chromatography (silica, PE/EA = 2:1) and the product was 
analyzed by chiral HPLC. 
For reactions under high pressure the prepared reaction mixture was transferred into a PTFE 
tube that was subsequently sealed by melting the tube and then incorporated into the 
high-pressure apparatus. Pressure was generated and maintained for the indicated time period 
without agitation of the reaction mixture.  
 
 
(R)-4-Hydroxy-4-(4-nitrophenyl)butan-2-one (225)[58] 
Rf = 0.17 (PE/EA = 2:1) – 1H-NMR (300 MHz, CDCl3): δH (ppm) = 2.22 (s, 3 H), 2.82-2.87 
(m, 2 H), 3.60 (bs, 1 H), 5.26 (dd, 1 H, J = 7.4 Hz, 4.9 Hz), 7.49-7.57 (m, 2 H), 8.16-8.23 (m, 
2 H). – HPLC analysis (Chiralcel AS-H, n-heptane/iPrOH 99:1, 0.5 ml/min, 254 nm) tr = 
18.97 min (R), tr = 22.38 min (S). 
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(S)-5-(((R)-1-Amino-1-oxopropan-2-yl)amino)-4-((1S,2R)-2-((1R,2S)-2-((R)-2-((S)-6-amino-
2-((1S,2R)-2-((1R,2S)-2-((R)-2-((S)-5-amino-2-((1S,2R)-2-((1R,2S)-2-((R)-2-
aminopropanamido)cyclopent-3-ene-1-carboxamido)cyclopentane-1-carboxamido)-5-
oxopentanamido)propanamido)cyclopent-3-ene-1-carboxamido)cyclopentane-1-
carboxamido)hexanamido)propanamido)cyclopent-3-ene-1-carboxamido)cyclopentane-1-
carboxamido)-5-oxopentanoic acid (226)[256] 
Foldamer 226 was obtained from solid phase synthesis on TentaGel R RAM resin via 
Fmoc/tBu strategy. For synthesis and purification details as well as spectroscopic data of 226 
see refs. [256, 257]. 
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G Appendix  
1 NMR spectra  
 
 
1H-NMR spectra:      upper image  
 
13C-NMR spectra (DEPT 135 integrated):   lower image  
 
Solvent and frequency are stated each spectrum. 
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(S)-N-Benzyl-4-iso-propyl-4,5-dihydrooxazol-2-amine (82)  
CDCl3, 300 MHz 
 
CDCl3, 75 MHz 
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(1S,5S,6S)-di-tert-Butyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate ((S,S,S)-(-)-103) 
CDCl3, 600 MHz 
 
CDCl3, 151 MHz 
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(1S,2S,3S,4S,6S,7S)-tri-tert-Butyl-5-azatricyclo[4.1.0.02,4]heptane-3,5,7-tricarboxylate (104) 
CDCl3, 300 MHz 
 
CDCl3, 75 MHz 
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(1S,5S,6S)-di-tert-Butyl-2-azabicyclo[3.1.0]hexane-2,6-dicarboxylate (149) 
CDCl3, 300 MHz  
 
CDCl3, 75 MHz 
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(S)-tert-Butyl-3-(2-(tert-butoxy)-2-oxoethyl)pyrrolidine-1-carboxylate (150) 
CDCl3, 300 MHz 
 
CDCl3, 75 MHz 
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(1S,5R,6S)-di-tert-Butyl-4-((1S,5S,6S)-2,6-bis(tert-butoxycarbonyl)-2-
azabicyclo[3.1.0]hexan-3-yl)-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate (151) 
CDCl3, 300 MHz 
 
CDCl3, 75 MHz 
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(1S,3S,5S,6S)-di-tert-Butyl-3-(tert-butylcarbamoyl)-2-azabicyclo[3.1.0]hexane-2,6-
dicarboxylate (165a) 
CDCl3, 300 MHz  
 
CDCl3, 151 MHz 
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(1S,3R,5S,6S)-di-tert-Butyl-3-(tert-butylcarbamoyl)-2-azabicyclo[3.1.0]hexane-2,6-
dicarboxylate (165b) 
CDCl3, 400 MHz, 223 K  
 
CDCl3, 101 MHz, 223 K  
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di-tert-Butyl-(1S,5S,6S)-3-(2,4,6-trimethoxyphenyl)-2-azabicyclo[3.1.0]hexane-2,6-
dicarboxylate (172)  
CDCl3, 400 MHz 
 
 
CDCl3, 101 MHz  
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((1S,2S,3S,4S,6S,7S)-5-(tert-Butoxycarbonyl)-5-azatricyclo[4.1.0.02,4]heptane-3,7-
diyl)bis(methylene) diacetate (187)  
CDCl3, 300 MHz 
 
 
CDCl3, 75 MHz  
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2 HPLC chromatograms 
di-tert-Butyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate ((rac)-(±)-103) 
 
 
(1S,5S,6S)-di-tert-Butyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate ((S,S,S)-(-)-103) 
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(1R,5R,6R)-di-tert-Butyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate ((R,R,R)-(+)-103) 
 
 
tri-tert-Butyl-5-azatricyclo[4.1.0.02,4]heptane-3,5,7-tricarboxylate ((rac)-(±)-104) 
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(1S,2S,3S,4S,6S,7S)-tri-tert-Butyl-5-azatricyclo[4.1.0.02,4]heptane-3,5,7-tricarboxylate 
((S,S,S,S,S,S)-(+)-104, 41% ee) 
 
 
di-tert-Butyl-2-azabicyclo[3.1.0]hexane-2,6-dicarboxylate ((rac)-(±)-149) 
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(1S,5S,6S)-di-tert-Butyl-2-azabicyclo[3.1.0]hexane-2,6-dicarboxylate ((S,S,S)-(-)-149) 
 
 
tert-Butyl-3-(2-(tert-butoxy)-2-oxoethyl)pyrrolidine-1-carboxylate ((rac)-(±)-150) 
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(S)-tert-Butyl-3-(2-(tert-butoxy)-2-oxoethyl)pyrrolidine-1-carboxylate ((S)-(+)-150, 73% ee) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3 X-ray crystallographic data
(1S,5S,6S)-di-tert-Butyl-2-azabicyclo[3.1.0]hex
Table 1. Crystal data and structure refinement for 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  
Space group  
a/Å  
b/Å  
c/Å  
α/°  
β/°  
γ/°  
Volume/Å3  
Z  
ρcalcmg/mm3  
m/mm-1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection  
Index ranges  
Reflections collected  
Independent reflections  
 
 
152 
 
-3-ene-2,6-dicarboxylate ((S,S,S
 
(S,S,S)-(-)-103.  
C15H23NO4  
281.34  
123.0  
monoclinic  
P21  
9.4639(3)  
6.1799(2)  
13.1692(5)  
90  
90.131(4)  
90  
770.21(5)  
2  
1.213  
0.715  
304.0  
0.53 × 0.081 × 0.0264  
CuKα (λ = 1.54184)  
6.72 to 149.3°  
-11 ≤ h ≤ 11, -6 ≤ k ≤ 7, -16 ≤ l ≤
3296  
2115 [Rint = 0.0341, Rsigma = 0.0469] 
Appendix 
 
)-(-)-103) 
 14  
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Data/restraints/parameters  2115/1/187  
Goodness-of-fit on F2  1.104  
Final R indexes [I>=2σ (I)]  R1 = 0.0610, wR2 = 0.1569  
Final R indexes [all data]  R1 = 0.0630, wR2 = 0.1602  
Largest diff. peak/hole / e Å-3  0.36/-0.29  
Flack parameter 0.0(3) 
 
 
Table 2. Fractional atomic coordinates (×104) and equivalent isotropic displacement 
parameters (Å2×103) for (S,S,S)-(-)-103. Ueq is defined as 1/3 of the trace of the 
orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O1 -8000(2) -8004(4) 846.3(15) 35.3(6) 
O2 -7734(2) -4482(3) 376.9(15) 34.5(6) 
O3 -7369(2) -4381(3) -3711.7(14) 31.4(5) 
O4 -5183(2) -3471(4) -3128.7(16) 34.8(6) 
N1 -6701(3) -7226(4) -498.4(18) 31.3(7) 
C1 -7512(3) -6395(5) 264(2) 30.6(8) 
C2 -6332(3) -9414(5) -675(2) 29.9(7) 
C3 -5449(3) -9566(5) -1450(2) 31.8(8) 
C4 -5179(3) -7407(5) -1889(2) 32.1(8) 
C5 -6031(3) -5882(5) -1248(2) 30.7(7) 
C6 -6497(3) -6301(5) -2341(2) 31.1(7) 
C7 -6252(3) -4558(5) -3088.7(18) 29.2(7) 
C8 -7402(3) -2753(5) -4532(2) 30.6(7) 
C9 -6213(4) -3113(6) -5289(2) 37.9(9) 
C10 -7367(4) -484(5) -4085(2) 36.7(8) 
C11 -8837(3) -3181(6) -5022(2) 38.2(8) 
C12 -8986(3) -7606(5) 1684(2) 32.8(8) 
C13 -10304(3) -6475(6) 1293(3) 42.8(9) 
C14 -8242(3) -6328(7) 2510(2) 43.1(9) 
C15 -9359(5) -9876(6) 2033(3) 49.0(11) 
  
Table 3. Anisotropic displacement parameters (Å2×103) for (S,S,S)-(-)-103. The anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O1 44.1(11) 27.7(10) 34.1(9) 1.3(8) 9.6(8) 2.4(9) 
O2 40.2(10) 23.2(10) 40.2(10) -3.0(9) -1.0(9) 6.2(9) 
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O3 34.4(9) 27.6(10) 32.2(9) 0.9(8) -2.4(8) -4.9(8) 
O4 35.9(10) 32.1(11) 36.3(9) -0.2(8) 0.1(8) -6.3(9) 
N1 40.0(12) 24.3(12) 29.6(10) -3.2(9) 1.9(9) 2.2(10) 
C1 30.8(13) 31.5(15) 29.5(11) 0.4(11) -2.5(10) 0.8(11) 
C2 33.6(13) 24.6(13) 31.4(12) 0.7(11) -2.1(10) -1.9(11) 
C3 34.1(13) 26.8(14) 34.4(12) -2.8(11) -2.4(10) 7.4(12) 
C4 29.2(13) 32.5(14) 34.6(12) 1.1(12) 0.9(11) -3.4(12) 
C5 35.8(13) 24.8(13) 31.5(12) -0.6(10) -0.4(11) -3.4(11) 
C6 32.5(13) 27.9(13) 32.8(12) -1.6(11) 0.6(10) -3.1(11) 
C7 33.0(13) 26.1(12) 28.5(11) -6.9(10) 0.8(10) -0.6(12) 
C8 36.5(14) 25.1(13) 30.3(11) 1.7(10) 1.0(11) -0.8(11) 
C9 44.9(16) 35.4(16) 33.3(13) -0.6(12) 2.8(12) 1.5(13) 
C10 42.5(15) 26.6(14) 41.1(14) -4.2(11) 1.3(12) -1.5(12) 
C11 41.2(15) 35.1(15) 38.4(13) 1.4(13) -6.4(12) 0.7(13) 
C12 35.1(13) 31.2(14) 32.2(12) -1.1(11) 6.0(11) 2.9(13) 
C13 33.4(15) 46.0(18) 49.0(16) -4.0(15) -1.4(13) 2.5(15) 
C14 36.2(15) 58(2) 35.1(13) -6.3(15) 2.3(12) 0.5(15) 
C15 58(2) 37.4(18) 51.8(17) 7.6(15) 20.8(16) 0.1(17) 
  
Table 4. Bond lengths for (S,S,S)-(-)-103. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
O1 C1 1.339(4) 
 
C4 C5 1.501(4) 
O1 C12 1.467(3) 
 
C4 C6 1.541(4) 
O2 C1 1.210(4) 
 
C5 C6 1.527(4) 
O3 C7 1.341(3) 
 
C6 C7 1.478(4) 
O3 C8 1.477(3) 
 
C8 C9 1.521(4) 
O4 C7 1.216(4) 
 
C8 C10 1.521(4) 
N1 C1 1.365(4) 
 
C8 C11 1.525(4) 
N1 C2 1.416(4) 
 
C12 C13 1.519(4) 
N1 C5 1.439(4) 
 
C12 C14 1.516(4) 
C2 C3 1.324(4) 
 
C12 C15 1.518(5) 
C3 C4 1.477(4) 
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Table 5. Bond angles for (S,S,S)-(-)-103. 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
C1 O1 C12 121.8(2) 
 
C4 C6 C7 116.9(2) 
C7 O3 C8 121.2(2) 
 
C5 C6 C7 117.3(2) 
C1 N1 C2 128.3(2) 
 
O3 C7 O4 125.7(3) 
C1 N1 C5 122.5(2) 
 
O3 C7 C6 110.0(2) 
C2 N1 C5 109.2(2) 
 
O4 C7 C6 124.3(3) 
O1 C1 O2 126.5(3) 
 
O3 C8 C9 111.4(2) 
O1 C1 N1 109.7(3) 
 
O3 C8 C10 110.2(2) 
O2 C1 N1 123.8(3) 
 
O3 C8 C11 102.1(2) 
N1 C2 C3 110.5(3) 
 
C9 C8 C10 111.9(3) 
C2 C3 C4 110.4(3) 
 
C9 C8 C11 110.9(2) 
C3 C4 C5 104.7(2) 
 
C10 C8 C11 110.0(3) 
C3 C4 C6 114.3(2) 
 
O1 C12 C13 110.2(2) 
C5 C4 C6 60.23(18) 
 
O1 C12 C14 109.4(2) 
N1 C5 C4 105.2(2) 
 
O1 C12 C15 102.8(3) 
N1 C5 C6 115.0(2) 
 
C13 C12 C14 112.5(3) 
C4 C5 C6 61.17(18) 
 
C13 C12 C15 109.7(3) 
C4 C6 C5 58.61(18) 
 
C14 C12 C15 111.8(3) 
  
Table 6. Hydrogen bonds for (S,S,S)-(-)-103. 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
C3 H3 O41 0.9500 2.4800 3.283(4) 142.00 
C9 H9A O4 0.9800 2.4300 3.013(3) 118.00 
C10 H10C O4 0.9800 2.4700 3.042(4) 117.00 
C13 H13A O2 0.9800 2.3900 2.984(4) 118.00 
C13 H13C O22 0.9800 2.4700 3.423(4) 165.00 
C14 H14C O2 0.9800 2.4900 3.071(4) 118.00 
1+X,-1+Y,+Z; 2-2-X,-1/2+Y,-Z 
  
Table 7. Torsion angles for (S,S,S)-(-)-103. 
A B C D Angle/˚ 
 
A B C D Angle/˚ 
N1 C2 C3 C4 -1.7(3) 
 
C3 C4 C6 C7 -159.4(2) 
N1 C5 C6 C4 -94.2(3) 
 
C4 C5 C6 C7 -106.4(3) 
N1 C5 C6 C7 159.5(3) 
 
C4 C6 C7 O3 154.1(2) 
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C1 O1 C12 C13 57.0(3) 
 
C4 C6 C7 O4 -25.3(4) 
C1 O1 C12 C14 -67.2(3) 
 
C5 N1 C1 O1 180.0(2) 
C1 O1 C12 C15 173.9(3) 
 
C5 N1 C1 O2 -0.2(4) 
C1 N1 C2 C3 -175.7(3) 
 
C5 N1 C2 C3 2.1(3) 
C1 N1 C5 C4 176.3(3) 
 
C5 C4 C6 C7 107.1(3) 
C1 N1 C5 C6 -118.8(3) 
 
C5 C6 C7 O3 -139.2(2) 
C2 N1 C1 O1 -2.5(4) 
 
C5 C6 C7 O4 41.4(4) 
C2 N1 C1 O2 177.3(3) 
 
C6 C4 C5 N1 110.5(3) 
C2 N1 C5 C4 -1.6(3) 
 
C7 O3 C8 C9 61.2(3) 
C2 N1 C5 C6 63.3(3) 
 
C7 O3 C8 C10 -63.6(3) 
C2 C3 C4 C5 0.6(3) 
 
C7 O3 C8 C11 179.6(2) 
C2 C3 C4 C6 -63.0(3) 
 
C8 O3 C7 O4 -0.7(4) 
C3 C4 C5 N1 0.6(3) 
 
C8 O3 C7 C6 179.9(2) 
C3 C4 C5 C6 -109.9(2) 
 
C12 O1 C1 O2 4.5(4) 
C3 C4 C6 C5 93.6(3) 
 
C12 O1 C1 N1 -175.6(2) 
  
Table 8. Hydrogen atom coordinates (Å×104) and isotropic displacement parameters 
(Å2×103) for (S,S,S)-(-)-103. 
Atom x y z U(eq) 
H2 -6672 -10606 -291 36 
H3 -5046 -10878 -1690 38 
H4 -4211 -6998 -2125 39 
H5 -5634 -4442 -1051 37 
H6 -7354 -7222 -2442 37 
H9A -5302 -2873 -4953 57 
H9B -6317 -2098 -5856 57 
H9C -6256 -4601 -5546 57 
H10A -8134 -325 -3592 55 
H10B -7487 581 -4630 55 
H10C -6458 -245 -3745 55 
H11A -8869 -4671 -5275 57 
H11B -8979 -2175 -5589 57 
H11C -9585 -2969 -4518 57 
H13A -10055 -5027 1049 64 
H13B -10994 -6353 1844 64 
H13C -10714 -7316 735 64 
H14A -7383 -7095 2719 65 
H14B -8872 -6170 3095 65 
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H14C -7990 -4893 2250 65 
H15A -9770 -10686 1465 74 
H15B -10044 -9794 2588 74 
H15C -8503 -10612 2270 74 
 
 
 
  
(1S,2S,3S,4S,6S,7S)-tri-tert-Butyl
Table 1. Crystal data and structure refinemen
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  
Space group  
a/Å  
b/Å  
c/Å  
α/°  
β/°  
γ/°  
Volume/Å3  
Z  
ρcalcmg/mm3  
m/mm-1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection  
Index ranges  
Reflections collected  
Independent reflections  
Data/restraints/parameters  
 
 
158 
-5-azatricyclo[4.1.0.02,4]heptane-3,5,7-tricarboxylate
t for 104.  
C21H33NO6  
395.48  
123.0  
monoclinic  
P21/c  
5.7733(2)  
9.1531(4)  
41.7797(19)  
90  
91.716(4)  
90  
2206.80(16)  
4  
1.190  
0.708  
856.0  
0.3002 × 0.1264 × 0.0446  
CuKα (λ = 1.54184)  
8.46 to 150.78°  
-7 ≤ h ≤ 5, -11 ≤ k ≤ 10, -52 
8423  
4381 [Rint = 0.0306, Rsigma = 0.0357] 
4381/0/262  
Appendix 
 
 (104) 
 
≤ l ≤ 51  
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Goodness-of-fit on F2  1.037  
Final R indexes [I>=2σ (I)]  R1 = 0.0498, wR2 = 0.1337  
Final R indexes [all data]  R1 = 0.0564, wR2 = 0.1421  
Largest diff. peak/hole / e Å-3  0.24/-0.34  
Flack parameter . 
 
 
Table 2. Fractional atomic coordinates (×104) and equivalent isotropic displacement 
parameters (Å2×103) for 104. Ueq is defined as 1/3 of the trace of the orthogonalised UIJ 
tensor. 
Atom x y z U(eq) 
O1 9298.9(16) 7580.4(12) 646.7(2) 23.2(3) 
O2 5881.0(17) 8358.1(12) 849.4(2) 26.2(3) 
O3 12033.9(18) 3358.8(11) 1108.9(3) 27.4(3) 
O4 14891.9(18) 4860.0(13) 1298.7(3) 33.4(3) 
O5 8016.3(18) 11151.3(11) 1975.2(2) 24.9(3) 
O6 6120(2) 9064.8(13) 2100.3(3) 38.1(4) 
N1 9050(2) 7899.7(13) 1170.1(3) 21.3(3) 
C1 7880(2) 7966.8(14) 883.0(3) 20.8(4) 
C2 11206(2) 7129.6(15) 1224.6(3) 22.0(4) 
C3 10923(2) 5544.1(16) 1333.3(3) 24.6(4) 
C4 12863(3) 4568.6(16) 1251.7(3) 25.2(4) 
C5 13575(3) 2217.9(16) 983.6(3) 27.0(4) 
C6 11860(3) 1128.8(18) 840.6(4) 34.7(5) 
C7 14997(3) 1544.3(19) 1256.0(4) 39.2(5) 
C8 15081(3) 2857(2) 727.2(4) 37.5(5) 
C9 11395(2) 6761.7(16) 1573.0(3) 22.9(4) 
C10 9286(2) 7372.8(16) 1725.8(3) 23.6(4) 
C11 7849(2) 8057.8(15) 1466.0(3) 21.2(4) 
C12 9069(3) 9028.2(16) 1715.8(3) 23.4(4) 
C13 7564(3) 9723.0(16) 1954.0(3) 24.7(4) 
C14 6848(3) 12092.5(17) 2210.3(3) 28.2(4) 
C15 7772(3) 13601.1(19) 2130.0(5) 41.7(5) 
C16 7618(3) 11625(2) 2544.0(4) 41.8(5) 
C17 4237(3) 12068(2) 2162.9(4) 36.0(5) 
C18 8389(2) 7500.2(16) 314.9(3) 22.8(4) 
C19 10538(3) 7119.5(18) 130.6(3) 30.1(4) 
C20 6615(3) 6284.6(18) 289.1(4) 31.6(4) 
C21 7419(3) 8972.3(18) 206.3(4) 30.7(4) 
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Table 3. Anisotropic displacement parameters (Å2×103) for 104. The anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O1 18.7(5) 31.0(5) 19.8(5) -2.8(4) -1.9(4) 3.1(4) 
O2 20.2(5) 32.8(6) 25.5(5) -0.5(4) -1.7(4) 6.3(4) 
O3 24.1(5) 21.8(5) 36.3(5) -5.3(4) -0.8(4) 2.1(4) 
O4 22.6(6) 30.7(6) 46.5(6) -8.4(5) -6.5(4) 4.3(4) 
O5 25.8(5) 23.3(5) 25.7(5) -4.2(4) 2.3(4) 0.6(4) 
O6 44.9(7) 30.4(6) 40.0(6) -3.0(5) 19.9(5) -5.1(5) 
N1 18.0(6) 26.1(6) 19.6(5) -1.3(4) -0.8(4) 2.6(4) 
C1 20.7(7) 20.2(6) 21.4(6) -0.7(5) -0.8(5) 0.3(5) 
C2 19.2(7) 23.9(7) 22.6(6) -1.8(5) -1.9(5) 1.1(5) 
C3 22.5(7) 23.4(7) 27.8(6) -1.7(5) -1.8(5) 0.3(5) 
C4 24.2(7) 23.0(7) 28.1(6) 0.3(5) -3.9(5) 2.0(5) 
C5 29.9(8) 23.4(7) 27.6(7) -2.2(5) -1.1(6) 5.9(6) 
C6 37.5(9) 26.8(8) 39.6(8) -7.6(6) -2.7(7) 1.6(6) 
C7 53.7(11) 29.3(8) 33.7(8) -3.1(6) -12.1(7) 12.2(8) 
C8 39.3(10) 40.9(9) 32.5(8) -2.6(7) 6.1(7) -0.6(7) 
C9 22.2(7) 23.6(7) 22.8(6) 0.9(5) -3.2(5) 1.7(5) 
C10 25.3(7) 23.6(7) 21.7(6) 0.2(5) -0.8(5) 0.2(5) 
C11 20.7(7) 22.3(6) 20.5(6) -1.6(5) 1.0(5) 1.0(5) 
C12 25.4(7) 23.1(7) 21.9(6) -1.5(5) 1.8(5) -0.6(5) 
C13 27.0(7) 25.1(7) 21.9(6) -0.6(5) 0.9(5) -0.7(6) 
C14 29.8(8) 28.2(7) 26.4(7) -7.6(6) -0.2(6) 5.3(6) 
C15 40.5(10) 29.1(8) 55.7(10) -10.7(7) 6.0(8) 0.8(7) 
C16 48.7(11) 49.9(10) 26.3(7) -10.9(7) -6.5(7) 18.4(8) 
C17 30.0(9) 42.7(9) 35.3(8) -8.8(7) 0.1(6) 6.3(7) 
C18 20.8(7) 27.4(7) 19.9(6) -1.5(5) -3.4(5) 1.6(5) 
C19 28.7(8) 38.2(8) 23.3(6) -2.9(6) 1.3(5) 3.8(6) 
C20 28.4(8) 32.4(8) 33.6(7) -7.0(6) -3.8(6) -3.3(6) 
C21 34.1(8) 31.7(8) 26.3(7) 3.7(6) -0.7(6) 6.4(6) 
 
 
Table 4. Bond lengths for 104. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
O1 C1 1.3488(15) 
 
C3 C9 1.5175(19) 
O1 C18 1.4695(15) 
 
C5 C6 1.515(2) 
O2 C1 1.2125(15) 
 
C5 C7 1.514(2) 
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O3 C4 1.3395(18) 
 
C5 C8 1.517(2) 
O3 C5 1.4779(19) 
 
C9 C10 1.4998(17) 
O4 C4 1.212(2) 
 
C10 C11 1.4851(18) 
O5 C13 1.3356(18) 
 
C10 C12 1.521(2) 
O5 C14 1.4838(18) 
 
C11 C12 1.5265(19) 
O6 C13 1.209(2) 
 
C12 C13 1.484(2) 
N1 C1 1.3603(17) 
 
C14 C15 1.521(2) 
N1 C2 1.4426(17) 
 
C14 C16 1.512(2) 
N1 C11 1.4427(17) 
 
C14 C17 1.515(2) 
C2 C3 1.531(2) 
 
C18 C19 1.520(2) 
C2 C9 1.4949(18) 
 
C18 C20 1.514(2) 
C3 C4 1.480(2) 
 
C18 C21 1.523(2) 
  
Table 5. Bond angles for 104. 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
C1 O1 C18 119.72(10) 
 
C3 C9 C10 115.01(10) 
C4 O3 C5 122.08(12) 
 
C9 C10 C11 106.81(10) 
C13 O5 C14 121.36(11) 
 
C9 C10 C12 115.29(12) 
C1 N1 C2 124.37(11) 
 
C11 C10 C12 61.02(9) 
C1 N1 C11 120.82(11) 
 
N1 C11 C10 108.16(10) 
C2 N1 C11 110.38(11) 
 
N1 C11 C12 114.86(11) 
O1 C1 O2 126.12(11) 
 
C10 C11 C12 60.64(9) 
O1 C1 N1 109.71(10) 
 
C10 C12 C11 58.33(9) 
O2 C1 N1 124.14(12) 
 
C10 C12 C13 117.26(12) 
N1 C2 C3 114.25(10) 
 
C11 C12 C13 116.13(14) 
N1 C2 C9 107.53(10) 
 
O5 C13 O6 126.20(14) 
C3 C2 C9 60.19(9) 
 
O5 C13 C12 110.29(13) 
C2 C3 C4 114.54(11) 
 
O6 C13 C12 123.50(14) 
C2 C3 C9 58.73(9) 
 
O5 C14 C15 102.22(12) 
C4 C3 C9 118.22(11) 
 
O5 C14 C16 108.61(13) 
O3 C4 O4 125.81(14) 
 
O5 C14 C17 112.04(12) 
O3 C4 C3 109.79(13) 
 
C15 C14 C16 111.39(14) 
O4 C4 C3 124.36(13) 
 
C15 C14 C17 109.80(14) 
O3 C5 C6 102.20(13) 
 
C16 C14 C17 112.35(13) 
O3 C5 C7 109.88(11) 
 
O1 C18 C19 102.43(10) 
O3 C5 C8 109.97(12) 
 
O1 C18 C20 109.02(11) 
C6 C5 C7 111.20(13) 
 
O1 C18 C21 110.78(12) 
C6 C5 C8 110.91(12) 
 
C19 C18 C20 110.86(12) 
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C7 C5 C8 112.23(14) 
 
C19 C18 C21 110.50(12) 
C2 C9 C3 61.08(9) 
 
C20 C18 C21 112.77(12) 
C2 C9 C10 107.09(10) 
     
  
Table 6. Hydrogen bonds for 104. 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
C2 H2 O21 1.0000 2.3600 3.3556(16) 175.00 
C3 H3 O42 1.0000 2.5700 3.5365(16) 163.00 
C6 H6C O23 0.9800 2.5700 3.438(2) 148.00 
C7 H7B O4 0.9800 2.4600 3.041(2) 117.00 
C7 H7C O23 0.9800 2.5500 3.421(2) 147.00 
C8 H8B O4 0.9800 2.4600 3.015(2) 115.00 
C16 H16B O6 0.9800 2.5400 3.095(2) 115.00 
C16 H16C O64 0.9800 2.5800 3.471(2) 151.00 
C17 H17B O6 0.9800 2.3700 2.970(2) 119.00 
C20 H20A O2 0.9800 2.4600 3.0530(19) 118.00 
C21 H21B O2 0.9800 2.3400 2.9097(19) 116.00 
11+X,+Y,+Z; 2-1+X,+Y,+Z; 31+X,-1+Y,+Z; 41-X,1/2+Y,1/2-Z 
  
Table 7. Torsion angles for 104. 
A B C D Angle/˚ 
 
A B C D Angle/˚ 
N1 C2 C3 C4 153.63(11) 
 
C4 C3 C9 C10 -160.49(12) 
N1 C2 C3 C9 -97.05(12) 
 
C5 O3 C4 O4 -1.1(2) 
N1 C2 C9 C3 108.39(11) 
 
C5 O3 C4 C3 176.50(11) 
N1 C2 C9 C10 -1.21(14) 
 
C9 C2 C3 C4 -109.32(12) 
N1 C11 C12 C10 -97.67(12) 
 
C9 C3 C4 O3 163.68(12) 
N1 C11 C12 C13 155.07(12) 
 
C9 C3 C4 O4 -18.7(2) 
C1 O1 C18 C19 177.06(12) 
 
C9 C10 C11 N1 -1.19(15) 
C1 O1 C18 C20 -65.45(16) 
 
C9 C10 C11 C12 -110.04(12) 
C1 O1 C18 C21 59.20(15) 
 
C9 C10 C12 C11 95.97(12) 
C1 N1 C2 C3 -91.36(15) 
 
C9 C10 C12 C13 -158.70(13) 
C1 N1 C2 C9 -155.93(12) 
 
C10 C11 C12 C13 -107.26(13) 
C1 N1 C11 C10 157.83(12) 
 
C10 C12 C13 O5 163.34(12) 
C1 N1 C11 C12 -136.80(13) 
 
C10 C12 C13 O6 -17.9(2) 
C2 N1 C1 O1 -17.02(17) 
 
C11 N1 C1 O1 -171.12(11) 
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C2 N1 C1 O2 164.89(13) 
 
C11 N1 C1 O2 10.8(2) 
C2 N1 C11 C10 0.45(15) 
 
C11 N1 C2 C3 65.05(14) 
C2 N1 C11 C12 65.82(15) 
 
C11 N1 C2 C9 0.48(15) 
C2 C3 C4 O3 -130.06(12) 
 
C11 C10 C12 C13 105.33(15) 
C2 C3 C4 O4 47.61(18) 
 
C11 C12 C13 O5 -130.55(13) 
C2 C3 C9 C10 96.48(12) 
 
C11 C12 C13 O6 48.3(2) 
C2 C9 C10 C11 1.46(15) 
 
C12 C10 C11 N1 108.86(12) 
C2 C9 C10 C12 -63.90(14) 
 
C13 O5 C14 C15 -176.27(13) 
C3 C2 C9 C10 -109.60(11) 
 
C13 O5 C14 C16 65.91(17) 
C3 C9 C10 C11 -64.03(15) 
 
C13 O5 C14 C17 -58.78(17) 
C3 C9 C10 C12 -129.39(12) 
 
C14 O5 C13 O6 4.9(2) 
C4 O3 C5 C6 -178.49(13) 
 
C14 O5 C13 C12 -176.37(12) 
C4 O3 C5 C7 63.37(17) 
 
C18 O1 C1 O2 -4.9(2) 
C4 O3 C5 C8 -60.65(17) 
 
C18 O1 C1 N1 177.03(11) 
C4 C3 C9 C2 103.04(13) 
      
  
Table 8. Hydrogen atom coordinates (Å×104) and isotropic displacement parameters 
(Å2×103) for 104. 
Atom x y z U(eq) 
H2 12616 7429 1108 26 
H3 9325 5122 1323 30 
H6A 10811 801 1006 52 
H6B 10960 1594 666 52 
H6C 12699 287 757 52 
H7A 13961 1196 1421 59 
H7B 16056 2279 1348 59 
H7C 15893 721 1175 59 
H8A 14106 3390 571 56 
H8B 16216 3527 826 56 
H8C 15894 2067 619 56 
H9 12934 6819 1689 28 
H10 8521 6809 1898 28 
H11 6124 7954 1466 25 
H12 10448 9595 1646 28 
H15A 7306 13853 1909 62 
H15B 9467 13599 2152 62 
H15C 7138 14323 2277 62 
H16A 9314 11598 2559 63 
  Appendix 
 
 
164 
 
H16B 7000 10652 2589 63 
H16C 7038 12324 2700 63 
H17A 3822 12365 1943 54 
H17B 3662 11077 2201 54 
H17C 3539 12745 2314 54 
H19A 11174 6189 209 45 
H19B 11701 7891 162 45 
H19C 10126 7034 -98 45 
H20A 5310 6511 425 47 
H20B 7331 5363 359 47 
H20C 6056 6193 66 47 
H21A 8558 9740 255 46 
H21B 5988 9176 319 46 
H21C 7086 8948 -25 46 
 
 
  
(S)-tert-Butyl-3-(2-(tert-butoxy)
Table 1. Crystal data and structure refinement for 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  
Space group  
a/Å  
b/Å  
c/Å  
α/°  
β/°  
γ/°  
Volume/Å3  
Z  
ρcalcmg/mm3  
m/mm-1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection  
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-2-oxoethyl)pyrrolidine-1-carboxylate (150
150.  
C15H27NO4  
285.37  
123.00(10)  
orthorhombic  
P22121  
6.02696(12)  
8.52370(17)  
15.8573(3)  
90  
90  
90  
814.62(3)  
2  
1.163  
0.676  
312.0  
0.1519 × 0.1343 × 0.0933  
CuKα (λ = 1.54184)  
11.16 to 140.508°  
Appendix 
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Index ranges  -7 ≤ h ≤ 7, -10 ≤ k ≤ 9, -17 ≤ l ≤ 19  
Reflections collected  4025  
Independent reflections  1515 [Rint = 0.0498, Rsigma = 0.0348]  
Data/restraints/parameters  1515/63/187  
Goodness-of-fit on F2  1.031  
Final R indexes [I>=2σ (I)]  R1 = 0.0289, wR2 = 0.0757  
Final R indexes [all data]  R1 = 0.0308, wR2 = 0.0767  
Largest diff. peak/hole / e Å-3  0.10/-0.13  
Flack parameter 0.10(17) 
 
 
Table 2. Fractional atomic coordinates (×104) and equivalent isotropic displacement 
parameters (Å2×103) for 150. Ueq is defined as 1/3 of the trace of the orthogonalised UIJ 
tensor. 
Atom x y z U(eq) 
O3 6310(19) 980(20) 6363(8) 31.4(15) 
O4 9274(6) 2744(5) 6208(2) 44.9(9) 
C12 7320(14) 2409(9) 6054(5) 28.9(16) 
C4 3650(7) 2887(5) 5403(3) 32.4(8) 
C1 6645(4) 4803(3) 5269.3(19) 34.6(6) 
N1 5936(6) 3310(3) 5624.7(18) 30.9(6) 
C2 4881(4) 5168(3) 4616.7(19) 30.6(6) 
C3 2806(4) 4386(3) 4981.1(19) 32.0(6) 
O1 8344(8) 7151(5) 3969(3) 40.2(10) 
C6 6480(10) 7710(11) 4007(5) 32.4(18) 
O2 5910(20) 9010(20) 3746(9) 32.8(16) 
C7 4554(9) 6899(5) 4424(2) 28.8(8) 
C10 8650(20) 9572(12) 2430(7) 37.8(18) 
C9 9394(19) 10740(20) 3795(8) 45(2) 
C8 7534(17) 10200(13) 3218(6) 32.2(16) 
C11 5830(30) 11480(16) 3072(8) 38(2) 
C15 8500(30) 691(14) 7472(7) 45(2) 
C14 9100(17) -838(19) 6065(7) 36.7(18) 
C13 7527(17) -112(14) 6703(6) 31.8(16) 
C16 5940(30) -1327(17) 7055(9) 43(2) 
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Table 3. Anisotropic displacement parameters (Å2×103) for 150. The anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O3 39(3) 25.8(19) 29(3) 5(2) -16(2) 8(3) 
O4 30(2) 33.3(15) 72(2) 11.0(13) -14.2(15) -1.6(15) 
C12 35(5) 14(3) 37(2) 4.4(18) 0(4) -7(3) 
C4 26(2) 29.8(17) 41(2) 6.7(15) -4.8(16) -7.2(18) 
C1 28.6(12) 24.9(14) 50.3(17) 6.1(14) -5.5(11) -3.4(12) 
N1 23.9(15) 23.1(14) 45.7(15) 7.5(12) -5.2(13) -3.1(12) 
C2 28.3(12) 24.8(13) 38.8(12) 2.2(12) 0.9(11) -1.9(11) 
C3 25.6(11) 34.0(12) 36.5(11) 6.3(14) -1.7(12) -4.8(10) 
O1 32(3) 26.6(18) 63(2) 12.4(16) 5.4(19) 1(2) 
C6 32(4) 30(3) 35(2) -6.0(19) -5(3) 9(3) 
O2 42(4) 23.4(17) 33(3) 10(2) 17(2) -7(3) 
C7 31(3) 23.8(19) 31.4(18) 4.7(13) 0(2) 2(2) 
C10 52(3) 26(3) 36(3) -2(3) 15(2) -7(3) 
C9 60(4) 36(3) 37(4) 0(3) 4(3) -7(3) 
C8 45(3) 22(2) 30(2) 9(2) 3(2) -10(2) 
C11 55(3) 21(3) 39(3) 6(3) 5(3) 10(2) 
C15 55(3) 37(4) 43(3) 10(2) -13(2) 11(3) 
C14 48(3) 30(3) 32(3) -1(2) 0(2) 4(2) 
C13 43(3) 22(3) 30(2) 3(2) -5(2) -5(2) 
C16 53(4) 33(4) 42(4) -2(2) -6(3) -5(3) 
  
Table 4. Bond lengths for 150. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
O3 C12 1.44(2) 
 
O1 C6 1.222(6) 
O3 C13 1.30(2) 
 
C6 O2 1.23(2) 
O4 C12 1.236(8) 
 
C6 C7 1.505(8) 
C12 N1 1.322(9) 
 
O2 C8 1.64(2) 
C4 N1 1.467(4) 
 
C10 C8 1.5176(18) 
C4 C3 1.529(5) 
 
C9 C8 1.5179(18) 
C1 N1 1.456(4) 
 
C8 C11 1.5176(18) 
C1 C2 1.516(4) 
 
C15 C13 1.5176(18) 
C2 C3 1.530(3) 
 
C14 C13 1.5178(18) 
C2 C7 1.519(5) 
 
C13 C16 1.5176(18) 
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Table 5. Bond angles for 150. 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
C13 O3 C12 120.4(10) 
 
O2 C6 C7 110.1(7) 
O4 C12 O3 121.9(7) 
 
C6 O2 C8 123.9(9) 
O4 C12 N1 124.6(6) 
 
C6 C7 C2 115.7(5) 
N1 C12 O3 113.4(7) 
 
C10 C8 O2 117.9(9) 
N1 C4 C3 102.2(3) 
 
C10 C8 C9 106.0(9) 
N1 C1 C2 103.8(2) 
 
C9 C8 O2 108.8(10) 
C12 N1 C4 125.0(5) 
 
C11 C8 O2 96.7(9) 
C12 N1 C1 121.5(4) 
 
C11 C8 C10 115.4(10) 
C1 N1 C4 113.4(3) 
 
C11 C8 C9 112.0(11) 
C1 C2 C3 103.0(2) 
 
O3 C13 C15 103.1(10) 
C1 C2 C7 115.3(2) 
 
O3 C13 C14 111.6(11) 
C7 C2 C3 113.2(3) 
 
O3 C13 C16 106.6(11) 
C4 C3 C2 104.9(2) 
 
C15 C13 C14 118.5(10) 
O1 C6 O2 126.3(9) 
 
C15 C13 C16 104.8(10) 
O1 C6 C7 123.5(8) 
 
C16 C13 C14 111.2(11) 
  
Table 6. Torsion angles for 150. 
A B C D Angle/˚ 
 
A B C D Angle/˚ 
O3 C12 N1 C4 -5.4(9) 
 
C3 C4 N1 C12 175.8(4) 
O3 C12 N1 C1 179.5(7) 
 
C3 C4 N1 C1 -8.8(4) 
O4 C12 N1 C4 176.7(5) 
 
C3 C2 C7 C6 -175.8(4) 
O4 C12 N1 C1 1.6(9) 
 
O1 C6 O2 C8 5(2) 
C12 O3 C13 C15 62.8(14) 
 
O1 C6 C7 C2 -14.4(9) 
C12 O3 C13 C14 -65.5(14) 
 
C6 O2 C8 C10 54.4(18) 
C12 O3 C13 C16 172.9(11) 
 
C6 O2 C8 C9 -66.2(16) 
C1 C2 C3 C4 -36.0(3) 
 
C6 O2 C8 C11 177.8(13) 
C1 C2 C7 C6 65.9(5) 
 
O2 C6 C7 C2 168.1(8) 
N1 C4 C3 C2 27.4(4) 
 
C7 C2 C3 C4 -161.2(3) 
N1 C1 C2 C3 29.9(3) 
 
C7 C6 O2 C8 -177.2(10) 
N1 C1 C2 C7 153.6(3) 
 
C13 O3 C12 O4 -10.9(17) 
C2 C1 N1 C12 162.2(4) 
 
C13 O3 C12 N1 171.2(10) 
C2 C1 N1 C4 -13.5(4) 
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Table 7. Hydrogen atom coordinates (Å×104) and isotropic displacement parameters 
(Å2×103) for 150. 
Atom x y z U(eq) 
H4A 2768 2628 5911 39 
H4B 3612 1987 5009 39 
H1A 8125 4709 5004 42 
H1B 6701 5628 5708 42 
H2 5282 4620 4081 37 
H3A 2077 5079 5398 38 
H3B 1732 4135 4528 38 
H7A 3237 7009 4056 35 
H7B 4223 7450 4959 35 
H10A 9795 8809 2590 57 
H10B 9341 10441 2121 57 
H10C 7545 9061 2071 57 
H9A 8766 11112 4329 67 
H9B 10214 11595 3524 67 
H9C 10402 9861 3905 67 
H11A 4631 11074 2715 58 
H11B 6537 12374 2791 58 
H11C 5214 11820 3614 58 
H15A 9507 1529 7292 67 
H15B 9324 -77 7810 67 
H15C 7301 1139 7813 67 
H14A 8249 -1247 5587 55 
H14B 9924 -1696 6331 55 
H14C 10144 -38 5865 55 
H16A 4909 -821 7449 64 
H16B 6777 -2143 7350 64 
H16C 5094 -1802 6592 64 
  
Table 8. Atomic occupancy for 150. 
Atom Occupancy 
 
Atom Occupancy 
 
Atom Occupancy 
O3 0.5 
 
O4 0.5 
 
C12 0.5 
C4 0.5 
 
H4A 0.5 
 
H4B 0.5 
C1 0.5 
 
H1A 0.5 
 
H1B 0.5 
N1 0.5 
 
C2 0.5 
 
H2 0.5 
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C3 0.5 
 
H3A 0.5 
 
H3B 0.5 
O1 0.5 
 
C6 0.5 
 
O2 0.5 
C7 0.5 
 
H7A 0.5 
 
H7B 0.5 
C10 0.5 
 
H10A 0.5 
 
H10B 0.5 
H10C 0.5 
 
C9 0.5 
 
H9A 0.5 
H9B 0.5 
 
H9C 0.5 
 
C8 0.5 
C11 0.5 
 
H11A 0.5 
 
H11B 0.5 
H11C 0.5 
 
C15 0.5 
 
H15A 0.5 
H15B 0.5 
 
H15C 0.5 
 
C14 0.5 
H14A 0.5 
 
H14B 0.5 
 
H14C 0.5 
C13 0.5 
 
C16 0.5 
 
H16A 0.5 
H16B 0.5 
 
H16C 0.5 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
(1S,2S,3S)-2-((tert-Butoxycarbonyl)amino)
acid (33) 
Table 1. Crystal data and structure refinement for 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  
Space group  
a/Å  
b/Å  
c/Å  
α/°  
β/°  
γ/°  
Volume/Å3  
Z  
ρcalcmg/mm3  
m/mm-1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection  
Index ranges  
Reflections collected  
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-3-(methoxycarbonyl)cyclopropane
33.  
C11H17NO6  
259.26  
293.0  
monoclinic  
P21/c  
5.6612(1)  
14.8842(3)  
16.2863(3)  
90  
92.0278(16)  
90  
1371.46(4)  
4  
1.256  
0.874  
552.0  
0.4343 × 0.1419 × 0.082  
CuKα (λ = 1.54184)  
8.04 to 151.28°  
-7 ≤ h ≤ 5, -18 ≤ k ≤ 16, -20 ≤ l ≤
5139  
Appendix 
 
-1-carboxylic 
 
 20  
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Independent reflections  2725 [Rint = 0.0153, Rsigma = 0.0189]  
Data/restraints/parameters  2725/0/169  
Goodness-of-fit on F2  1.086  
Final R indexes [I>=2σ (I)]  R1 = 0.0539, wR2 = 0.1602  
Final R indexes [all data]  R1 = 0.0583, wR2 = 0.1676  
Largest diff. peak/hole / e Å-3  0.20/-0.21  
Flack parameter . 
 
 
Table 2. Fractional atomic coordinates (×104) and equivalent isotropic displacement 
parameters (Å2×103) for 33. Ueq is defined as 1/3 of the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O1 3937(3) 2590.3(8) 190.9(9) 77.6(5) 
O2 6449(2) 2332.2(8) 1279.3(8) 60.9(4) 
O3 8572(3) 6204.0(9) 633.1(9) 74.7(5) 
O4 5295(2) 5429.0(8) 866.1(7) 59.7(4) 
O5 11855(3) 3891.4(13) 2578.9(11) 98.8(7) 
O6 8580(4) 3788.0(13) 3293.1(9) 96.2(7) 
N1 6841(3) 3567.5(9) 551.2(8) 53.8(4) 
C1 8707(3) 3849.6(10) 1100.1(9) 51.0(5) 
C2 9057(3) 4829.9(11) 1281.1(10) 54.5(5) 
C3 8123(3) 4202.8(11) 1929.7(9) 54.4(5) 
C4 5618(3) 2807.6(10) 646.4(10) 53.6(5) 
C5 5324(3) 1497.3(12) 1554.0(13) 66.8(6) 
C6 5702(8) 784.9(17) 921(2) 124.6(17) 
C7 2793(4) 1650(2) 1731(3) 126.9(16) 
C8 6698(5) 1288(2) 2335.9(17) 101.7(10) 
C9 7424(3) 5507.4(10) 915.2(9) 52.4(5) 
C10 9757(4) 3952.8(12) 2621.5(11) 66.7(6) 
C11 10011(8) 3478(3) 3996.8(16) 132.4(17) 
  
Table 3. Anisotropic displacement parameters (Å2×103) for 33. The anisotropic displacement 
factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O1 99.3(10) 47.6(7) 82.8(9) 13.3(6) -39.5(8) -19.6(6) 
O2 60.1(7) 52.3(7) 69.4(7) 20.9(5) -10.2(5) -6.5(5) 
O3 80.7(9) 53.9(7) 88.0(9) 24.1(6) -19.1(7) -16.6(6) 
O4 66.0(7) 53.7(7) 59.0(7) 9.9(5) -4.6(5) 1.3(5) 
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O5 82.4(11) 109.9(13) 101.2(12) 25.8(10) -37.0(9) -3.9(9) 
O6 131.2(15) 104.1(13) 52.4(8) 19.3(7) -9.5(8) 22.3(10) 
N1 70.2(8) 42.3(7) 47.9(7) 7.1(5) -11.2(6) -7.4(6) 
C1 55.4(8) 45.7(8) 51.4(8) 5.0(6) -5.6(6) -0.7(6) 
C2 60.2(9) 47.5(8) 54.9(8) 6.5(6) -11.3(6) -7.7(6) 
C3 65.5(9) 47.9(8) 49.1(8) 6.0(6) -9.2(7) -2.0(7) 
C4 65.3(9) 40.6(8) 54.0(8) 4.4(6) -8.7(7) -0.8(6) 
C5 56.9(9) 51.7(9) 91.4(13) 25.9(9) -0.7(8) -1.4(7) 
C6 190(4) 50.8(13) 133(3) 9.3(14) 8(2) -2.1(16) 
C7 63.0(13) 114(2) 205(4) 80(2) 23.5(16) 10.6(13) 
C8 86.6(15) 106.9(19) 110.9(19) 64.9(16) -7.6(13) -12.0(13) 
C9 69.5(10) 42.5(8) 44.4(7) 1.6(6) -9.4(6) -7.2(6) 
C10 89.4(14) 49.0(9) 59.9(10) 4.7(7) -21.1(9) -1.3(8) 
C11 196(4) 133(3) 65.2(14) 29.5(15) -37.8(18) 23(2) 
  
Table 4. Bond lengths for 33. 
Atom Atom Length/Å 
 
Atom Atom Length/Å 
O1 C4 1.229(2) 
 
N1 C4 1.338(2) 
O2 C4 1.323(2) 
 
C1 C2 1.500(2) 
O2 C5 1.473(2) 
 
C1 C3 1.498(2) 
O3 C9 1.315(2) 
 
C2 C3 1.519(2) 
O4 C9 1.211(2) 
 
C2 C9 1.479(2) 
O5 C10 1.196(3) 
 
C3 C10 1.480(3) 
O6 C10 1.324(3) 
 
C5 C6 1.500(4) 
O6 C11 1.455(4) 
 
C5 C7 1.489(3) 
N1 C1 1.423(2) 
 
C5 C8 1.501(3) 
  
Table 5. Bond angles for 33. 
Atom Atom Atom Angle/˚ 
 
Atom Atom Atom Angle/˚ 
C4 O2 C5 122.83(13) 
 
O2 C4 N1 111.79(14) 
C10 O6 C11 115.3(2) 
 
O2 C5 C6 108.30(19) 
C1 N1 C4 123.53(13) 
 
O2 C5 C7 111.06(17) 
N1 C1 C2 120.03(14) 
 
O2 C5 C8 102.48(16) 
N1 C1 C3 119.19(14) 
 
C6 C5 C7 113.8(3) 
C2 C1 C3 60.87(11) 
 
C6 C5 C8 110.7(2) 
C1 C2 C3 59.48(10) 
 
C7 C5 C8 109.9(2) 
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C1 C2 C9 120.50(14) 
 
O3 C9 O4 123.78(15) 
C3 C2 C9 118.12(14) 
 
O3 C9 C2 111.64(15) 
C1 C3 C2 59.66(10) 
 
O4 C9 C2 124.57(14) 
C1 C3 C10 116.53(15) 
 
O5 C10 O6 124.3(2) 
C2 C3 C10 117.42(15) 
 
O5 C10 C3 124.79(18) 
O1 C4 O2 125.16(15) 
 
O6 C10 C3 110.88(19) 
O1 C4 N1 123.04(15) 
     
  
Table 6. Hydrogen bonds for 33. 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
N1 H1N O41 0.83(2) 2.16(2) 2.9705(18) 167(2) 
O3 H3O O11 0.92(2) 1.72(3) 2.628(2) 172(2) 
C6 H6A O1 0.9600 2.5200 3.090(3) 118.00 
C7 H7B O1 0.9600 2.3500 2.964(5) 121.00 
11-X,1-Y,-Z 
  
Table 7. Torsion angles for 33. 
A B C D Angle/˚ 
 
A B C D Angle/˚ 
N1 C1 C2 C3 108.83(17) 
 
C3 C1 C2 C9 -106.72(17) 
N1 C1 C2 C9 2.1(2) 
 
C3 C2 C9 O3 154.88(14) 
N1 C1 C3 C2 -110.17(16) 
 
C3 C2 C9 O4 -26.3(2) 
N1 C1 C3 C10 142.12(15) 
 
C4 O2 C5 C6 70.1(2) 
C1 N1 C4 O1 176.49(16) 
 
C4 O2 C5 C7 -55.5(3) 
C1 N1 C4 O2 -3.8(2) 
 
C4 O2 C5 C8 -172.87(17) 
C1 C2 C3 C10 106.22(17) 
 
C4 N1 C1 C2 -144.59(16) 
C1 C2 C9 O3 -135.82(15) 
 
C4 N1 C1 C3 -73.3(2) 
C1 C2 C9 O4 43.0(2) 
 
C5 O2 C4 O1 -4.6(3) 
C1 C3 C10 O5 37.2(3) 
 
C5 O2 C4 N1 175.71(14) 
C1 C3 C10 O6 -141.58(16) 
 
C9 C2 C3 C1 110.67(16) 
C2 C1 C3 C10 -107.71(17) 
 
C9 C2 C3 C10 -143.11(15) 
C2 C3 C10 O5 -30.7(3) 
 
C11 O6 C10 O5 -2.7(3) 
C2 C3 C10 O6 150.58(16) 
 
C11 O6 C10 C3 176.1(2) 
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Table 8. Hydrogen atom coordinates (Å×104) and isotropic displacement parameters 
(Å2×103) for 33. 
Atom x y z U(eq) 
H1 10159 3493 1083 61 
H1N 6460(40) 3884(14) 148(14) 65 
H2 10700 5024 1368 65 
H3 6444 4255 2049 65 
H3O 7570(40) 6599(17) 362(16) 90 
H6A 4924 957 412 150 
H6B 5061 226 1105 150 
H6C 7365 716 841 150 
H7A 2112 1101 1923 152 
H7B 1957 1842 1238 152 
H7C 2677 2105 2145 152 
H8A 8355 1271 2230 122 
H8B 6210 716 2542 122 
H8C 6409 1745 2736 122 
H11A 11178 3923 4142 159 
H11B 10783 2926 3859 159 
H11C 9016 3378 4453 159 
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